Quiver News

Apellis Pharmaceuticals Receives FDA Approval for EMPAVELI® as First Treatment for C3 Glomerulopathy and Primary IC-MPGN

43 minutes ago | July 28, 2025 11:30 p.m. UTC

EMPAVELI® approved for treating C3G and primary IC-MPGN, showing significant proteinuria reduction and established safety profile.

Quiver AI Summary

Apellis Pharmaceuticals announced FDA approval for EMPAVELI® (pegcetacoplan), marking the first treatment for C3 glomerulopathy (C3G) and primary immune complex membranoproliferative glomerulonephritis (IC-MPGN) in patients 12 and older, aimed at reducing proteinuria. The approval stems from the Phase 3 VALIANT study, which demonstrated significant efficacy, including a 68% reduction in proteinuria and stabilization of kidney function alongside clearance of C3 deposits. The treatment has a well-established safety profile based on over 2,200 patient years across approved indications. Given the serious nature of C3G and primary IC-MPGN, which can lead to kidney failure, the introduction of EMPAVELI is seen as a crucial advancement in managing these rare kidney diseases.

Potential Positives

EMPAVELI® is the first FDA-approved treatment for C3G and primary IC-MPGN in patients 12 years and older, addressing a significant unmet medical need in rare kidney diseases.
The product demonstrated a groundbreaking 68% reduction in proteinuria, indicating strong efficacy in treating these severe conditions.
The approval enhances Apellis Pharmaceuticals' portfolio, marking their third FDA approval in four years, showcasing their focus and success in complement-based therapies.
EMPAVELI's well-established safety profile is based on over 2,200 patient years of data, contributing to its credibility and potential acceptance in the medical community.

Potential Negatives

Approval of EMPAVELI is contingent upon a Risk Evaluation and Mitigation Strategy (REMS) due to the risk of serious infections caused by encapsulated bacteria, which may limit its accessibility for patients.
The most common adverse reactions reported (≥10%) include infusion site reactions, pyrexia, and nausea, which could deter some patients from using the treatment.
EMPAVELI may cause embryo-fetal harm, requiring pregnancy testing and effective contraception for female patients of reproductive potential, which adds complexity to its administration and could restrict its use among women.

FAQ

What is EMPAVELI® approved for?

EMPAVELI® is approved for treating C3 glomerulopathy (C3G) and primary immune complex membranoproliferative glomerulonephritis (IC-MPGN) in patients 12 and older.

How effective is EMPAVELI®?

EMPAVELI® demonstrated a 68% reduction in proteinuria and stabilization of kidney function in clinical trials.

Who can benefit from EMPAVELI®?

EMPAVELI® is suitable for adults and adolescents with C3G or primary IC-MPGN, including those with post-transplant disease recurrence.

What is the safety profile of EMPAVELI®?

EMPAVELI® has a well-established safety profile based on over 2,200 patient years, with common adverse reactions including infusion site reactions and pyrexia.

When is the conference call to discuss EMPAVELI®?

The conference call will be held tomorrow, July 29, 2025, at 8:00 a.m. ET to discuss the FDA's approval of EMPAVELI®.

Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.

$APLS Insider Trading Activity

$APLS insiders have traded $APLS stock on the open market 17 times in the past 6 months. Of those trades, 0 have been purchases and 17 have been sales.

Here’s a breakdown of recent trading of $APLS stock by insiders over the last 6 months:

CEDRIC FRANCOIS (Chief Executive Officer) has made 0 purchases and 4 sales selling 161,914 shares for an estimated $3,295,201.
DAVID O. WATSON (General Counsel) has made 0 purchases and 4 sales selling 16,264 shares for an estimated $351,908.
PASCAL DESCHATELETS (Chief Scientific Officer) sold 826 shares for an estimated $24,386
NUR NICHOLSON (Chief Technical Officer) sold 825 shares for an estimated $24,356
MARK JEFFREY DELONG (Chief Business & Strat Officer) has made 0 purchases and 2 sales selling 728 shares for an estimated $21,135.
ADAM J. TOWNSEND (Chief Commercial Officer) sold 695 shares for an estimated $20,518
TIMOTHY EUGENE SULLIVAN (Chief Financial Officer) sold 546 shares for an estimated $16,119
KAREN LEWIS (Chief People Officer) sold 364 shares for an estimated $10,746
JEFFREY EISELE (Chief Development Officer) sold 278 shares for an estimated $8,207
JAMES GEORGE CHOPAS (VP/Chief Accounting Officer) sold 183 shares for an estimated $4,542

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$APLS Hedge Fund Activity

We have seen 135 institutional investors add shares of $APLS stock to their portfolio, and 126 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

OCTAGON CAPITAL ADVISORS LP removed 3,006,980 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $65,762,652
AQR CAPITAL MANAGEMENT LLC added 2,220,977 shares (+119.6%) to their portfolio in Q1 2025, for an estimated $48,572,766
BANK OF AMERICA CORP /DE/ added 1,451,223 shares (+86.4%) to their portfolio in Q1 2025, for an estimated $31,738,247
ORBIMED ADVISORS LLC added 1,432,300 shares (+inf%) to their portfolio in Q1 2025, for an estimated $31,324,401
CIBC WORLD MARKETS CORP removed 1,285,300 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $28,109,511
POINT72 ASSET MANAGEMENT, L.P. removed 1,267,958 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $27,730,241
CANADA PENSION PLAN INVESTMENT BOARD added 1,013,500 shares (+2879.3%) to their portfolio in Q1 2025, for an estimated $22,165,245

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$APLS Analyst Ratings

Wall Street analysts have issued reports on $APLS in the last several months. We have seen 7 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Baird issued a "Outperform" rating on 07/18/2025
Citigroup issued a "Buy" rating on 05/22/2025
Raymond James issued a "Outperform" rating on 05/09/2025
Needham issued a "Buy" rating on 05/07/2025
Cantor Fitzgerald issued a "Overweight" rating on 04/29/2025
JP Morgan issued a "Overweight" rating on 03/04/2025
HC Wainwright & Co. issued a "Buy" rating on 03/03/2025

To track analyst ratings and price targets for $APLS, check out Quiver Quantitative's $APLS forecast page.

$APLS Price Targets

Multiple analysts have issued price targets for $APLS recently. We have seen 15 analysts offer price targets for $APLS in the last 6 months, with a median target of $29.0.

Here are some recent targets:

Colleen Kusy from Baird set a target price of $50.0 on 07/18/2025
Tazeen Ahmad from B of A Securities set a target price of $24.0 on 07/16/2025
Judah Frommer from Morgan Stanley set a target price of $26.0 on 07/02/2025
Derek Archila from Wells Fargo set a target price of $29.0 on 06/02/2025
Yigal Nochomovitz from Citigroup set a target price of $41.0 on 05/22/2025
Graig Suvannavejh from Mizuho set a target price of $20.0 on 05/14/2025
Ryan Deschner from Raymond James set a target price of $52.0 on 05/09/2025

Full Release

Proven efficacy across all three key markers of disease—68% reduction in proteinuria, stabilization of kidney function, and substantial clearance of C3 deposits

Broad label includes adults and adolescents with C3G or primary IC-MPGN, and post-transplant C3G disease recurrence

Well-established safety profile, consistent across >2,200 patient years in approved indications

C3G and primary IC-MPGN are rare kidney diseases with high risk of kidney failure

Conference call tomorrow at 8:00 a.m. ET

WALTHAM, Mass., July 28, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the U.S. Food and Drug Administration (FDA) has approved EMPAVELI ^® (pegcetacoplan) as the first treatment for C3 glomerulopathy (C3G) or primary immune complex membranoproliferative glomerulonephritis (IC-MPGN) in patients 12 years of age and older, to reduce proteinuria. C3G and primary IC-MPGN are rare kidney diseases, affecting 5,000 people in the United States. ¹

“I’m excited to now have a highly effective therapy for a broad range of patients living with C3G and primary IC-MPGN,” said Carla Nester, M.D., MSA, FASN, lead principal investigator for the VALIANT study, professor of internal medicine and pediatrics and director of pediatric nephrology, University of Iowa Stead Family Children's Hospital. “With standard of care, patients living with these rare and severe diseases frequently progress to kidney failure, necessitating lifelong dialysis and/or a kidney transplant. Given the urgent need, particularly in children, the approval of EMPAVELI marks a pivotal moment in the treatment of rare kidney diseases.”

In the Phase 3 VALIANT study, EMPAVELI demonstrated an unprecedented 68% reduction in proteinuria, stabilization of kidney function, and substantial clearance of C3 deposits as measured by C3 staining, compared to placebo. The positive results were consistent across adolescent and adult patients with C3G and primary IC-MPGN, and in C3G patients with post-transplant disease recurrence.

“EMPAVELI has the potential to be truly transformational for patients with C3G and primary IC-MPGN, who until now have had very few treatment options. In the largest pivotal study of these diseases, EMPAVELI demonstrated its potential to preserve kidney function by controlling all three key markers of disease,” said Cedric Francois, M.D., Ph.D., co-founder and chief executive officer, Apellis. “As Apellis’ third approval in four years, this milestone underscores the unique ability of targeting C3 to improve patients’ lives. We are deeply grateful to everyone who made this approval possible and look forward to building on this momentum as we advance pivotal studies of EMPAVELI in other rare kidney diseases.”

“The approval of EMPAVELI is a historic milestone for people living with C3G and primary IC-MPGN, many of whom are adolescents or young adults,” said Josh Tarnoff, chief executive officer, NephCure. “We recognize Apellis’ commitment to these patients and their families, and to the research and innovation that will bring this life-changing treatment into the hands of patients that need it most.”

The approval of EMPAVELI is based on positive six-month results from the VALIANT study, demonstrating benefits across all three key markers of disease:

Proteinuria reduction: The study met its primary endpoint, demonstrating a statistically significant 68% (p<0.0001) proteinuria reduction in EMPAVELI-treated patients compared to placebo.
Stabilization of kidney function: EMPAVELI-treated patients achieved stabilization of kidney function compared to placebo (nominal p=0.03) as measured by estimated glomerular filtration rate (eGFR).
Reduction of C3 staining: A majority of EMPAVELI-treated patients achieved a reduction in C3 staining intensity (nominal p<0.0001) compared to placebo. 71% of EMPAVELI-treated patients achieved zero C3 staining intensity, demonstrating complete clearance of C3 deposits.

The safety profile of EMPAVELI is well-established, with >2,200 patient years across all approved indications. The most common adverse reactions in the VALIANT study (≥10%) were infusion site reactions, pyrexia, nasopharyngitis, influenza, cough, and nausea.

Apellis is committed to helping patients with treatment access and support. ApellisAssist ^® is a program designed to help EMPAVELI patients along their treatment journey by providing a comprehensive system of support including help navigating insurance coverage, financial assistance for eligible patients, disease education, and ongoing product support. Patients and healthcare providers can call 1-888-273-5547 for more information.

Conference Call and Webcast
Apellis will host a conference call and webcast to discuss the FDA’s approval of EMPAVELI tomorrow, July 29, 2025 at 8:00 a.m. ET. To access the live call by phone, please pre-register for the call here . A live audio webcast of the event and accompanying slides may also be accessed through the “Events and Presentations” page of the “Investors and Media” section of the company’s website . A replay of the webcast will be available for 30 days following the event.

About C3 Glomerulopathy (C3G) and Primary Immune-Complex Membranoproliferative Glomerulonephritis (IC-MPGN)
C3G and primary IC-MPGN are rare and debilitating kidney diseases that can lead to kidney failure. Excessive C3 deposits are a key marker of disease activity, which can lead to kidney inflammation, damage, and failure. Approximately 50% of people living with C3G and primary IC-MPGN suffer from kidney failure within five to 10 years of diagnosis, requiring a burdensome kidney transplant or lifelong dialysis therapy. ² ^-4 Additionally, approximately 90% of patients who previously received a kidney transplant will experience disease recurrence. ⁵ The diseases are estimated to affect 5,000 people in the United States and up to 8,000 in Europe. ¹

About the VALIANT Study
The VALIANT Phase 3 study ( NCT05067127 ) was a randomized, placebo-controlled, double-blinded, multi-center study that evaluated EMPAVELI® (pegcetacoplan) efficacy and safety in 124 patients who were 12 years of age and older with C3G or primary IC-MPGN. It is the largest single trial conducted in these populations and the only study to include pediatric and adult patients, with native and post-transplant kidneys. Study participants were randomized to receive EMPAVELI or placebo twice weekly for 26 weeks. Following this 26-week randomized controlled period, patients were able to proceed to a 26-week open-label phase in which all patients received EMPAVELI. The primary endpoint of the study was the log transformed ratio of urine protein-to-creatinine ratio (UPCR) at Week 26 compared to baseline.

About EMPAVELI ^® /Aspaveli ^® (pegcetacoplan)
EMPAVELI ^® /Aspaveli ^® (pegcetacoplan) is a targeted C3 therapy designed to regulate excessive activation of the complement cascade, part of the body’s immune system, which can lead to the onset and progression of many serious diseases. It is approved for the treatment of C3 glomerulopathy (C3G) and primary immune complex membranoproliferative glomerulonephritis (IC-MPGN) in the United States and paroxysmal nocturnal hemoglobinuria (PNH) in the United States, European Union, and other countries globally. The therapy is also under investigation for other rare diseases.

U.S. Important Safety Information for EMPAVELI

BOXED WARNING: SERIOUS INFECTIONS CAUSED BY ENCAPSULATED BACTERIA

EMPAVELI, a complement inhibitor, increases the risk of serious infections, especially those caused by encapsulated bacteria, such as Streptococcus pneumoniae , Neisseria meningitidis , and Haemophilus influenzae type B. Life-threatening and fatal infections with encapsulated bacteria have occurred in patients treated with complement inhibitors. These infections may become rapidly life-threatening or fatal if not recognized and treated early.

Complete or update vaccination for encapsulated bacteria at least 2 weeks prior to the first dose of EMPAVELI, unless the risks of delaying therapy with EMPAVELI outweigh the risks of developing a serious infection. Comply with the most current Advisory Committee on Immunization Practices (ACIP) recommendations for vaccinations against encapsulated bacteria in patients receiving a complement inhibitor.
Patients receiving EMPAVELI are at increased risk for invasive disease caused by encapsulated bacteria, even if they develop antibodies following vaccination. Monitor patients for early signs and symptoms of serious infections and evaluate immediately if infection is suspected.

Because of the risk of serious infections caused by encapsulated bacteria, EMPAVELI is available only through a restricted program under a Risk Evaluation and Mitigation Strategy (REMS) called the EMPAVELI REMS.

CONTRAINDICATIONS

Hypersensitivity to pegcetacoplan or to any of the excipients
For initiation in patients with unresolved serious infection caused by encapsulated bacteria including Streptococcus pneumoniae , Neisseria meningitidis , and Haemophilus influenzae type B

WARNINGS AND PRECAUTIONS

Serious Infections Caused by Encapsulated Bacteria

EMPAVELI, a complement inhibitor, increases a patient’s susceptibility to serious, life-threatening, or fatal infections caused by encapsulated bacteria including Streptococcus pneumoniae , Neisseria meningitidis (caused by any serogroup, including non-groupable strains), and Haemophilus influenzae type B. Life-threatening and fatal infections with encapsulated bacteria have occurred in both vaccinated and unvaccinated patients treated with complement inhibitors. The initiation of EMPAVELI treatment is contraindicated in patients with unresolved serious infection caused by encapsulated bacteria.

Complete or update vaccination against encapsulated bacteria at least 2 weeks prior to administration of the first dose of EMPAVELI, according to the most current ACIP recommendations for patients receiving a complement inhibitor. Revaccinate patients in accordance with ACIP recommendations considering the duration of therapy with EMPAVELI. Note that ACIP recommends an administration schedule in patients receiving complement inhibitors that differs from the administration schedule in the vaccine prescribing information. If urgent EMPAVELI therapy is indicated in a patient who is not up to date with vaccines against encapsulated bacteria according to ACIP recommendations, provide the patient with antibacterial drug prophylaxis and administer these vaccines as soon as possible. The benefits and risks of treatment with EMPAVELI, as well as the benefits and risks of antibacterial drug prophylaxis in unvaccinated or vaccinated patients, must be considered against the known risks for serious infections caused by encapsulated bacteria.

Vaccination does not eliminate the risk of serious encapsulated bacterial infections, despite development of antibodies following vaccination. Closely monitor patients for early signs and symptoms of serious infection and evaluate patients immediately if an infection is suspected. Inform patients of these signs and symptoms and instruct patients to seek immediate medical care if these signs and symptoms occur. Promptly treat known infections. Serious infection may become rapidly life-threatening or fatal if not recognized and treated early. Consider interruption of EMPAVELI in patients who are undergoing treatment for serious infections.

EMPAVELI is available only through a restricted program under a REMS.

EMPAVELI REMS

EMPAVELI is available only through a restricted program under a REMS called EMPAVELI REMS, because of the risk of serious infections caused by encapsulated bacteria. Notable requirements of the EMPAVELI REMS include the following:

Under the EMPAVELI REMS, prescribers must enroll in the program. Prescribers must counsel patients about the risks, signs, and symptoms of serious infections caused by encapsulated bacteria, provide patients with the REMS educational materials, ensure patients are vaccinated against encapsulated bacteria at least 2 weeks prior to the first dose of EMPAVELI, prescribe antibacterial drug prophylaxis if patients’ vaccine status is not up to date and treatment must be started urgently, and provide instructions to always carry the Patient Safety Card both during treatment, as well as for 2 months following last dose of EMPAVELI. Pharmacies that dispense EMPAVELI must be certified in the EMPAVELI REMS and must verify prescribers are certified.

Further information is available at www.empavelirems.com or 1-888-343-7073.

Infusion-Related Reactions

Systemic hypersensitivity reactions (eg, facial swelling, rash, urticaria, pyrexia) have occurred in patients treated with EMPAVELI, which may resolve after treatment with antihistamines. Cases of anaphylaxis leading to treatment discontinuation have been reported. If a severe hypersensitivity reaction (including anaphylaxis) occurs, discontinue EMPAVELI infusion immediately, institute appropriate treatment, per standard of care, and monitor until signs and symptoms are resolved.

Interference with Laboratory Tests

There may be interference between silica reagents in coagulation panels and EMPAVELI that results in artificially prolonged activated partial thromboplastin time (aPTT); therefore, avoid the use of silica reagents in coagulation panels.

ADVERSE REACTIONS

Most common adverse reactions in adult and pediatric patients 12 years of age and older with C3G or primary IC-MPGN (incidence ≥10%) were infusion-site reactions, pyrexia, nasopharyngitis, influenza, cough, and nausea.

USE IN SPECIFIC POPULATIONS

Females of Reproductive Potential

EMPAVELI may cause embryo-fetal harm when administered to pregnant women. Pregnancy testing is recommended for females of reproductive potential prior to treatment with EMPAVELI. Advise female patients of reproductive potential to use effective contraception during treatment with EMPAVELI and for 40 days after the last dose.

Please see full Prescribing Information , including Boxed WARNING regarding serious infections caused by encapsulated bacteria, and Medication Guide .

About Apellis

Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company leading the way in complement science to develop life-changing therapies for some of the most challenging diseases patients face. We ushered in the first new class of complement medicine in 15 years and now have two C3-targeting medicines approved to treat four serious diseases. Breakthroughs for patients include the first-ever therapy for geographic atrophy, a leading cause of blindness, and the first treatment for patients 12 and older with C3G or primary IC-MPGN, two severe, rare kidney diseases. We believe we have only begun to unlock the potential of targeting C3 across many serious diseases. For more information, please visit http://apellis.com or follow us on LinkedIn and X .

Apellis Forward-Looking Statement
Statements in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute “forward-looking statements” within the meaning of The Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements regarding the potential market opportunity of EMPAVELI for C3G and IC-MPGN. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will,” “would” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including whether the clinical trial results of EMPAVELI for C3G and IC-MPGN indicate an effect that is greater than the actual positive effect; and any other factors discussed in the “Risk Factors” section of Apellis’ Annual Report on Form 10-K with the Securities and Exchange Commission on February 28, 2025 and the risks described in other filings that Apellis may make with the Securities and Exchange Commission. Any forward-looking statements contained in this press release speak only as of the date hereof, and Apellis specifically disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise.

Media:
Tracy Vineis
media@apellis.com
617.420.4839

Investors:
Neil Carnahan, CFA
neil.carnahan@apellis.com
617.977.5703

References
1. Data on file using literature consensus.
2. Smith RJH, et al. Nat Rev Nephrol . 2019;15(3):129-143.
3. Servais A, et al. Kidney Int . 2012;82(4):454-464.
4. Zand L, et al. J Am Soc Nephrol . 2014;25(5):1110-1117.
5. Tarragón, B, et al. C3 Glomerulopathy Recurs Early after Kidney Transplantation in Serial Biopsies Performed within the First 2 Years after Transplantation. Clinical Journal of the American Society of Nephrology. August 2024; 19(8)1005-1015 . doi: 10.2215/CJN.0000000000000474.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/4fa47f8b-688f-4233-a671-6fe022cb99b7

Read Full Article

Insider Sale: Director at $CRAI Sells 88 Shares

an hour ago | July 28, 2025 11:01 p.m. UTC

Heather Tookes, a director at $CRAI, sold 88 shares of the company on 07-24-2025 for an estimated $15,578. We received data on the trade from a recent SEC filing. This was a sale of approximately 2.8% of their shares of this class of stock. Following this trade, they now own 3,051 shares of this class of $CRAI stock.

$CRAI Insider Trading Activity

$CRAI insiders have traded $CRAI stock on the open market 37 times in the past 6 months. Of those trades, 0 have been purchases and 37 have been sales.

Here’s a breakdown of recent trading of $CRAI stock by insiders over the last 6 months:

PAUL A MALEH (PRESIDENT AND CEO) has made 0 purchases and 23 sales selling 25,000 shares for an estimated $4,693,609.
JONATHAN D YELLIN (EVP AND GENERAL COUNSEL) has made 0 purchases and 8 sales selling 3,500 shares for an estimated $663,208.
THOMAS AIKEN AVERY sold 1,000 shares for an estimated $199,045
DANIEL K. MAHONEY (EVP, CFO AND TREASURER) has made 0 purchases and 3 sales selling 1,000 shares for an estimated $185,802.
HEATHER TOOKES has made 0 purchases and 2 sales selling 212 shares for an estimated $38,995.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$CRAI Hedge Fund Activity

We have seen 94 institutional investors add shares of $CRAI stock to their portfolio, and 98 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

PERTENTO PARTNERS LLP removed 50,606 shares (-18.4%) from their portfolio in Q1 2025, for an estimated $8,764,959
SWEDBANK AB removed 40,000 shares (-44.4%) from their portfolio in Q2 2025, for an estimated $7,494,800
ALLIANZ ASSET MANAGEMENT GMBH removed 35,628 shares (-48.2%) from their portfolio in Q2 2025, for an estimated $6,675,618
JANUS HENDERSON GROUP PLC removed 34,292 shares (-15.4%) from their portfolio in Q1 2025, for an estimated $5,939,374
UNITED CAPITAL FINANCIAL ADVISORS, LLC added 34,228 shares (+68.2%) to their portfolio in Q1 2025, for an estimated $5,928,289
ENVESTNET ASSET MANAGEMENT INC added 30,363 shares (+30.8%) to their portfolio in Q1 2025, for an estimated $5,258,871
OBERWEIS ASSET MANAGEMENT INC/ added 30,000 shares (+inf%) to their portfolio in Q1 2025, for an estimated $5,196,000

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$CRAI Analyst Ratings

Wall Street analysts have issued reports on $CRAI in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Barrington Research issued a "Outperform" rating on 05/21/2025

To track analyst ratings and price targets for $CRAI, check out Quiver Quantitative's $CRAI forecast page.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read Full Article

GBANK FINANCIAL HOLDINGS Earnings Results: $GBFH Reports Quarterly Earnings

an hour ago | July 28, 2025 10:50 p.m. UTC

GBANK FINANCIAL HOLDINGS ($GBFH) posted quarterly earnings results on Monday, July 28th. The company reported earnings of $0.33 per share, missing estimates of $0.40 by $0.07. The company also reported revenue of $17,770,000, beating estimates of $13,056,000 by $4,714,000.

You can see Quiver Quantitative's $GBFH stock page to track data on insider trading, hedge fund activity, congressional trading, and more.

GBANK FINANCIAL HOLDINGS Insider Trading Activity

GBANK FINANCIAL HOLDINGS insiders have traded $GBFH stock on the open market 21 times in the past 6 months. Of those trades, 0 have been purchases and 21 have been sales.

Here’s a breakdown of recent trading of $GBFH stock by insiders over the last 6 months:

CHARLES WILLIAM JR. GRIEGE has made 0 purchases and 2 sales selling 100,000 shares for an estimated $4,200,875.
ALFRED LEE FINLEY has made 0 purchases and 6 sales selling 32,417 shares for an estimated $1,365,431.
EDWARD MICHAEL NIGRO (Executive Chairman) has made 0 purchases and 6 sales selling 34,239 shares for an estimated $1,347,524.
ALAN CURTIS SKLAR has made 0 purchases and 7 sales selling 1,808 shares for an estimated $65,167.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

GBANK FINANCIAL HOLDINGS Hedge Fund Activity

We have seen 4 institutional investors add shares of GBANK FINANCIAL HOLDINGS stock to their portfolio, and 0 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

CHAPIN DAVIS, INC. added 203,600 shares (+inf%) to their portfolio in Q2 2025, for an estimated $7,209,475
RVW WEALTH, LLC added 11,275 shares (+inf%) to their portfolio in Q2 2025, for an estimated $399,247
DESTINY WEALTH PARTNERS, LLC added 10,285 shares (+inf%) to their portfolio in Q2 2025, for an estimated $364,191
FNY INVESTMENT ADVISERS, LLC added 10,000 shares (+166.7%) to their portfolio in Q1 2025, for an estimated $374,000
KENNEDY CAPITAL MANAGEMENT LLC added 0 shares (+0.0%) to their portfolio in Q1 2025, for an estimated $0
EMERALD MUTUAL FUND ADVISERS TRUST added 0 shares (+0.0%) to their portfolio in Q1 2025, for an estimated $0

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read Full Article

BROWN & BROWN Earnings Results: $BRO Reports Quarterly Earnings

an hour ago | July 28, 2025 10:50 p.m. UTC

BROWN & BROWN ($BRO) posted quarterly earnings results on Monday, July 28th. The company reported earnings of $1.03 per share, beating estimates of $1.00 by $0.03. The company also reported revenue of $1,285,000,000, missing estimates of $1,291,606,180 by $-6,606,180.

You can see Quiver Quantitative's $BRO stock page to track data on insider trading, hedge fund activity, congressional trading, and more.

BROWN & BROWN Hedge Fund Activity

We have seen 440 institutional investors add shares of BROWN & BROWN stock to their portfolio, and 413 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

PARNASSUS INVESTMENTS, LLC added 7,227,805 shares (+inf%) to their portfolio in Q1 2025, for an estimated $899,138,942
CAPITAL WORLD INVESTORS added 4,069,273 shares (+97.0%) to their portfolio in Q1 2025, for an estimated $506,217,561
SELECT EQUITY GROUP, L.P. removed 1,704,535 shares (-21.4%) from their portfolio in Q1 2025, for an estimated $212,044,154
FIRST TRUST ADVISORS LP removed 1,693,872 shares (-72.1%) from their portfolio in Q1 2025, for an estimated $210,717,676
MORGAN STANLEY removed 1,174,686 shares (-13.7%) from their portfolio in Q1 2025, for an estimated $146,130,938
GAMMA INVESTING LLC removed 1,103,823 shares (-99.2%) from their portfolio in Q2 2025, for an estimated $122,380,856
PROFICIO CAPITAL PARTNERS LLC removed 1,098,089 shares (-99.0%) from their portfolio in Q1 2025, for an estimated $136,602,271

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

BROWN & BROWN Congressional Stock Trading

Members of Congress have traded $BRO stock 5 times in the past 6 months. Of those trades, 2 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $BRO stock by members of Congress over the last 6 months:

REPRESENTATIVE BYRON DONALDS has traded it 2 times. They made 2 purchases worth up to $30,000 on 03/20 and 0 sales.
REPRESENTATIVE APRIL MCCLAIN DELANEY has traded it 3 times. They made 0 purchases and 3 sales worth up to $45,000 on 02/10, 02/06, 02/05.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

BROWN & BROWN Analyst Ratings

Wall Street analysts have issued reports on $BRO in the last several months. We have seen 3 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

Keefe, Bruyette & Woods issued a "Underperform" rating on 07/09/2025
BMO Capital issued a "Outperform" rating on 06/12/2025
Wells Fargo issued a "Overweight" rating on 06/12/2025
Truist Securities issued a "Buy" rating on 04/30/2025

To track analyst ratings and price targets for BROWN & BROWN, check out Quiver Quantitative's $BRO forecast page.

BROWN & BROWN Price Targets

Multiple analysts have issued price targets for $BRO recently. We have seen 9 analysts offer price targets for $BRO in the last 6 months, with a median target of $120.0.

Here are some recent targets:

Meyer Shields from Keefe, Bruyette & Woods set a target price of $104.0 on 07/09/2025
Alex Scott from Barclays set a target price of $111.0 on 07/07/2025
Michael Zaremski from BMO Capital set a target price of $122.0 on 06/12/2025
Elyse Greenspan from Wells Fargo set a target price of $127.0 on 06/12/2025
Robert Cox from Goldman Sachs set a target price of $119.0 on 05/13/2025
Mark Hughes from Truist Securities set a target price of $130.0 on 04/30/2025
Yaron Kinar from Jefferies set a target price of $109.0 on 04/11/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read Full Article

HOMESTREET Earnings Results: $HMST Reports Quarterly Earnings

an hour ago | July 28, 2025 10:50 p.m. UTC

HOMESTREET ($HMST) posted quarterly earnings results on Monday, July 28th. The company reported earnings of -$0.16 per share, missing estimates of $0.04 by $0.20. The company also reported revenue of $48,970,000, missing estimates of $49,163,490 by $-193,490.

You can see Quiver Quantitative's $HMST stock page to track data on insider trading, hedge fund activity, congressional trading, and more.

HOMESTREET Hedge Fund Activity

We have seen 48 institutional investors add shares of HOMESTREET stock to their portfolio, and 53 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

ENDEAVOUR CAPITAL ADVISORS INC removed 723,747 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $8,496,789
SCULPTOR CAPITAL LP added 407,271 shares (+inf%) to their portfolio in Q1 2025, for an estimated $4,781,361
STIEVEN CAPITAL ADVISORS, L.P. added 300,000 shares (+inf%) to their portfolio in Q1 2025, for an estimated $3,522,000
BASSWOOD CAPITAL MANAGEMENT, L.L.C. removed 286,130 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $3,359,166
WELLINGTON MANAGEMENT GROUP LLP added 261,759 shares (+28.5%) to their portfolio in Q1 2025, for an estimated $3,073,050
GATOR CAPITAL MANAGEMENT, LLC added 189,024 shares (+inf%) to their portfolio in Q1 2025, for an estimated $2,219,141
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 113,812 shares (+168.1%) to their portfolio in Q1 2025, for an estimated $1,336,152

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

HOMESTREET Price Targets

Multiple analysts have issued price targets for $HMST recently. We have seen 2 analysts offer price targets for $HMST in the last 6 months, with a median target of $13.75.

Here are some recent targets:

Wood Lay from Keefe, Bruyette & Woods set a target price of $13.5 on 05/07/2025
Matthew Clark from Piper Sandler set a target price of $14.0 on 04/01/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read Full Article

NATIONAL OILWELL VARCO Earnings Results: $NOV Reports Quarterly Earnings

an hour ago | July 28, 2025 10:50 p.m. UTC

NATIONAL OILWELL VARCO ($NOV) posted quarterly earnings results on Monday, July 28th. The company reported earnings of $0.29 per share, missing estimates of $0.30 by $0.01. The company also reported revenue of $2,188,000,000, beating estimates of $2,165,340,575 by $22,659,425.

You can see Quiver Quantitative's $NOV stock page to track data on insider trading, hedge fund activity, congressional trading, and more.

NATIONAL OILWELL VARCO Hedge Fund Activity

We have seen 223 institutional investors add shares of NATIONAL OILWELL VARCO stock to their portfolio, and 216 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

PACER ADVISORS, INC. removed 7,358,552 shares (-59.8%) from their portfolio in Q1 2025, for an estimated $111,997,161
AMERIPRISE FINANCIAL INC removed 5,087,705 shares (-89.0%) from their portfolio in Q1 2025, for an estimated $77,434,870
BANK OF NEW YORK MELLON CORP removed 4,657,393 shares (-51.8%) from their portfolio in Q1 2025, for an estimated $70,885,521
AQR CAPITAL MANAGEMENT LLC added 3,362,853 shares (+88.9%) to their portfolio in Q1 2025, for an estimated $51,182,622
FIRST TRUST ADVISORS LP added 3,292,990 shares (+220.1%) to their portfolio in Q1 2025, for an estimated $50,119,307
ARIEL INVESTMENTS, LLC removed 2,294,639 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $34,924,405
DEPRINCE RACE & ZOLLO INC removed 1,983,938 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $30,195,536

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

NATIONAL OILWELL VARCO Analyst Ratings

Wall Street analysts have issued reports on $NOV in the last several months. We have seen 6 firms issue buy ratings on the stock, and 3 firms issue sell ratings.

Here are some recent analyst ratings:

Stifel issued a "Buy" rating on 07/16/2025
Susquehanna issued a "Positive" rating on 07/01/2025
Wells Fargo issued a "Underweight" rating on 06/05/2025
Morgan Stanley issued a "Overweight" rating on 05/16/2025
Barclays issued a "Underweight" rating on 04/30/2025
JP Morgan issued a "Overweight" rating on 04/30/2025
RBC Capital issued a "Outperform" rating on 04/30/2025

To track analyst ratings and price targets for NATIONAL OILWELL VARCO, check out Quiver Quantitative's $NOV forecast page.

NATIONAL OILWELL VARCO Price Targets

Multiple analysts have issued price targets for $NOV recently. We have seen 10 analysts offer price targets for $NOV in the last 6 months, with a median target of $16.5.

Here are some recent targets:

Stephen Gengaro from Stifel set a target price of $22.0 on 07/16/2025
Charles Minervino from Susquehanna set a target price of $18.0 on 07/01/2025
Roger Read from Wells Fargo set a target price of $10.0 on 06/05/2025
Elizabeth Porter from Morgan Stanley set a target price of $15.0 on 05/16/2025
Luke Lemoine from Piper Sandler set a target price of $16.0 on 05/01/2025
David Anderson from Barclays set a target price of $11.0 on 04/30/2025
Arun Jayaram from JP Morgan set a target price of $17.0 on 04/30/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read Full Article

NORTHEAST BANK Earnings Results: $NBN Reports Quarterly Earnings

an hour ago | July 28, 2025 10:50 p.m. UTC

NORTHEAST BANK ($NBN) posted quarterly earnings results on Monday, July 28th. The company reported earnings of $3.00 per share, beating estimates of $2.59 by $0.41. The company also reported revenue of $62,700,000, beating estimates of $57,069,040 by $5,630,960.

You can see Quiver Quantitative's $NBN stock page to track data on insider trading, hedge fund activity, congressional trading, and more.

NORTHEAST BANK Hedge Fund Activity

We have seen 65 institutional investors add shares of NORTHEAST BANK stock to their portfolio, and 69 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

STATE STREET CORP added 61,959 shares (+40.5%) to their portfolio in Q1 2025, for an estimated $5,671,726
ROYCE & ASSOCIATES LP added 45,893 shares (+87.3%) to their portfolio in Q1 2025, for an estimated $4,201,045
DIMENSIONAL FUND ADVISORS LP removed 40,307 shares (-10.4%) from their portfolio in Q1 2025, for an estimated $3,689,702
GW&K INVESTMENT MANAGEMENT, LLC added 40,145 shares (+31.7%) to their portfolio in Q1 2025, for an estimated $3,674,873
JPMORGAN CHASE & CO removed 37,419 shares (-63.2%) from their portfolio in Q1 2025, for an estimated $3,425,335
CITADEL ADVISORS LLC removed 30,009 shares (-88.4%) from their portfolio in Q1 2025, for an estimated $2,747,023
QUBE RESEARCH & TECHNOLOGIES LTD added 26,812 shares (+215.9%) to their portfolio in Q1 2025, for an estimated $2,454,370

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read Full Article

CNO FINANCIAL GROUP Earnings Results: $CNO Reports Quarterly Earnings

an hour ago | July 28, 2025 10:50 p.m. UTC

CNO FINANCIAL GROUP ($CNO) posted quarterly earnings results on Monday, July 28th. The company reported earnings of $0.87 per share, beating estimates of $0.86 by $0.01. The company also reported revenue of $1,151,500,000, beating estimates of $988,428,420 by $163,071,580.

You can see Quiver Quantitative's $CNO stock page to track data on insider trading, hedge fund activity, congressional trading, and more.

CNO FINANCIAL GROUP Insider Trading Activity

CNO FINANCIAL GROUP insiders have traded $CNO stock on the open market 13 times in the past 6 months. Of those trades, 0 have been purchases and 13 have been sales.

Here’s a breakdown of recent trading of $CNO stock by insiders over the last 6 months:

GARY C BHOJWANI (Chief Executive Officer) has made 0 purchases and 5 sales selling 114,034 shares for an estimated $4,676,711.
MATTHEW J. ZIMPFER (General Counsel) has made 0 purchases and 2 sales selling 81,600 shares for an estimated $3,329,182.
SCOTT L. GOLDBERG (President, Consumer Division) has made 0 purchases and 2 sales selling 51,000 shares for an estimated $2,043,294.
MICHAEL E. MEAD (Chief Information Officer) has made 0 purchases and 2 sales selling 24,970 shares for an estimated $950,902.
YVONNE K FRANZESE (Chief Human Resources Officer) has made 0 purchases and 2 sales selling 10,206 shares for an estimated $429,826.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

CNO FINANCIAL GROUP Hedge Fund Activity

We have seen 148 institutional investors add shares of CNO FINANCIAL GROUP stock to their portfolio, and 168 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

FIRST TRUST ADVISORS LP added 1,400,588 shares (+903.6%) to their portfolio in Q1 2025, for an estimated $58,334,490
VANGUARD GROUP INC removed 757,582 shares (-5.7%) from their portfolio in Q1 2025, for an estimated $31,553,290
ALLIANZ ASSET MANAGEMENT GMBH added 641,950 shares (+70.9%) to their portfolio in Q2 2025, for an estimated $24,766,431
ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC added 561,327 shares (+72.7%) to their portfolio in Q2 2025, for an estimated $21,655,995
BLACKROCK, INC. removed 426,563 shares (-2.9%) from their portfolio in Q1 2025, for an estimated $17,766,348
JPMORGAN CHASE & CO removed 359,747 shares (-28.2%) from their portfolio in Q1 2025, for an estimated $14,983,462
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC removed 327,712 shares (-33.6%) from their portfolio in Q1 2025, for an estimated $13,649,204

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

CNO FINANCIAL GROUP Congressional Stock Trading

Members of Congress have traded $CNO stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $CNO stock by members of Congress over the last 6 months:

REPRESENTATIVE JEFFERSON SHREVE sold up to $50,000 on 05/12.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

CNO FINANCIAL GROUP Analyst Ratings

Wall Street analysts have issued reports on $CNO in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Piper Sandler issued a "Overweight" rating on 04/02/2025
RBC Capital issued a "Outperform" rating on 02/10/2025

To track analyst ratings and price targets for CNO FINANCIAL GROUP, check out Quiver Quantitative's $CNO forecast page.

CNO FINANCIAL GROUP Price Targets

Multiple analysts have issued price targets for $CNO recently. We have seen 3 analysts offer price targets for $CNO in the last 6 months, with a median target of $45.0.

Here are some recent targets:

John Barnidge from Piper Sandler set a target price of $49.0 on 04/02/2025
Ryan Krueger from Keefe, Bruyette & Woods set a target price of $44.0 on 02/12/2025
Scott Heleniak from RBC Capital set a target price of $45.0 on 02/10/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read Full Article

TILRAY Earnings Results: $TLRY Reports Quarterly Earnings

an hour ago | July 28, 2025 10:50 p.m. UTC

TILRAY ($TLRY) posted quarterly earnings results on Monday, July 28th. The company reported earnings of $0.02 per share, beating estimates of -$0.02 by $0.04. The company also reported revenue of $224,540,000, missing estimates of $242,040,900 by $-17,500,900.

You can see Quiver Quantitative's $TLRY stock page to track data on insider trading, hedge fund activity, congressional trading, and more.

TILRAY Hedge Fund Activity

We have seen 118 institutional investors add shares of TILRAY stock to their portfolio, and 143 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

TIDAL INVESTMENTS LLC added 14,600,161 shares (+137.8%) to their portfolio in Q1 2025, for an estimated $9,599,605
HIGHBRIDGE CAPITAL MANAGEMENT LLC removed 6,810,500 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $4,477,903
SUSQUEHANNA INTERNATIONAL GROUP, LLP removed 5,554,478 shares (-53.0%) from their portfolio in Q1 2025, for an estimated $3,652,069
UBS GROUP AG added 2,425,519 shares (+97.5%) to their portfolio in Q1 2025, for an estimated $1,594,778
CITADEL ADVISORS LLC removed 2,416,715 shares (-88.5%) from their portfolio in Q1 2025, for an estimated $1,588,990
JANE STREET GROUP, LLC removed 2,347,191 shares (-94.3%) from their portfolio in Q1 2025, for an estimated $1,543,278
GEODE CAPITAL MANAGEMENT, LLC removed 1,923,396 shares (-79.9%) from their portfolio in Q1 2025, for an estimated $1,264,632

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read Full Article

H20 AMERICA Earnings Results: $HTO Reports Quarterly Earnings

an hour ago | July 28, 2025 10:50 p.m. UTC

H20 AMERICA ($HTO) posted quarterly earnings results on Monday, July 28th. The company reported earnings of $0.75 per share, beating estimates of $0.70 by $0.05. The company also reported revenue of $198,260,000, beating estimates of $189,206,663 by $9,053,337.

You can see Quiver Quantitative's $HTO stock page to track data on insider trading, hedge fund activity, congressional trading, and more.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read Full Article

RANGER ENERGY SERVICES Earnings Results: $RNGR Reports Quarterly Earnings

an hour ago | July 28, 2025 10:50 p.m. UTC

RANGER ENERGY SERVICES ($RNGR) posted quarterly earnings results on Monday, July 28th. The company reported earnings of $0.32 per share, beating estimates of $0.22 by $0.10. The company also reported revenue of $140,600,000, missing estimates of $142,800,000 by $-2,200,000.

You can see Quiver Quantitative's $RNGR stock page to track data on insider trading, hedge fund activity, congressional trading, and more.

RANGER ENERGY SERVICES Insider Trading Activity

RANGER ENERGY SERVICES insiders have traded $RNGR stock on the open market 8 times in the past 6 months. Of those trades, 0 have been purchases and 8 have been sales.

Here’s a breakdown of recent trading of $RNGR stock by insiders over the last 6 months:

BRETT T. AGEE has made 0 purchases and 8 sales selling 166,644 shares for an estimated $2,377,722.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

RANGER ENERGY SERVICES Hedge Fund Activity

We have seen 55 institutional investors add shares of RANGER ENERGY SERVICES stock to their portfolio, and 61 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

JACOBS LEVY EQUITY MANAGEMENT, INC added 150,996 shares (+inf%) to their portfolio in Q1 2025, for an estimated $2,142,633
CITADEL ADVISORS LLC added 113,675 shares (+inf%) to their portfolio in Q1 2025, for an estimated $1,613,048
ROYCE & ASSOCIATES LP removed 104,790 shares (-10.1%) from their portfolio in Q1 2025, for an estimated $1,486,970
ALLIANCEBERNSTEIN L.P. added 101,460 shares (+100.1%) to their portfolio in Q1 2025, for an estimated $1,439,717
FRANKLIN RESOURCES INC removed 94,183 shares (-27.7%) from their portfolio in Q1 2025, for an estimated $1,336,456
PRUDENTIAL FINANCIAL INC removed 87,317 shares (-39.8%) from their portfolio in Q1 2025, for an estimated $1,239,028
DIMENSIONAL FUND ADVISORS LP added 73,459 shares (+7.1%) to their portfolio in Q1 2025, for an estimated $1,042,383

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read Full Article

Insider Sale: Director at $TDY Sells 1,378 Shares

an hour ago | July 28, 2025 10:45 p.m. UTC

SIMON M LORNE, a director at $TDY, sold 1,378 shares of the company on 07-25-2025 for an estimated $758,416. We received data on the trade from a recent SEC filing. This was a sale of approximately 2.2% of their shares of this class of stock. Following this trade, they now own 62,313 shares of this class of $TDY stock.

$TDY Insider Trading Activity

$TDY insiders have traded $TDY stock on the open market 16 times in the past 6 months. Of those trades, 0 have been purchases and 16 have been sales.

Here’s a breakdown of recent trading of $TDY stock by insiders over the last 6 months:

ROBERT MEHRABIAN (Executive Chairman) has made 0 purchases and 7 sales selling 37,305 shares for an estimated $19,142,729.
MELANIE SUSAN CIBIK (EVP, GenCounsel, CCO & Sec.) has made 0 purchases and 4 sales selling 10,808 shares for an estimated $5,527,348.
SIMON M LORNE has made 0 purchases and 3 sales selling 6,311 shares for an estimated $3,468,792.
JASON VANWEES (Vice Chairman) sold 3,700 shares for an estimated $1,924,204
MICHAEL T SMITH sold 2,100 shares for an estimated $1,072,050

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$TDY Hedge Fund Activity

We have seen 349 institutional investors add shares of $TDY stock to their portfolio, and 317 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

GAMMA INVESTING LLC removed 495,653 shares (-99.8%) from their portfolio in Q2 2025, for an estimated $253,927,988
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 394,718 shares (-30.1%) from their portfolio in Q1 2025, for an estimated $196,455,095
FIL LTD added 251,057 shares (+96.5%) to their portfolio in Q1 2025, for an estimated $124,953,579
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 232,401 shares (+56.9%) to their portfolio in Q1 2025, for an estimated $115,668,301
CONGRESS ASSET MANAGEMENT CO removed 208,838 shares (-98.6%) from their portfolio in Q2 2025, for an estimated $106,989,795
BLACKROCK, INC. added 199,262 shares (+5.2%) to their portfolio in Q1 2025, for an estimated $99,174,690
MILLENNIUM MANAGEMENT LLC removed 178,152 shares (-83.2%) from their portfolio in Q1 2025, for an estimated $88,668,031

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$TDY Congressional Stock Trading

Members of Congress have traded $TDY stock 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $TDY stock by members of Congress over the last 6 months:

REPRESENTATIVE ROBERT BRESNAHAN purchased up to $15,000 on 04/08.
REPRESENTATIVE APRIL MCCLAIN DELANEY sold up to $50,000 on 02/22.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$TDY Analyst Ratings

Wall Street analysts have issued reports on $TDY in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

UBS issued a "Buy" rating on 07/24/2025
Stifel issued a "Buy" rating on 06/24/2025
TD Securities issued a "Buy" rating on 04/24/2025
Needham issued a "Buy" rating on 04/24/2025
B of A Securities issued a "Buy" rating on 03/17/2025

To track analyst ratings and price targets for $TDY, check out Quiver Quantitative's $TDY forecast page.

$TDY Price Targets

Multiple analysts have issued price targets for $TDY recently. We have seen 6 analysts offer price targets for $TDY in the last 6 months, with a median target of $590.0.

Here are some recent targets:

Damian Karas from UBS set a target price of $630.0 on 07/24/2025
Kristine Liwag from Morgan Stanley set a target price of $580.0 on 07/17/2025
Jonathan Siegmann from Stifel set a target price of $626.0 on 06/24/2025
Joe Giordano from TD Securities set a target price of $550.0 on 04/24/2025
James Ricchiuti from Needham set a target price of $550.0 on 04/24/2025
Ronald Epstein from B of A Securities set a target price of $600.0 on 03/17/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read Full Article

Press Release: Risch Introduces Legislation to Reduce Federal Regulations and Promote Energy Production

an hour ago | July 28, 2025 10:22 p.m. UTC

Senator Risch introduces legislation aimed at reducing federal regulations to enhance American energy production and efficiency.

Quiver AI Summary

U.S. Senator Jim Risch (R-Idaho) has introduced the Zero-Based Regulatory Budgeting to Unleash American Energy Act, aiming to streamline federal regulations impacting energy projects. Risch stated, "Idahoans are tired of the federal government delaying critical energy projects," asserting the legislation supports President Trump's goals to enhance American energy production.

The proposed act mandates that the Department of Energy, the Department of Interior, and the Federal Energy Regulatory Commission review and potentially sunset existing energy regulations. It allows regulations to be extended for five years only after public review and requires that new regulations also include a five-year sunset provision.

This initiative follows Risch's previous efforts to reduce federal regulations through the Zero-Based Regulations Act and to address national debt with the Zero-Based Budget Act. He emphasizes eliminating "unnecessary and costly regulations" to promote responsible resource use in Idaho.

Disclaimer: This is an AI-generated summary of a press release. The model used to summarize this release may make mistakes. See the full release here.

James E. Risch Net Worth

Quiver Quantitative estimates that James E. Risch is worth $54.9M, as of July 28th, 2025. This is the 22nd highest net worth in Congress, per our live estimates.

Risch has approximately $945.7K invested in publicly traded assets which Quiver is able to track live.

You can track James E. Risch's net worth on Quiver Quantitative's politician page for Risch.

James E. Risch Bill Proposals

Here are some bills which have recently been proposed by James E. Risch:

S.2427: A bill to require certain agencies to impose extendable sunset dates on certain regulations, and for other purposes.
S.2401: A bill to amend section 287(g) of the Immigration and Nationality Act to clarify congressional intent with respect to agreements under such section, and for other purposes.
S.2251: Say No to Indoctrination Act
S.1902: ETAP Act of 2025
S.1801: International Nuclear Energy Act of 2025
S.1774: Protecting Minors in Federal Health Plans Act

You can track bills proposed by James E. Risch on Quiver Quantitative's politician page for Risch.

James E. Risch Fundraising

James E. Risch recently disclosed $520.8K of fundraising in a Q2 FEC disclosure filed on July 15th, 2025. This was the 142nd most from all Q2 reports we have seen this year. 72.8% came from individual donors.

Risch disclosed $163.1K of spending. This was the 341st most from all Q2 reports we have seen from politicians so far this year.

Risch disclosed $2.9M of cash on hand at the end of the filing period. This was the 97th most from all Q2 reports we have seen this year.

You can see the disclosure here, or track James E. Risch's fundraising on Quiver Quantitative.

Read Full Article

Press Release: Pressley, Lynch, and Moulton Urge Republic Services to Negotiate Fair Contract for Teamsters Local 25

an hour ago | July 28, 2025 10:22 p.m. UTC

Massachusetts lawmakers urge Republic Services to negotiate a fair contract for striking Teamsters Local 25 workers.

Quiver AI Summary

Massachusetts lawmakers, including Congresswoman Ayanna Pressley and Congressmen Stephen Lynch and Seth Moulton, have sent a letter urging Republic Services to negotiate a fair contract with Teamsters Local 25, whose members have been on strike for weeks. The lawmakers emphasized the importance of fair wages and benefits for essential municipal services workers.

In their letter, the lawmakers requested that Republic Services CEO Jon Vander Ark return to negotiations without delay, highlighting that the contract should reflect the workers' contributions and ensure safe working conditions. They conveyed that the workers seek wages and benefits in line with industry standards.

Teamsters Local 25 President Tom Mari expressed gratitude for the lawmakers' support and stated: “All we want...is to have the Republic employees...enjoy the same wages and benefits...Republic refuses to treat its employees with dignity and respect.” A copy of the letter is available for public viewing.

Disclaimer: This is an AI-generated summary of a press release. The model used to summarize this release may make mistakes. See the full release here.

Ayanna Pressley Net Worth

Quiver Quantitative estimates that Ayanna Pressley is worth $5.2M, as of July 28th, 2025. This is the 144th highest net worth in Congress, per our live estimates.

Pressley has approximately $0 invested in publicly traded assets which Quiver is able to track live.

You can track Ayanna Pressley's net worth on Quiver Quantitative's politician page for Pressley.

Ayanna Pressley Bill Proposals

Here are some bills which have recently been proposed by Ayanna Pressley:

H.R.4719: To direct the Secretary of Transportation to carry out a grant program to support efforts to provide fare-free transit service, and for other purposes.
H.R.4611: To ensure affordable abortion coverage and care for every person, and for other purposes.
H.R.4524: To amend titles 5, 31, and 44, United States Code, to improve the equitable provision of services to underserved communities and individuals, to establish an Agency Equity Advisory Team, and for other purposes.
H.R.4111: MASS Act
H.R.3603: Andrew Kearse Accountability for Denial of Medical Care Act of 2025
H.R.3602: Ending Qualified Immunity Act

You can track bills proposed by Ayanna Pressley on Quiver Quantitative's politician page for Pressley.

Ayanna Pressley Fundraising

Ayanna Pressley recently disclosed $106.3K of fundraising in a Q2 FEC disclosure filed on July 15th, 2025. This was the 602nd most from all Q2 reports we have seen this year. 92.0% came from individual donors.

Pressley disclosed $163.2K of spending. This was the 339th most from all Q2 reports we have seen from politicians so far this year.

Pressley disclosed $125.1K of cash on hand at the end of the filing period. This was the 749th most from all Q2 reports we have seen this year.

You can see the disclosure here, or track Ayanna Pressley's fundraising on Quiver Quantitative.

Read Full Article

Press Release: Dingell Seeks Clarity from EGLE Regarding Gelman Plume Contamination Concerns

an hour ago | July 28, 2025 10:22 p.m. UTC

Dingell seeks clarification from EGLE on the Gelman plume's contaminating spread affecting local drinking water sources.

Quiver AI Summary

Congresswoman Debbie Dingell has expressed concerns to the Michigan Department of Environment, Great Lakes, and Energy (EGLE) regarding the spreading Gelman plume, following new dioxane detections impacting at least 52 residential wells. She noted that these findings bring contamination closer to vital water sources in Ann Arbor.

Dingell's letter highlights that 47 out of 117 tested wells showed detectable dioxane levels, raising alarms about the inadequacy of current cleanup efforts and Michigan's legal standards, which some experts argue do not adequately protect public health.

She has requested answers about the plume's current situation, protective measures for residents, plans for future testing sensitivity, and improved communication regarding health risks associated with dioxane, emphasizing the need for coordinated action among federal, state, and local authorities.

Disclaimer: This is an AI-generated summary of a press release. The model used to summarize this release may make mistakes. See the full release here.

Debbie Dingell Net Worth

Quiver Quantitative estimates that Debbie Dingell is worth $14.5M, as of July 28th, 2025. This is the 73rd highest net worth in Congress, per our live estimates.

Dingell has approximately $7.6M invested in publicly traded assets which Quiver is able to track live.

You can track Debbie Dingell's net worth on Quiver Quantitative's politician page for Dingell.

Debbie Dingell Bill Proposals

Here are some bills which have recently been proposed by Debbie Dingell:

H.R.4166: To amend title 18, United States Code, to define intimate partner to include someone with whom there is or was a dating relationship, and for other purposes.
H.R.4127: Tech Safety for Victims of Domestic Violence, Dating Violence, Sexual Assault, and Stalking Act
H.R.4029: To provide for an emergency increase in Federal funding to State Medicaid programs for expenditures on home and community-based services.
H.R.4028: Stabilize Medicaid and CHIP Coverage Act
H.R.3858: Sport Fish Restoration, Recreational Boating Safety, and Wildlife Restoration Act of 2025
H.R.3714: Forage Fish Conservation Act of 2025

You can track bills proposed by Debbie Dingell on Quiver Quantitative's politician page for Dingell.

Debbie Dingell Fundraising

Debbie Dingell recently disclosed $207.9K of fundraising in a Q2 FEC disclosure filed on July 15th, 2025. This was the 416th most from all Q2 reports we have seen this year. 36.3% came from individual donors.

Dingell disclosed $179.3K of spending. This was the 300th most from all Q2 reports we have seen from politicians so far this year.

Dingell disclosed $352.5K of cash on hand at the end of the filing period. This was the 547th most from all Q2 reports we have seen this year.

You can see the disclosure here, or track Debbie Dingell's fundraising on Quiver Quantitative.

Read Full Article

Press Release: Byron Donalds Launches Initiative to Modernize Cape Canaveral Space Launch Complex 37

an hour ago | July 28, 2025 10:22 p.m. UTC

Congressman Byron Donalds promotes modernization of Cape Canaveral's Launch Site 37 to enhance America's space capabilities.

Quiver AI Summary

U.S. Congressman Byron Donalds has urged the Secretary of the Air Force, Troy Meink, to expedite modernization efforts at Cape Canaveral Space Launch Complex 37 (SLC-37). He highlighted the importance of updating the site, which currently sits idle, to maintain America's competitive edge in space.

The Air Force plans to demolish outdated infrastructure at SLC-37, but further construction for new capabilities awaits approval. Donalds' initiative, supported by Senator Ashley Moody, aims to ensure timely upgrades and operational readiness at the launch site.

Donalds expressed concern that delays could hinder national security and the U.S.'s access to space, calling for quicker action under existing guidelines to support the modernization of the site.

Disclaimer: This is an AI-generated summary of a press release. The model used to summarize this release may make mistakes. See the full release here.

Byron Donalds Net Worth

Quiver Quantitative estimates that Byron Donalds is worth $1.5M, as of July 28th, 2025. This is the 253rd highest net worth in Congress, per our live estimates.

Donalds has approximately $906.7K invested in publicly traded assets which Quiver is able to track live.

You can track Byron Donalds's net worth on Quiver Quantitative's politician page for Donalds.

Byron Donalds Bill Proposals

Here are some bills which have recently been proposed by Byron Donalds:

H.R.4494: To amend the Internal Revenue Code of 1986 to provide an above-the-line deduction for flood insurance premiums.
H.R.3667: Strengthening American Nuclear Energy Act
H.R.3626: International Nuclear Energy Act of 2025
H.R.3433: WILD Act of 2025
H.R.2835: Small Bank Holding Company Relief Act
H.R.2544: Financial Freedom Act of 2025

You can track bills proposed by Byron Donalds on Quiver Quantitative's politician page for Donalds.

Byron Donalds Fundraising

Byron Donalds recently disclosed $74.7K of fundraising in a Q2 FEC disclosure filed on July 15th, 2025. This was the 670th most from all Q2 reports we have seen this year. 70.8% came from individual donors.

Donalds disclosed $147.6K of spending. This was the 377th most from all Q2 reports we have seen from politicians so far this year.

Donalds disclosed $456.1K of cash on hand at the end of the filing period. This was the 488th most from all Q2 reports we have seen this year.

You can see the disclosure here, or track Byron Donalds's fundraising on Quiver Quantitative.

Read Full Article

Press Release: Rep. Robin Kelly and Environmental Leaders Oppose Trump Administration's EPA Policy Changes

an hour ago | July 28, 2025 10:22 p.m. UTC

Rep. Kelly and environmental leaders oppose Trump administration's efforts to weaken the EPA's climate change regulations.

Quiver AI Summary

U.S. Rep. Robin Kelly (IL-02) and environmental advocates voiced strong opposition to the Trump administration's plans to repeal the Environmental Protection Agency's "Endangerment Finding." This finding is essential for the EPA's role in combating climate change.

Rep. Kelly stated, “Big Polluters poured $1 billion into President Trump’s reelection campaign, and he’s now repaying them by stripping the ‘Endangerment Finding.’” She emphasized the importance of scientific truth and public support in defending climate protections.

Joining Rep. Kelly at the press conference were U.S. Rep. Bill Foster (IL-11) and representatives from the American Federation of Government Employees Local 704, highlighting a wider coalition against the proposed environmental changes.

Disclaimer: This is an AI-generated summary of a press release. The model used to summarize this release may make mistakes. See the full release here.

Robin L. Kelly Net Worth

Quiver Quantitative estimates that Robin L. Kelly is worth $40.5K, as of July 28th, 2025. This is the 429th highest net worth in Congress, per our live estimates.

Kelly has approximately $0 invested in publicly traded assets which Quiver is able to track live.

You can track Robin L. Kelly's net worth on Quiver Quantitative's politician page for Kelly.

Robin L. Kelly Bill Proposals

Here are some bills which have recently been proposed by Robin L. Kelly:

H.R.4084: Access to Birth Control Act
H.R.3974: Protect Black Women and Girls Act
H.R.2937: PROTECT 911 Act
H.R.2618: Federal Firearm Licensee Act
H.R.2507: Helping to Encourage Real Opportunities (HERO) for Youth Act of 2025
H.R.2506: AID Youth Employment Act

You can track bills proposed by Robin L. Kelly on Quiver Quantitative's politician page for Kelly.

Robin L. Kelly Fundraising

Robin L. Kelly recently disclosed $305.1K of fundraising in a Q2 FEC disclosure filed on July 15th, 2025. This was the 290th most from all Q2 reports we have seen this year. 76.5% came from individual donors.

Kelly disclosed $253.5K of spending. This was the 204th most from all Q2 reports we have seen from politicians so far this year.

Kelly disclosed $2.2M of cash on hand at the end of the filing period. This was the 138th most from all Q2 reports we have seen this year.

You can see the disclosure here, or track Robin L. Kelly's fundraising on Quiver Quantitative.

Read Full Article

Press Release: Ryan and Wittman Announce Key Wins for Defense Innovation in NDAA

an hour ago | July 28, 2025 10:22 p.m. UTC

Ryan and Wittman announce defense modernization initiatives in the NDAA to enhance the defense innovation ecosystem.

Quiver AI Summary

Congressman Pat Ryan and Congressman Rob Wittman announced key initiatives they secured in the National Defense Authorization Act (NDAA) to enhance the defense innovation ecosystem. Through the House Defense Modernization Caucus, they aim to strengthen private sector partnerships, accelerate technology adoption, and reduce bureaucracy within the Department of Defense.

Ryan stated, “I’m very proud of what we accomplished,” highlighting the focus on acquisition reform and emerging technologies. Wittman emphasized the need for American innovation to support military capabilities, alongside reducing pointless red tape.

The measures include providing equity investment authority for the Office of Strategic Capital, enhancing operational use of Sensitive Compartmented Information Facilities, and requiring feedback on integrating AI across the Department of Defense.

Disclaimer: This is an AI-generated summary of a press release. The model used to summarize this release may make mistakes. See the full release here.

Patrick Ryan Net Worth

Quiver Quantitative estimates that Patrick Ryan is worth $2.8M, as of July 28th, 2025. This is the 199th highest net worth in Congress, per our live estimates.

Ryan has approximately $567.7K invested in publicly traded assets which Quiver is able to track live.

You can track Patrick Ryan's net worth on Quiver Quantitative's politician page for Ryan.

Patrick Ryan Bill Proposals

Here are some bills which have recently been proposed by Patrick Ryan:

H.R.4768: To amend title 10, United States Code, to improve dependent coverage under the TRICARE Young Adult Program.
H.R.4260: To ensure the appropriate administration of the Impact Aid program.
H.R.3734: Stop MUSK Act
H.R.3500: More Funding for COPS Act
H.R.2959: Hudson River Protection Act
H.R.2391: Strengthening Supply Chains Through Truck Driver Incentives Act of 2025

You can track bills proposed by Patrick Ryan on Quiver Quantitative's politician page for Ryan.

Patrick Ryan Fundraising

Patrick Ryan recently disclosed $740.4K of fundraising in a Q2 FEC disclosure filed on July 15th, 2025. This was the 77th most from all Q2 reports we have seen this year. 87.8% came from individual donors.

Ryan disclosed $274.6K of spending. This was the 184th most from all Q2 reports we have seen from politicians so far this year.

Ryan disclosed $1.7M of cash on hand at the end of the filing period. This was the 190th most from all Q2 reports we have seen this year.

You can see the disclosure here, or track Patrick Ryan's fundraising on Quiver Quantitative.

Read Full Article

Press Release: Senator Tammy Baldwin and Colleagues Demand Answers on Gaza Humanitarian Foundation and Violence Issues

an hour ago | July 28, 2025 10:22 p.m. UTC

Senator Tammy Baldwin and colleagues demand answers regarding the Gaza Humanitarian Foundation's funding and humanitarian practices.

Quiver AI Summary

Senator Tammy Baldwin, along with 20 Senate colleagues, has called on the Trump Administration to stop funding the Gaza Humanitarian Foundation (GHF) and support existing UN aid mechanisms. They expressed serious concerns about civilian deaths and the foundation's transparency, following reports of violence at GHF distribution sites amid a humanitarian crisis in Gaza.

The Senators highlighted that over 700 people have reportedly died while seeking food at GHF sites, and emphasized the need for adherence to humanitarian principles. They urge the Administration to provide answers regarding GHF's funding, operations, and compliance with these principles.

Senators Baldwin's concerns reflect broader issues about the conflict's impact on civilians, particularly as the Netanyahu government has enforced a blockade affecting food and medical supplies. The letter seeks immediate action to revert to UN-led aid coordination for safety and effectiveness in delivering humanitarian assistance.

Disclaimer: This is an AI-generated summary of a press release. The model used to summarize this release may make mistakes. See the full release here.

Tammy Baldwin Net Worth

Quiver Quantitative estimates that Tammy Baldwin is worth $933.0K, as of July 28th, 2025. This is the 300th highest net worth in Congress, per our live estimates.

Baldwin has approximately $0 invested in publicly traded assets which Quiver is able to track live.

You can track Tammy Baldwin's net worth on Quiver Quantitative's politician page for Baldwin.

Tammy Baldwin Bill Proposals

Here are some bills which have recently been proposed by Tammy Baldwin:

S.2436: A bill to amend the Consolidated Farm and Rural Development Act to establish a grant program to assist with the purchase, installation, and maintenance of point-of-entry and point-of-use drinking water quality improvement products, and for other purposes.
S.2370: A bill to provide for eligibility for veterans of Operation End Sweep for the Vietnam Service Medal.
S.2282: Farmers First Act of 2025
S.2245: A bill to amend the Digital Coast Act to improve the acquisition, integration, and accessibility of data of the Digital Coast program and to extend the program.
S.2195: WWII Nurses Congressional Gold Medal Act
S.2150: Women’s Health Protection Act of 2025

You can track bills proposed by Tammy Baldwin on Quiver Quantitative's politician page for Baldwin.

Tammy Baldwin Fundraising

Tammy Baldwin recently disclosed $428.6K of fundraising in a Q2 FEC disclosure filed on July 15th, 2025. This was the 195th most from all Q2 reports we have seen this year. 98.6% came from individual donors.

Baldwin disclosed $360.5K of spending. This was the 130th most from all Q2 reports we have seen from politicians so far this year.

Baldwin disclosed $178.7K of cash on hand at the end of the filing period. This was the 687th most from all Q2 reports we have seen this year.

You can see the disclosure here, or track Tammy Baldwin's fundraising on Quiver Quantitative.

Read Full Article

Press Release: Padilla, Schiff, and Lofgren Call for Reversal of Layoffs and Budget Cuts at National Laboratories

an hour ago | July 28, 2025 10:22 p.m. UTC

California lawmakers demand reversal of layoffs and budget cuts at national laboratories, citing risks to AI and research.

Quiver AI Summary

U.S. Senators Alex Padilla and Adam Schiff, along with Representative Zoe Lofgren, have called for the reversal of proposed budget cuts by the Trump Administration that could lead to layoffs at the Department of Energy’s National Laboratories. They argue these cuts threaten critical research in artificial intelligence and national security.

The lawmakers emphasize that California's labs, essential for technological advancements and national defense, are facing staffing reductions that could hinder America's global leadership. They warned that existing layoffs and potential future layoffs could jeopardize innovation and security.

In a letter to the administration, they highlighted Energy Secretary Chris Wright’s earlier comments, indicating openness to reducing the proposed cuts, which would amount to $2.75 billion in funding, an 11% decrease from the previous year. The lawmakers stress the need to maintain full staffing and resources to protect U.S. interests in cutting-edge technology.

Disclaimer: This is an AI-generated summary of a press release. The model used to summarize this release may make mistakes. See the full release here.

Alex Padilla Net Worth

Quiver Quantitative estimates that Alex Padilla is worth $288.0K, as of July 28th, 2025. This is the 389th highest net worth in Congress, per our live estimates.

Padilla has approximately $30.0K invested in publicly traded assets which Quiver is able to track live.

You can track Alex Padilla's net worth on Quiver Quantitative's politician page for Padilla.

Alex Padilla Bill Proposals

Here are some bills which have recently been proposed by Alex Padilla:

S.2446: A bill to amend the Public Health Service Act to provide for a behavioral and mental health outreach and education strategy to reduce stigma associated with mental health among the Hispanic and Latino population, and for other purposes.
S.2347: A bill to prohibit discrimination in health care and require the provision of equitable health care, and for other purposes.
S.2298: A bill to direct the Secretary of Labor to promulgate an occupational safety and health standard to protect workers from heat-related injuries and illnesses.
S.2265: A bill to require the Secretary of the Treasury to mint coins in commemoration of the 2028 Olympic and Paralympic Games in Los Angeles, California, and the 2034 Olympics and Paralympic Winter Games in Salt Lake City, Utah.
S.2261: A bill to amend the Clean Air Act to provide for the establishment of standards to limit the carbon intensity of the fuel used by certain vessels, and for other purposes.
S.2260: Border Water Quality Restoration and Protection Act

You can track bills proposed by Alex Padilla on Quiver Quantitative's politician page for Padilla.

Alex Padilla Fundraising

Alex Padilla recently disclosed $376.7K of fundraising in a Q2 FEC disclosure filed on July 15th, 2025. This was the 232nd most from all Q2 reports we have seen this year. 92.8% came from individual donors.

Padilla disclosed $107.6K of spending. This was the 476th most from all Q2 reports we have seen from politicians so far this year.

Padilla disclosed $6.8M of cash on hand at the end of the filing period. This was the 29th most from all Q2 reports we have seen this year.

You can see the disclosure here, or track Alex Padilla's fundraising on Quiver Quantitative.

Read Full Article

Press Release: Senator Chris Murphy and 19 Colleagues Seek Clarification on Gaza Humanitarian Foundation Funding

an hour ago | July 28, 2025 10:22 p.m. UTC

Senator Chris Murphy and 19 colleagues demand answers from the Trump Administration regarding the Gaza Humanitarian Foundation's operations.

Quiver AI Summary

U.S. Senator Chris Murphy, alongside 19 colleagues, has urged the Trump Administration to cease funding for the Gaza Humanitarian Foundation (GHF) and to restore support for UN aid distribution. They raised concerns about GHF's transparency and its links to violence against civilians seeking aid amidst worsening conditions in Gaza.

The senators highlighted that over 700 people have died near GHF distribution sites, and have called into question the decision to allocate $30 million to GHF without proper audits or oversight, citing risks and compliance issues associated with the funding. They have requested detailed answers from the Administration regarding these matters.

This letter aligns with growing criticism of GHF's operational model, which they claim undermines humanitarian principles and contributes to the humanitarian crisis in Gaza. The senators are seeking accountability and clarity on the funding mechanisms and safety of civilians affected by the aid distribution efforts.

Disclaimer: This is an AI-generated summary of a press release. The model used to summarize this release may make mistakes. See the full release here.

Christopher Murphy Net Worth

Quiver Quantitative estimates that Christopher Murphy is worth $1.3M, as of July 28th, 2025. This is the 263rd highest net worth in Congress, per our live estimates.

Murphy has approximately $0 invested in publicly traded assets which Quiver is able to track live.

You can track Christopher Murphy's net worth on Quiver Quantitative's politician page for Murphy.

Christopher Murphy Bill Proposals

Here are some bills which have recently been proposed by Christopher Murphy:

S.2031: Workforce Mobility Act of 2025
S.1620: MEME Act
S.1201: Strengthening Immigration Procedures Act of 2025
S.595: Office of Gun Violence Prevention Act of 2025
S.543: Fair Play for Women Act
S.328: Stop Sports Blackouts Act

You can track bills proposed by Christopher Murphy on Quiver Quantitative's politician page for Murphy.

Christopher Murphy Fundraising

Christopher Murphy recently disclosed $2.3M of fundraising in a Q2 FEC disclosure filed on July 15th, 2025. This was the 9th most from all Q2 reports we have seen this year. 100.0% came from individual donors.

Murphy disclosed $1.6M of spending. This was the 18th most from all Q2 reports we have seen from politicians so far this year.

Murphy disclosed $10.3M of cash on hand at the end of the filing period. This was the 11th most from all Q2 reports we have seen this year.

You can see the disclosure here, or track Christopher Murphy's fundraising on Quiver Quantitative.

Read Full Article

Press Release: Senator Dave McCormick and HUD Secretary Scott Turner Discuss Homeownership and Community Development in Pittsburgh

an hour ago | July 28, 2025 10:22 p.m. UTC

Senator McCormick and HUD Secretary Turner toured Pittsburgh, highlighting homeownership initiatives and community development programs.

Quiver AI Summary

Senator Dave McCormick and HUD Secretary Scott Turner visited Pittsburgh to explore community investment initiatives, including programs at United States Steel Corporation, Bedford Dwellings, and Light of Life Rescue Mission. McCormick highlighted the efforts to enhance homeownership and community support, stating, "From U. S. Steel's historic Edgar Thomson Works... to Bedford Dwellings' efforts... we saw the best western Pennsylvania has to offer."

Turner praised Pittsburgh's resilience and emphasized the importance of local services in revitalizing communities. He remarked, "Pittsburgh stands as a testament to America’s spirit of hard work and resilience," after touring significant sites that support job creation and housing supply, including discussions about ongoing collaborations to expand affordable housing opportunities.

Bedford Dwellings provides affordable housing and tailored support services, while Light of Life offers essential services to individuals facing homelessness and poverty. The tour focused on the role of non-governmental organizations in providing community resources and solutions.

Disclaimer: This is an AI-generated summary of a press release. The model used to summarize this release may make mistakes. See the full release here.

David McCormick Bill Proposals

Here are some bills which have recently been proposed by David McCormick:

S.2146: China Exchange Rate Transparency Act of 2025
S.2044: Office of Fossil Energy and Carbon Management Relocation Act of 2025
S.1900: Taiwan Non-Discrimination Act of 2025
S.1808: Access to Small Business Investor Capital Act
S.1780: Mexico Security Assistance Accountability Act
S.1739: International Nuclear Energy Financing Act of 2025

You can track bills proposed by David McCormick on Quiver Quantitative's politician page for McCormick.

David McCormick Fundraising

David McCormick recently disclosed $0 of fundraising in a Q2 FEC disclosure filed on July 15th, 2025. This was the 1167th most from all Q2 reports we have seen this year. nan% came from individual donors.

McCormick disclosed $4.1K of spending. This was the 1072nd most from all Q2 reports we have seen from politicians so far this year.

McCormick disclosed $12.3K of cash on hand at the end of the filing period. This was the 1108th most from all Q2 reports we have seen this year.

You can see the disclosure here, or track David McCormick's fundraising on Quiver Quantitative.

Read Full Article

Press Release: Congresswoman Maggie Goodlander Introduces Bipartisan Health Care Fairness for Military Families Act

an hour ago | July 28, 2025 10:22 p.m. UTC

Congresswoman Maggie Goodlander introduces bipartisan legislation to extend TRICARE health coverage for military families until children turn 26.

Quiver AI Summary

Congresswoman Maggie Goodlander announced the introduction of the bipartisan Health Care Fairness for Military Families Act, aimed at extending TRICARE health coverage for adult children of military families up to age 26. The legislation seeks to align military health benefits with civilian standards, reducing costs for military families.

Goodlander emphasized the obligation to provide equitable health care, stating, "I'm proud to introduce this commonsense bill," which is expected to save families thousands annually. The legislation has garnered support from various military organizations and aims to alleviate financial burdens on military families.

The current coverage allows TRICARE beneficiaries to maintain battlefield health insurance for dependents only until they are 21, or 23 if they are full-time students. Goodlander's proposed bill intends to offer similar provisions as those enacted under the Affordable Care Act, which allows coverage until age 26.

Disclaimer: This is an AI-generated summary of a press release. The model used to summarize this release may make mistakes. See the full release here.

Maggie Goodlander Net Worth

Quiver Quantitative estimates that Maggie Goodlander is worth $3.8M, as of July 28th, 2025. This is the 165th highest net worth in Congress, per our live estimates.

Goodlander has approximately $0 invested in publicly traded assets which Quiver is able to track live.

You can track Maggie Goodlander's net worth on Quiver Quantitative's politician page for Goodlander.

Maggie Goodlander Bill Proposals

Here are some bills which have recently been proposed by Maggie Goodlander:

H.R.4594: To authorize the use of veterans educational assistance for examinations and assessments to receive credit toward degrees awarded by institutions of higher learning, and for other purposes.
H.R.4549: Office of Rural Affairs Enhancement Act
H.R.3587: Investing in Digital Skills Act

You can track bills proposed by Maggie Goodlander on Quiver Quantitative's politician page for Goodlander.

Maggie Goodlander Fundraising

Maggie Goodlander recently disclosed $510.8K of fundraising in a Q2 FEC disclosure filed on July 15th, 2025. This was the 147th most from all Q2 reports we have seen this year. 87.4% came from individual donors.

Goodlander disclosed $198.8K of spending. This was the 268th most from all Q2 reports we have seen from politicians so far this year.

Goodlander disclosed $763.0K of cash on hand at the end of the filing period. This was the 360th most from all Q2 reports we have seen this year.

You can see the disclosure here, or track Maggie Goodlander's fundraising on Quiver Quantitative.

Read Full Article

Press Release: Rosen and Colleagues Urge Trump to Cease Tariff Threats on Brazil, Citing Rising Costs for Americans

an hour ago | July 28, 2025 10:22 p.m. UTC

Senator Jacky Rosen urges President Trump to cease tariff threats on Brazil, warning it could increase costs for American families.

Quiver AI Summary

U.S. Senator Jacky Rosen (D-NV) and Senator Tim Kaine (D-VA) have sent a letter to President Trump urging him to cease threats of tariffs on Brazil. They argue that such measures would increase costs for American families while jeopardizing economic relations based on baseless allegations regarding Brazil's legal proceedings against former President Jair Bolsonaro.

The senators warned, "Interfering in another sovereign nation’s legal system sets a dangerous precedent, provokes an unnecessary trade war, and could derail our broader interests in the region." They emphasize that the tariffs could harm U.S. businesses and consumers further, amid already rising costs.

In previous actions, Senator Rosen has opposed Trump's tariffs, advocating for greater transparency and potential studies on the economic impacts of these tariffs on U.S. and Nevada industries.

Disclaimer: This is an AI-generated summary of a press release. The model used to summarize this release may make mistakes. See the full release here.

Jacky Rosen Net Worth

Quiver Quantitative estimates that Jacky Rosen is worth $15.1M, as of July 28th, 2025. This is the 69th highest net worth in Congress, per our live estimates.

Rosen has approximately $4.5M invested in publicly traded assets which Quiver is able to track live.

You can track Jacky Rosen's net worth on Quiver Quantitative's politician page for Rosen.

Jacky Rosen Bill Proposals

Here are some bills which have recently been proposed by Jacky Rosen:

S.2443: A bill to amend the Internal Revenue Code of 1986 to establish a small business start-up tax credit for veterans creating businesses in underserved communities.
S.2331: A bill to amend the Robert T. Stafford Disaster Relief and Emergency Assistance Act to include extreme temperature in the definition of a major disaster.
S.2306: A bill to amend the Workforce Innovation and Opportunity Act to create a new national program to support mid-career workers in reentering the STEM workforce, by providing funding to small- and medium-sized STEM businesses so the businesses can offer paid internships or other returnships that lead to positions above entry level.
S.2220: A bill to expand presumptions of exposure by members of the Armed Forces to toxic substances, and for other purposes.
S.2218: Combat Action Recognition and Evaluation (CARE) for Remotely Piloted Aircraft (RPA) Crews Act of 2025
S.1936: Improving Access to Transfusion Care for Hospice Patients Act of 2025

You can track bills proposed by Jacky Rosen on Quiver Quantitative's politician page for Rosen.

Jacky Rosen Fundraising

Jacky Rosen recently disclosed $198.8K of fundraising in a Q2 FEC disclosure filed on July 15th, 2025. This was the 437th most from all Q2 reports we have seen this year. 87.4% came from individual donors.

Rosen disclosed $290.2K of spending. This was the 169th most from all Q2 reports we have seen from politicians so far this year.

Rosen disclosed $923.4K of cash on hand at the end of the filing period. This was the 318th most from all Q2 reports we have seen this year.

You can see the disclosure here, or track Jacky Rosen's fundraising on Quiver Quantitative.

Read Full Article

Press Release: Sen. Jon Ossoff Announces Expansion of Scholarships and Tutoring for First-Generation College Students in Georgia

an hour ago | July 28, 2025 10:22 p.m. UTC

Senator Jon Ossoff announces over $4 million in federal grants to support scholarships and tutoring for first-generation college students in Georgia.

Quiver AI Summary

U.S. Senator Jon Ossoff announced the allocation of over $4 million from the Department of Education's TRIO Student Support Services grant program to enhance scholarship and tutoring access for first-generation college students in Georgia. He affirmed the importance of these resources in supporting students’ academic success.

The funds will be distributed among various institutions, including Georgia State University and the University of Georgia, to offer comprehensive support services. Ossoff emphasized his commitment to increasing educational access and opportunities for young people in the state.

Additionally, he noted recent efforts to bolster job training programs in Georgia, reflecting a broader initiative to enhance economic prospects for residents through funding for various educational initiatives.

Disclaimer: This is an AI-generated summary of a press release. The model used to summarize this release may make mistakes. See the full release here.

Jon Ossoff Net Worth

Quiver Quantitative estimates that Jon Ossoff is worth $3.2M, as of July 28th, 2025. This is the 187th highest net worth in Congress, per our live estimates.

Ossoff has approximately $28.4K invested in publicly traded assets which Quiver is able to track live.

You can track Jon Ossoff's net worth on Quiver Quantitative's politician page for Ossoff.

Jon Ossoff Bill Proposals

Here are some bills which have recently been proposed by Jon Ossoff:

S.2102: Ralph David Abernathy, Sr., National Historic Site Act
S.1879: Ban Congressional Stock Trading Act
S.1550: Improving SCRA Benefit Utilization Act of 2025
S.1419: Youth Sports Facilities Act of 2024
S.1322: Family Notification of Death, Injury, or Illness in Custody Act of 2025
S.1131: Ocmulgee Mounds National Park and Preserve Establishment Act

You can track bills proposed by Jon Ossoff on Quiver Quantitative's politician page for Ossoff.

Jon Ossoff Fundraising

Jon Ossoff recently disclosed $9.1M of fundraising in a Q2 FEC disclosure filed on July 15th, 2025. This was the most from all Q2 reports we have seen this year. 97.9% came from individual donors.

Ossoff disclosed $5.7M of spending. This was the 2nd most from all Q2 reports we have seen from politicians so far this year.

Ossoff disclosed $15.5M of cash on hand at the end of the filing period. This was the 6th most from all Q2 reports we have seen this year.

You can see the disclosure here, or track Jon Ossoff's fundraising on Quiver Quantitative.

Read Full Article

Press Release: Senator Mike Crapo Addresses False Claims About the One Big Beautiful Bill

an hour ago | July 28, 2025 10:22 p.m. UTC

Senator Mike Crapo defends the One Big Beautiful Bill Act, citing its benefits for Idahoans against critics' claims.

Quiver AI Summary

In a response to a Lewiston Tribune opinion piece by Marc Johnson, Senator Mike Crapo defended the One Big Beautiful Bill Act, asserting its benefits for Idahoans. He claimed the legislation aims to prevent major tax increases and provide tax relief for families, while countering accusations of favoring the wealthy and risking rural hospitals.

Crapo emphasized that the bill includes significant tax relief primarily benefiting low- and middle-income families, backed by the Joint Committee on Taxation. He also argued that reforms in federal spending and Medicaid are essential for maintaining the program's sustainability.

The Senator outlined the establishment of a $50 billion Rural Transformation Fund, intended to aid rural hospitals, while maintaining existing programs. He asserted that the bill represents a crucial investment in rural healthcare and promotes efficient use of taxpayer dollars without harming essential services.

Disclaimer: This is an AI-generated summary of a press release. The model used to summarize this release may make mistakes. See the full release here.

Mike Crapo Net Worth

Quiver Quantitative estimates that Mike Crapo is worth $3.5M, as of July 28th, 2025. This is the 177th highest net worth in Congress, per our live estimates.

Crapo has approximately $0 invested in publicly traded assets which Quiver is able to track live.

You can track Mike Crapo's net worth on Quiver Quantitative's politician page for Crapo.

Mike Crapo Bill Proposals

Here are some bills which have recently been proposed by Mike Crapo:

S.2360: A bill to amend title 25, United States Code, to provide for the appointment of additional Federal circuit judges, to divide the Ninth Judicial Circuit of the United States into two judicial circuits, and for other purposes.
S.2019: TRAPS Act
S.1714: Disabled Veterans Housing Support Act
S.1532: A bill to amend the Internal Revenue Code of 1986 to modify the railroad track maintenance credit.
S.1163: Rural Veterinary Workforce Act
S.1150: Increased TSP Access Act of 2025

You can track bills proposed by Mike Crapo on Quiver Quantitative's politician page for Crapo.

Mike Crapo Fundraising

Mike Crapo recently disclosed $202.7K of fundraising in a Q2 FEC disclosure filed on July 14th, 2025. This was the 427th most from all Q2 reports we have seen this year. 42.3% came from individual donors.

Crapo disclosed $73.0K of spending. This was the 596th most from all Q2 reports we have seen from politicians so far this year.

Crapo disclosed $2.8M of cash on hand at the end of the filing period. This was the 102nd most from all Q2 reports we have seen this year.

You can see the disclosure here, or track Mike Crapo's fundraising on Quiver Quantitative.

Read Full Article

New Analyst Forecast: $VRT Given 'Outperform' Rating

an hour ago | July 28, 2025 10:20 p.m. UTC

We just received data on a new analyst forecast for $VRT. William Blair gave a rating of 'Outperform' for $VRT.

$VRT Analyst Ratings

Wall Street analysts have issued reports on $VRT in the last several months. We have seen 10 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

William Blair issued a "Outperform" rating on 07/28/2025
B of A Securities issued a "Buy" rating on 07/17/2025
Oppenheimer issued a "Outperform" rating on 07/17/2025
Mizuho issued a "Outperform" rating on 07/16/2025
Citigroup issued a "Buy" rating on 07/14/2025
Goldman Sachs issued a "Buy" rating on 06/10/2025
Evercore ISI Group issued a "Outperform" rating on 05/27/2025

To track analyst ratings and price targets for $VRT, check out Quiver Quantitative's $VRT forecast page.

$VRT Price Targets

Multiple analysts have issued price targets for $VRT recently. We have seen 11 analysts offer price targets for $VRT in the last 6 months, with a median target of $140.0.

Here are some recent targets:

Andrew Obin from B of A Securities set a target price of $150.0 on 07/17/2025
Noah Kaye from Oppenheimer set a target price of $140.0 on 07/17/2025
Brett Linzey from Mizuho set a target price of $150.0 on 07/16/2025
Andrew Kaplowitz from Citigroup set a target price of $149.0 on 07/14/2025
Julian Mitchell from Barclays set a target price of $110.0 on 07/09/2025
Scott Davis from Melius Research set a target price of $165.0 on 07/08/2025
Mark Delaney from Goldman Sachs set a target price of $122.0 on 06/10/2025

$VRT Congressional Stock Trading

Members of Congress have traded $VRT stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $VRT stock by members of Congress over the last 6 months:

REPRESENTATIVE JOSH GOTTHEIMER sold up to $15,000 on 02/25.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$VRT Insider Trading Activity

$VRT insiders have traded $VRT stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.

Here’s a breakdown of recent trading of $VRT stock by insiders over the last 6 months:

KARSTEN WINTHER (President, EMEA) has made 0 purchases and 3 sales selling 59,700 shares for an estimated $5,749,235.
STEPHEN LIANG (Chief Technology Officer & EVP) has made 0 purchases and 2 sales selling 43,683 shares for an estimated $5,060,017.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$VRT Hedge Fund Activity

We have seen 747 institutional investors add shares of $VRT stock to their portfolio, and 573 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

COATUE MANAGEMENT LLC removed 6,375,917 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $460,341,207
BARROW HANLEY MEWHINNEY & STRAUSS LLC added 5,434,741 shares (+inf%) to their portfolio in Q1 2025, for an estimated $392,388,300
JPMORGAN CHASE & CO removed 4,398,691 shares (-33.7%) from their portfolio in Q1 2025, for an estimated $317,585,490
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ removed 3,888,920 shares (-74.0%) from their portfolio in Q1 2025, for an estimated $280,780,024
JENNISON ASSOCIATES LLC removed 3,489,250 shares (-45.0%) from their portfolio in Q1 2025, for an estimated $251,923,850
AMUNDI added 3,420,144 shares (+96.8%) to their portfolio in Q1 2025, for an estimated $246,934,396
FMR LLC removed 2,626,976 shares (-22.8%) from their portfolio in Q1 2025, for an estimated $189,667,667

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read Full Article

New Analyst Forecast: $EXPE Given $182.0 Price Target

an hour ago | July 28, 2025 10:20 p.m. UTC

We just received data on a new analyst forecast for $EXPE. Stephen Ju from UBS set a price target of 182.0 for EXPE.

To track analyst ratings and price targets for $EXPE, check out Quiver Quantitative's $EXPE forecast page.

$EXPE Price Targets

Multiple analysts have issued price targets for $EXPE recently. We have seen 17 analysts offer price targets for $EXPE in the last 6 months, with a median target of $183.0.

Here are some recent targets:

Stephen Ju from UBS set a target price of $182.0 on 07/28/2025
Brian Nowak from Morgan Stanley set a target price of $165.0 on 07/21/2025
Ken Gawrelski from Wells Fargo set a target price of $178.0 on 07/07/2025
Greg Miller from Truist Securities set a target price of $168.0 on 06/24/2025
Deepak Mathivanan from Cantor Fitzgerald set a target price of $170.0 on 05/15/2025
Shyam Patil from Susquehanna set a target price of $175.0 on 05/12/2025
Jed Kelly from Oppenheimer set a target price of $210.0 on 05/09/2025

$EXPE Insider Trading Activity

$EXPE insiders have traded $EXPE stock on the open market 16 times in the past 6 months. Of those trades, 0 have been purchases and 16 have been sales.

Here’s a breakdown of recent trading of $EXPE stock by insiders over the last 6 months:

DARA KHOSROWSHAHI has made 0 purchases and 13 sales selling 20,000 shares for an estimated $3,660,613.
ROBERT J DZIELAK (Chief Legal Officer & Sec'y) has made 0 purchases and 2 sales selling 9,869 shares for an estimated $2,016,907.
LANCE A SOLIDAY (SVP & Chief Accounting Officer) sold 691 shares for an estimated $132,098

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$EXPE Hedge Fund Activity

We have seen 464 institutional investors add shares of $EXPE stock to their portfolio, and 437 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

LOS ANGELES CAPITAL MANAGEMENT LLC added 999,454 shares (+3369.4%) to their portfolio in Q1 2025, for an estimated $168,008,217
WINDACRE PARTNERSHIP LLC removed 933,000 shares (-22.9%) from their portfolio in Q1 2025, for an estimated $156,837,300
AQR CAPITAL MANAGEMENT LLC added 917,192 shares (+174.0%) to their portfolio in Q1 2025, for an estimated $154,179,975
FISHER ASSET MANAGEMENT, LLC removed 908,994 shares (-98.0%) from their portfolio in Q1 2025, for an estimated $152,801,891
VALUEACT HOLDINGS, L.P. removed 900,250 shares (-44.6%) from their portfolio in Q1 2025, for an estimated $151,332,025
AMUNDI added 856,285 shares (+197.5%) to their portfolio in Q1 2025, for an estimated $143,941,508
VICTORY CAPITAL MANAGEMENT INC added 736,004 shares (+27.8%) to their portfolio in Q1 2025, for an estimated $123,722,272

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read Full Article

New Analyst Forecast: $ABNB Given $156.0 Price Target

an hour ago | July 28, 2025 10:20 p.m. UTC

We just received data on a new analyst forecast for $ABNB. Stephen Ju from UBS set a price target of 156.0 for ABNB.

To track analyst ratings and price targets for $ABNB, check out Quiver Quantitative's $ABNB forecast page.

$ABNB Price Targets

Multiple analysts have issued price targets for $ABNB recently. We have seen 23 analysts offer price targets for $ABNB in the last 6 months, with a median target of $145.0.

Here are some recent targets:

Stephen Ju from UBS set a target price of $156.0 on 07/28/2025
Brian Nowak from Morgan Stanley set a target price of $130.0 on 07/21/2025
Trevor Young from Barclays set a target price of $104.0 on 07/16/2025
Ken Gawrelski from Wells Fargo set a target price of $111.0 on 07/07/2025
Patrick Scholes from Truist Securities set a target price of $106.0 on 05/30/2025
Deepak Mathivanan from Cantor Fitzgerald set a target price of $100.0 on 05/14/2025
Shyam Patil from Susquehanna set a target price of $150.0 on 05/05/2025

$ABNB Congressional Stock Trading

Members of Congress have traded $ABNB stock 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $ABNB stock by members of Congress over the last 6 months:

REPRESENTATIVE ROBERT BRESNAHAN has traded it 2 times. They made 1 purchase worth up to $15,000 on 02/25 and 1 sale worth up to $15,000 on 04/08.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$ABNB Insider Trading Activity

$ABNB insiders have traded $ABNB stock on the open market 132 times in the past 6 months. Of those trades, 0 have been purchases and 132 have been sales.

Here’s a breakdown of recent trading of $ABNB stock by insiders over the last 6 months:

JOSEPH GEBBIA has made 0 purchases and 63 sales selling 3,111,074 shares for an estimated $403,523,226.
BRIAN CHESKY (CEO and Chairman) has made 0 purchases and 32 sales selling 676,339 shares for an estimated $100,279,757.
NATHAN BLECHARCZYK (Chief Strategy Officer) has made 0 purchases and 4 sales selling 214,189 shares for an estimated $33,443,491.
ELINOR MERTZ (Chief Financial Officer) has made 0 purchases and 9 sales selling 73,395 shares for an estimated $10,365,872.
ARISTOTLE N BALOGH (Chief Technology Officer) has made 0 purchases and 23 sales selling 26,963 shares for an estimated $3,841,036.
DAVID C BERNSTEIN (Chief Accounting Officer) sold 5,000 shares for an estimated $710,000

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$ABNB Hedge Fund Activity

We have seen 601 institutional investors add shares of $ABNB stock to their portfolio, and 553 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

HARRIS ASSOCIATES L P added 4,598,125 shares (+86.0%) to their portfolio in Q1 2025, for an estimated $549,292,012
JENNISON ASSOCIATES LLC removed 3,219,864 shares (-32.1%) from their portfolio in Q1 2025, for an estimated $384,644,953
PACER ADVISORS, INC. added 2,685,026 shares (+2297.4%) to their portfolio in Q1 2025, for an estimated $320,753,205
FARALLON CAPITAL MANAGEMENT LLC removed 2,429,200 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $290,192,232
MORGAN STANLEY removed 2,025,536 shares (-13.0%) from their portfolio in Q1 2025, for an estimated $241,970,530
AQR CAPITAL MANAGEMENT LLC added 1,916,676 shares (+81.0%) to their portfolio in Q1 2025, for an estimated $228,966,114
JACOBS LEVY EQUITY MANAGEMENT, INC removed 1,812,579 shares (-94.9%) from their portfolio in Q1 2025, for an estimated $216,530,687

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read Full Article

New Analyst Forecast: $LEA Given $109.0 Price Target

an hour ago | July 28, 2025 10:20 p.m. UTC

We just received data on a new analyst forecast for $LEA. Joseph Spak from UBS set a price target of 109.0 for LEA.

To track analyst ratings and price targets for $LEA, check out Quiver Quantitative's $LEA forecast page.

$LEA Price Targets

Multiple analysts have issued price targets for $LEA recently. We have seen 9 analysts offer price targets for $LEA in the last 6 months, with a median target of $115.0.

Here are some recent targets:

Joseph Spak from UBS set a target price of $109.0 on 07/28/2025
Dan Levy from Barclays set a target price of $120.0 on 07/16/2025
Colin Langan from Wells Fargo set a target price of $103.0 on 07/01/2025
Michael Ward from Citigroup set a target price of $136.0 on 06/30/2025
John Murphy from B of A Securities set a target price of $115.0 on 06/16/2025
Adam Jonas from Morgan Stanley set a target price of $115.0 on 05/19/2025
Ryan Brinkman from JP Morgan set a target price of $120.0 on 05/09/2025

$LEA Insider Trading Activity

$LEA insiders have traded $LEA stock on the open market 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $LEA stock by insiders over the last 6 months:

ROD LACHE purchased 2,178 shares for an estimated $199,944
CONRAD L JR MALLETT sold 1,187 shares for an estimated $110,218

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$LEA Hedge Fund Activity

We have seen 203 institutional investors add shares of $LEA stock to their portfolio, and 199 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

FIRST TRUST ADVISORS LP removed 650,127 shares (-57.4%) from their portfolio in Q1 2025, for an estimated $57,354,203
OLDFIELD PARTNERS LLP added 609,824 shares (+inf%) to their portfolio in Q1 2025, for an estimated $53,798,673
AQR CAPITAL MANAGEMENT LLC added 470,096 shares (+483.4%) to their portfolio in Q1 2025, for an estimated $41,471,869
BLACKROCK, INC. added 404,120 shares (+5.9%) to their portfolio in Q1 2025, for an estimated $35,651,466
AMERICAN CENTURY COMPANIES INC added 365,382 shares (+105.7%) to their portfolio in Q1 2025, for an estimated $32,234,000
GOLDMAN SACHS GROUP INC removed 361,147 shares (-41.2%) from their portfolio in Q1 2025, for an estimated $31,860,388
QUBE RESEARCH & TECHNOLOGIES LTD removed 283,067 shares (-71.0%) from their portfolio in Q1 2025, for an estimated $24,972,170

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read Full Article

New Analyst Forecast: $TRIP Given $18.0 Price Target

an hour ago | July 28, 2025 10:20 p.m. UTC

We just received data on a new analyst forecast for $TRIP. Stephen Ju from UBS set a price target of 18.0 for TRIP.

To track analyst ratings and price targets for $TRIP, check out Quiver Quantitative's $TRIP forecast page.

$TRIP Price Targets

Multiple analysts have issued price targets for $TRIP recently. We have seen 8 analysts offer price targets for $TRIP in the last 6 months, with a median target of $16.125.

Here are some recent targets:

Stephen Ju from UBS set a target price of $18.0 on 07/28/2025
Nafeesa Gupta from B of A Securities set a target price of $19.0 on 07/14/2025
Tom White from DA Davidson set a target price of $16.25 on 05/29/2025
Ronald Josey from Citigroup set a target price of $16.0 on 05/28/2025
Doug Anmuth from JP Morgan set a target price of $13.0 on 05/09/2025
Naved Khan from B. Riley Securities set a target price of $18.0 on 03/10/2025
Deepak Mathivanan from Cantor Fitzgerald set a target price of $13.0 on 02/21/2025

$TRIP Insider Trading Activity

$TRIP insiders have traded $TRIP stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $TRIP stock by insiders over the last 6 months:

ALMIR AMBESKOVIC (CEO, TheFork) has made 0 purchases and 2 sales selling 16,643 shares for an estimated $255,064.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$TRIP Hedge Fund Activity

We have seen 155 institutional investors add shares of $TRIP stock to their portfolio, and 129 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

UBS GROUP AG added 6,043,457 shares (+455.5%) to their portfolio in Q1 2025, for an estimated $85,635,785
INFINITUM ASSET MANAGEMENT, LLC added 2,834,000 shares (+inf%) to their portfolio in Q1 2025, for an estimated $40,157,780
CITADEL ADVISORS LLC added 2,269,856 shares (+677.8%) to their portfolio in Q1 2025, for an estimated $32,163,859
BANK OF AMERICA CORP /DE/ added 1,791,015 shares (+1253.5%) to their portfolio in Q1 2025, for an estimated $25,378,682
SOUTHEASTERN ASSET MANAGEMENT INC/TN/ added 1,728,253 shares (+inf%) to their portfolio in Q1 2025, for an estimated $24,489,345
HOLOCENE ADVISORS, LP added 1,675,142 shares (+1006.7%) to their portfolio in Q1 2025, for an estimated $23,736,762
RENAISSANCE TECHNOLOGIES LLC removed 1,635,810 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $23,179,427

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read Full Article

New Analyst Forecast: $AMD Given $210.0 Price Target

an hour ago | July 28, 2025 10:20 p.m. UTC

We just received data on a new analyst forecast for $AMD. Timothy Arcuri from UBS set a price target of 210.0 for AMD.

To track analyst ratings and price targets for $AMD, check out Quiver Quantitative's $AMD forecast page.

$AMD Price Targets

Multiple analysts have issued price targets for $AMD recently. We have seen 32 analysts offer price targets for $AMD in the last 6 months, with a median target of $140.0.

Here are some recent targets:

Timothy Arcuri from UBS set a target price of $210.0 on 07/28/2025
Stacy Rasgon from Bernstein set a target price of $140.0 on 07/21/2025
Christopher Danely from Citigroup set a target price of $165.0 on 07/18/2025
Vijay Rakesh from Mizuho set a target price of $175.0 on 07/16/2025
Aaron Rakers from Wells Fargo set a target price of $185.0 on 07/16/2025
Frank Lee from HSBC set a target price of $200.0 on 07/10/2025
James Schneider from Goldman Sachs set a target price of $140.0 on 07/10/2025

$AMD Congressional Stock Trading

Members of Congress have traded $AMD stock 12 times in the past 6 months. Of those trades, 8 have been purchases and 4 have been sales.

Here’s a breakdown of recent trading of $AMD stock by members of Congress over the last 6 months:

REPRESENTATIVE ROBERT BRESNAHAN has traded it 2 times. They made 1 purchase worth up to $50,000 on 05/15 and 1 sale worth up to $50,000 on 04/08.
REPRESENTATIVE MARJORIE TAYLOR GREENE has traded it 4 times. They made 4 purchases worth up to $60,000 on 05/14, 05/05, 04/09, 04/08 and 0 sales.
REPRESENTATIVE JEFFERSON SHREVE has traded it 5 times. They made 3 purchases worth up to $200,000 on 05/08, 03/31, 03/05 and 2 sales worth up to $200,000 on 05/12, 04/07.
SENATOR MARKWAYNE MULLIN sold up to $100,000 on 02/13.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$AMD Insider Trading Activity

$AMD insiders have traded $AMD stock on the open market 15 times in the past 6 months. Of those trades, 2 have been purchases and 13 have been sales.

Here’s a breakdown of recent trading of $AMD stock by insiders over the last 6 months:

MARK D PAPERMASTER (Chief Technology Officer & EVP) has made 0 purchases and 13 sales selling 87,998 shares for an estimated $10,285,820.
PHILIP GUIDO (EVP & Chief Commercial Officer) has made 2 purchases buying 13,445 shares for an estimated $1,498,944 and 0 sales.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$AMD Hedge Fund Activity

We have seen 1,196 institutional investors add shares of $AMD stock to their portfolio, and 1,217 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

FISHER ASSET MANAGEMENT, LLC removed 22,735,111 shares (-94.4%) from their portfolio in Q1 2025, for an estimated $2,335,805,304
JENNISON ASSOCIATES LLC removed 9,096,394 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $934,563,519
INFINITUM ASSET MANAGEMENT, LLC added 7,191,800 shares (+inf%) to their portfolio in Q1 2025, for an estimated $738,885,532
MARSHALL WACE, LLP added 6,944,358 shares (+327.1%) to their portfolio in Q1 2025, for an estimated $713,463,340
KINGSTONE CAPITAL PARTNERS TEXAS, LLC added 6,870,480 shares (+inf%) to their portfolio in Q2 2025, for an estimated $974,921,112
BAILLIE GIFFORD & CO removed 6,350,514 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $652,451,808
JANE STREET GROUP, LLC added 6,187,535 shares (+238.4%) to their portfolio in Q1 2025, for an estimated $635,707,345

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read Full Article

New Analyst Forecast: $GFS Given $43.0 Price Target

an hour ago | July 28, 2025 10:20 p.m. UTC

We just received data on a new analyst forecast for $GFS. Timothy Arcuri from UBS set a price target of 43.0 for GFS.

To track analyst ratings and price targets for $GFS, check out Quiver Quantitative's $GFS forecast page.

$GFS Price Targets

Multiple analysts have issued price targets for $GFS recently. We have seen 7 analysts offer price targets for $GFS in the last 6 months, with a median target of $43.0.

Here are some recent targets:

Timothy Arcuri from UBS set a target price of $43.0 on 07/28/2025
James Sheehan from Goldman Sachs set a target price of $40.0 on 07/10/2025
Christopher Danely from Citigroup set a target price of $42.0 on 07/07/2025
David Toung from Argus Research set a target price of $52.0 on 07/01/2025
Joseph Moore from Morgan Stanley set a target price of $38.0 on 05/07/2025
Matt Bryson from Wedbush set a target price of $60.0 on 02/12/2025
Quinn Bolton from Needham set a target price of $50.0 on 02/12/2025

$GFS Hedge Fund Activity

We have seen 149 institutional investors add shares of $GFS stock to their portfolio, and 131 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

MATRIX CAPITAL MANAGEMENT COMPANY, LP removed 7,300,000 shares (-51.2%) from their portfolio in Q1 2025, for an estimated $269,443,000
PACER ADVISORS, INC. added 2,444,018 shares (+8540.7%) to their portfolio in Q1 2025, for an estimated $90,208,704
ANALOG CENTURY MANAGEMENT LP removed 1,172,167 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $43,264,683
ALYESKA INVESTMENT GROUP, L.P. added 1,097,076 shares (+inf%) to their portfolio in Q1 2025, for an estimated $40,493,075
WOODLINE PARTNERS LP added 907,731 shares (+inf%) to their portfolio in Q1 2025, for an estimated $33,504,351
PROSHARE ADVISORS LLC added 822,811 shares (+129.0%) to their portfolio in Q1 2025, for an estimated $30,369,954
MARSHALL WACE, LLP removed 819,127 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $30,233,977

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read Full Article

New Analyst Forecast: $NICE Given $195.0 Price Target

an hour ago | July 28, 2025 10:20 p.m. UTC

We just received data on a new analyst forecast for $NICE. Clark Wright from DA Davidson set a price target of 195.0 for NICE.

To track analyst ratings and price targets for $NICE, check out Quiver Quantitative's $NICE forecast page.

$NICE Price Targets

Multiple analysts have issued price targets for $NICE recently. We have seen 12 analysts offer price targets for $NICE in the last 6 months, with a median target of $200.0.

Here are some recent targets:

Clark Wright from DA Davidson set a target price of $195.0 on 07/28/2025
Daniel Ives from Wedbush set a target price of $200.0 on 06/20/2025
Rishi Jaluria from RBC Capital set a target price of $200.0 on 06/18/2025
Thomas Blakey from Cantor Fitzgerald set a target price of $161.0 on 06/18/2025
Patrick Walravens from JMP Securities set a target price of $300.0 on 06/18/2025
Catharine Trebnick from Rosenblatt set a target price of $190.0 on 06/18/2025
James Fish from Piper Sandler set a target price of $182.0 on 06/13/2025

$NICE Hedge Fund Activity

We have seen 166 institutional investors add shares of $NICE stock to their portfolio, and 213 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

CAPITAL RESEARCH GLOBAL INVESTORS removed 1,676,089 shares (-98.6%) from their portfolio in Q1 2025, for an estimated $258,402,641
BOSTON PARTNERS removed 1,288,661 shares (-77.2%) from their portfolio in Q1 2025, for an estimated $198,672,866
ALLIANCEBERNSTEIN L.P. added 705,997 shares (+1125.3%) to their portfolio in Q1 2025, for an estimated $108,843,557
HAREL INSURANCE INVESTMENTS & FINANCIAL SERVICES LTD. added 638,809 shares (+inf%) to their portfolio in Q1 2025, for an estimated $98,485,183
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 623,014 shares (+218.6%) to their portfolio in Q1 2025, for an estimated $96,050,068
LAZARD ASSET MANAGEMENT LLC added 491,546 shares (+645.0%) to their portfolio in Q1 2025, for an estimated $75,781,646
ACADIAN ASSET MANAGEMENT LLC removed 459,207 shares (-72.2%) from their portfolio in Q1 2025, for an estimated $70,795,943

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read Full Article

New Analyst Forecast: $IMVT Given $18.0 Price Target

an hour ago | July 28, 2025 10:20 p.m. UTC

We just received data on a new analyst forecast for $IMVT. Ashwani Verma from UBS set a price target of 18.0 for IMVT.

To track analyst ratings and price targets for $IMVT, check out Quiver Quantitative's $IMVT forecast page.

$IMVT Price Targets

Multiple analysts have issued price targets for $IMVT recently. We have seen 5 analysts offer price targets for $IMVT in the last 6 months, with a median target of $33.0.

Here are some recent targets:

Ashwani Verma from UBS set a target price of $18.0 on 07/28/2025
Jason Gerberry from B of A Securities set a target price of $33.0 on 03/20/2025
Douglas Tsao from HC Wainwright & Co. set a target price of $51.0 on 03/19/2025
Yatin Suneja from Guggenheim set a target price of $44.0 on 02/10/2025

$IMVT Insider Trading Activity

$IMVT insiders have traded $IMVT stock on the open market 11 times in the past 6 months. Of those trades, 0 have been purchases and 11 have been sales.

Here’s a breakdown of recent trading of $IMVT stock by insiders over the last 6 months:

PETER SALZMANN (Chief Executive Officer) has made 0 purchases and 2 sales selling 36,415 shares for an estimated $488,840.
ANDREW J. FROMKIN has made 0 purchases and 2 sales selling 8,000 shares for an estimated $156,768.
JAY S STOUT (Chief Technology Officer) has made 0 purchases and 3 sales selling 6,249 shares for an estimated $105,569.
MICHAEL GEFFNER (Chief Medical Officer) has made 0 purchases and 3 sales selling 5,894 shares for an estimated $98,027.
EVA RENEE BARNETT (Chief Financial Officer) sold 2,993 shares for an estimated $44,565

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$IMVT Hedge Fund Activity

We have seen 118 institutional investors add shares of $IMVT stock to their portfolio, and 75 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

FMR LLC added 4,143,120 shares (+31.6%) to their portfolio in Q1 2025, for an estimated $70,805,920
BAKER BROS. ADVISORS LP added 3,750,000 shares (+219.6%) to their portfolio in Q1 2025, for an estimated $64,087,500
DEEP TRACK CAPITAL, LP added 3,500,000 shares (+58.3%) to their portfolio in Q1 2025, for an estimated $59,815,000
FRANKLIN RESOURCES INC removed 984,063 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $16,817,636
WOODLINE PARTNERS LP added 855,143 shares (+133.0%) to their portfolio in Q1 2025, for an estimated $14,614,393
BOXER CAPITAL MANAGEMENT, LLC removed 825,000 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $14,099,250
POINT72 ASSET MANAGEMENT, L.P. added 801,927 shares (+inf%) to their portfolio in Q1 2025, for an estimated $13,704,932

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read Full Article

New Analyst Forecast: $BAM Given $75.0 Price Target

an hour ago | July 28, 2025 10:20 p.m. UTC

We just received data on a new analyst forecast for $BAM. Cherilyn Radbourne from TD Securities set a price target of 75.0 for BAM.

To track analyst ratings and price targets for $BAM, check out Quiver Quantitative's $BAM forecast page.

$BAM Price Targets

Multiple analysts have issued price targets for $BAM recently. We have seen 7 analysts offer price targets for $BAM in the last 6 months, with a median target of $60.0.

Here are some recent targets:

Cherilyn Radbourne from TD Securities set a target price of $75.0 on 07/28/2025
Michael Brown from Wells Fargo set a target price of $57.0 on 07/11/2025
John Barnidge from Piper Sandler set a target price of $60.0 on 06/30/2025
Bart Dziarski from RBC Capital set a target price of $72.0 on 06/18/2025
An analyst from Morgan Stanley set a target price of $54.0 on 05/16/2025
Craig Siegenthaler from B of A Securities set a target price of $65.0 on 04/10/2025
Mario Saric from Scotiabank set a target price of $58.0 on 04/07/2025

$BAM Hedge Fund Activity

We have seen 280 institutional investors add shares of $BAM stock to their portfolio, and 226 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

FIL LTD removed 4,596,108 shares (-29.9%) from their portfolio in Q1 2025, for an estimated $222,681,432
FMR LLC removed 2,131,533 shares (-10.8%) from their portfolio in Q1 2025, for an estimated $103,272,773
NATIONAL BANK OF CANADA /FI/ removed 1,856,729 shares (-45.4%) from their portfolio in Q1 2025, for an estimated $89,958,520
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. removed 1,809,596 shares (-45.3%) from their portfolio in Q1 2025, for an estimated $87,674,926
SUSQUEHANNA INTERNATIONAL GROUP, LLP added 1,775,684 shares (+inf%) to their portfolio in Q1 2025, for an estimated $86,031,889
BRITISH COLUMBIA INVESTMENT MANAGEMENT CORP added 1,601,155 shares (+975.9%) to their portfolio in Q1 2025, for an estimated $77,575,959
ROYAL BANK OF CANADA removed 1,432,301 shares (-7.1%) from their portfolio in Q1 2025, for an estimated $69,394,983

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read Full Article

New Analyst Forecast: $CRI Given $26.0 Price Target

an hour ago | July 28, 2025 10:20 p.m. UTC

We just received data on a new analyst forecast for $CRI. Jay Sole from UBS set a price target of 26.0 for CRI.

To track analyst ratings and price targets for $CRI, check out Quiver Quantitative's $CRI forecast page.

$CRI Price Targets

Multiple analysts have issued price targets for $CRI recently. We have seen 4 analysts offer price targets for $CRI in the last 6 months, with a median target of $27.0.

Here are some recent targets:

Jay Sole from UBS set a target price of $26.0 on 07/28/2025
Ike Boruchow from Wells Fargo set a target price of $28.0 on 05/14/2025
Paul Kearney from Barclays set a target price of $25.0 on 04/28/2025
Paul Lejuez from Citigroup set a target price of $45.0 on 02/26/2025

$CRI Hedge Fund Activity

We have seen 155 institutional investors add shares of $CRI stock to their portfolio, and 177 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

PACER ADVISORS, INC. removed 2,399,591 shares (-84.2%) from their portfolio in Q1 2025, for an estimated $98,143,271
MILLENNIUM MANAGEMENT LLC added 1,620,140 shares (+14270.6%) to their portfolio in Q1 2025, for an estimated $66,263,726
FIRST TRUST ADVISORS LP removed 1,513,719 shares (-78.8%) from their portfolio in Q1 2025, for an estimated $61,911,107
RWWM, INC. added 1,297,607 shares (+145.3%) to their portfolio in Q1 2025, for an estimated $53,072,126
MARSHALL WACE, LLP added 1,124,391 shares (+inf%) to their portfolio in Q1 2025, for an estimated $45,987,591
UBS GROUP AG removed 825,408 shares (-51.1%) from their portfolio in Q1 2025, for an estimated $33,759,187
BALYASNY ASSET MANAGEMENT L.P. added 753,442 shares (+inf%) to their portfolio in Q1 2025, for an estimated $30,815,777

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read Full Article

New Analyst Forecast: $LSPD Given $12.0 Price Target

an hour ago | July 28, 2025 10:20 p.m. UTC

We just received data on a new analyst forecast for $LSPD. Kevin Krishnaratne from Scotiabank set a price target of 12.0 for LSPD.

To track analyst ratings and price targets for $LSPD, check out Quiver Quantitative's $LSPD forecast page.

$LSPD Price Targets

Multiple analysts have issued price targets for $LSPD recently. We have seen 12 analysts offer price targets for $LSPD in the last 6 months, with a median target of $12.0.

Here are some recent targets:

Kevin Krishnaratne from Scotiabank set a target price of $12.0 on 07/28/2025
Matthew Coad from Truist Securities set a target price of $12.0 on 07/17/2025
Raimo Lenschow from Barclays set a target price of $12.0 on 04/21/2025
Josh Baer from Morgan Stanley set a target price of $12.0 on 04/16/2025
Tien-Tsin Huang from JP Morgan set a target price of $9.0 on 04/14/2025
Andrew Bauch from Wells Fargo set a target price of $11.0 on 03/28/2025
Thanos Moschopoulos from BMO Capital set a target price of $14.0 on 03/27/2025

$LSPD Hedge Fund Activity

We have seen 51 institutional investors add shares of $LSPD stock to their portfolio, and 72 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

WESTFIELD CAPITAL MANAGEMENT CO LP removed 3,702,418 shares (-99.4%) from their portfolio in Q1 2025, for an estimated $32,396,157
WISHBONE MANAGEMENT, LP added 3,675,000 shares (+inf%) to their portfolio in Q1 2025, for an estimated $32,156,250
FIL LTD added 2,942,756 shares (+20.1%) to their portfolio in Q1 2025, for an estimated $25,749,115
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 2,269,661 shares (-54.3%) from their portfolio in Q1 2025, for an estimated $19,859,533
AZORA CAPITAL LP removed 1,460,772 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $12,781,755
GOLDMAN SACHS GROUP INC added 1,295,469 shares (+151.8%) to their portfolio in Q1 2025, for an estimated $11,335,353
POINT72 ASSET MANAGEMENT, L.P. added 879,777 shares (+208.0%) to their portfolio in Q1 2025, for an estimated $7,698,048

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read Full Article

New Analyst Forecast: $WWW Given $30.0 Price Target

an hour ago | July 28, 2025 10:20 p.m. UTC

We just received data on a new analyst forecast for $WWW. Jay Sole from UBS set a price target of 30.0 for WWW.

To track analyst ratings and price targets for $WWW, check out Quiver Quantitative's $WWW forecast page.

$WWW Price Targets

Multiple analysts have issued price targets for $WWW recently. We have seen 5 analysts offer price targets for $WWW in the last 6 months, with a median target of $19.0.

Here are some recent targets:

Jay Sole from UBS set a target price of $30.0 on 07/28/2025
Dana Telsey from Telsey Advisory Group set a target price of $17.0 on 05/09/2025
Jonathan Komp from Baird set a target price of $20.0 on 05/06/2025
Anna Andreeva from Piper Sandler set a target price of $18.0 on 04/11/2025
Jim Duffy from Stifel set a target price of $19.0 on 04/10/2025

$WWW Insider Trading Activity

$WWW insiders have traded $WWW stock on the open market 4 times in the past 6 months. Of those trades, 3 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $WWW stock by insiders over the last 6 months:

DEMONTY PRICE purchased 35,000 shares for an estimated $535,500
CHRISTOPHER HUFNAGEL (President and CEO) purchased 20,000 shares for an estimated $295,400
BRENDA J LAUDERBACK sold 6,500 shares for an estimated $108,355
TARYN L MILLER (Chief Financial Officer) purchased 6,600 shares for an estimated $100,914

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$WWW Hedge Fund Activity

We have seen 122 institutional investors add shares of $WWW stock to their portfolio, and 122 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

PACER ADVISORS, INC. removed 2,052,003 shares (-70.1%) from their portfolio in Q1 2025, for an estimated $28,543,361
J. GOLDMAN & CO LP added 1,724,261 shares (+inf%) to their portfolio in Q1 2025, for an estimated $23,984,470
CALLODINE CAPITAL MANAGEMENT, LP added 1,145,455 shares (+60.2%) to their portfolio in Q1 2025, for an estimated $15,933,279
JANE STREET GROUP, LLC added 1,099,019 shares (+1279.7%) to their portfolio in Q1 2025, for an estimated $15,287,354
UBS GROUP AG removed 1,043,560 shares (-47.5%) from their portfolio in Q1 2025, for an estimated $14,515,919
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 888,873 shares (-53.2%) from their portfolio in Q1 2025, for an estimated $12,364,223
JPMORGAN CHASE & CO added 775,313 shares (+32.0%) to their portfolio in Q1 2025, for an estimated $10,784,603

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read Full Article

Insider Sale: Chief Financial Officer of $OS Sells 25,000 Shares

an hour ago | July 28, 2025 10:15 p.m. UTC

William A Koefoed, the Chief Financial Officer of $OS, sold 25,000 shares of the company on 07-25-2025 for an estimated $625,000. We received data on the trade from a recent SEC filing. This was a sale of approximately 9.5% of their shares of this class of stock. Following this trade, they now own 237,839 shares of this class of $OS stock.

$OS Insider Trading Activity

$OS insiders have traded $OS stock on the open market 19 times in the past 6 months. Of those trades, 0 have been purchases and 19 have been sales.

Here’s a breakdown of recent trading of $OS stock by insiders over the last 6 months:

CRAIG COLBY has made 0 purchases and 3 sales selling 286,279 shares for an estimated $7,315,947.
WILLIAM A KOEFOED (Chief Financial Officer) has made 0 purchases and 6 sales selling 100,855 shares for an estimated $2,708,149.
KEN HOHENSTEIN (Chief Revenue Officer) has made 0 purchases and 4 sales selling 66,280 shares for an estimated $1,798,684.
JOHN KINZER has made 0 purchases and 3 sales selling 70,000 shares for an estimated $1,659,027.
JONATHAN D MARINER has made 0 purchases and 2 sales selling 13,261 shares for an estimated $361,296.
THOMAS ANTHONY SHEA (CEO and President) sold 9,913 shares for an estimated $279,843

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$OS Analyst Ratings

Wall Street analysts have issued reports on $OS in the last several months. We have seen 14 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

William Blair issued a "Outperform" rating on 05/20/2025
Piper Sandler issued a "Overweight" rating on 05/16/2025
Mizuho issued a "Outperform" rating on 05/15/2025
BMO Capital issued a "Outperform" rating on 05/15/2025
B of A Securities issued a "Buy" rating on 05/14/2025
Wedbush issued a "Outperform" rating on 05/09/2025
Stephens & Co. issued a "Overweight" rating on 05/09/2025

To track analyst ratings and price targets for $OS, check out Quiver Quantitative's $OS forecast page.

$OS Price Targets

Multiple analysts have issued price targets for $OS recently. We have seen 15 analysts offer price targets for $OS in the last 6 months, with a median target of $31.0.

Here are some recent targets:

Steven Enders from Citigroup set a target price of $29.0 on 07/16/2025
Brent Bracelin from Piper Sandler set a target price of $34.0 on 05/16/2025
Daniel Jester from BMO Capital set a target price of $33.0 on 05/15/2025
Siti Panigrahi from Mizuho set a target price of $33.0 on 05/15/2025
Koji Ikeda from B of A Securities set a target price of $33.0 on 05/14/2025
Daniel Ives from Wedbush set a target price of $35.0 on 05/09/2025
Brett Huff from Stephens & Co. set a target price of $30.0 on 05/09/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read Full Article

Insider Purchase: Director at $AMTB Buys 5,000 Shares

an hour ago | July 28, 2025 10:15 p.m. UTC

JACK L KOPNISKY, a director at $AMTB, bought 5,000 shares of the company on 07-28-2025 for an estimated $101,050. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings of this class of stock by approximately inf%. Following this trade, they now own 5,000 shares of this class of $AMTB stock.

$AMTB Insider Trading Activity

$AMTB insiders have traded $AMTB stock on the open market 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $AMTB stock by insiders over the last 6 months:

JACK L KOPNISKY purchased 5,000 shares for an estimated $101,050
HOWARD A. LEVINE (See remarks) sold 3,628 shares for an estimated $83,580

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$AMTB Hedge Fund Activity

We have seen 60 institutional investors add shares of $AMTB stock to their portfolio, and 52 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC added 426,660 shares (+inf%) to their portfolio in Q1 2025, for an estimated $8,806,262
KENNEDY CAPITAL MANAGEMENT LLC removed 220,017 shares (-23.5%) from their portfolio in Q1 2025, for an estimated $4,541,150
CUBIST SYSTEMATIC STRATEGIES, LLC removed 148,765 shares (-79.4%) from their portfolio in Q1 2025, for an estimated $3,070,509
RHINO INVESTMENT PARTNERS, INC added 133,869 shares (+inf%) to their portfolio in Q1 2025, for an estimated $2,763,056
ENDEAVOUR CAPITAL ADVISORS INC added 126,491 shares (+52.4%) to their portfolio in Q1 2025, for an estimated $2,610,774
TWO SIGMA ADVISERS, LP added 100,600 shares (+461.5%) to their portfolio in Q1 2025, for an estimated $2,076,384
TWO SIGMA INVESTMENTS, LP added 88,655 shares (+90.9%) to their portfolio in Q1 2025, for an estimated $1,829,839

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$AMTB Analyst Ratings

Wall Street analysts have issued reports on $AMTB in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Piper Sandler issued a "Overweight" rating on 07/28/2025
Stephens & Co. issued a "Overweight" rating on 04/29/2025

To track analyst ratings and price targets for $AMTB, check out Quiver Quantitative's $AMTB forecast page.

$AMTB Price Targets

Multiple analysts have issued price targets for $AMTB recently. We have seen 3 analysts offer price targets for $AMTB in the last 6 months, with a median target of $24.0.

Here are some recent targets:

Wood Lay from Keefe, Bruyette & Woods set a target price of $22.0 on 07/28/2025
Stephen Scouten from Piper Sandler set a target price of $26.0 on 07/28/2025
Russell Gunther from Stephens & Co. set a target price of $24.0 on 04/29/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read Full Article

H2O America Reports 11% Increase in Q2 2025 Diluted EPS and Strategic Acquisition of Quadvest Assets

2 hours ago | July 28, 2025 10:10 p.m. UTC

H2O America reports Q2 2025 diluted EPS of $0.71, 11% increase, with $207.2 million infrastructure investments and Quadvest acquisition.

Quiver AI Summary

H2O America reported strong financial results for the second quarter of 2025, with a reported diluted earnings per share (EPS) of $0.71, an 11% increase from the previous year, and an adjusted diluted EPS of $0.75, a 14% increase. Year-to-date, the company achieved a reported diluted EPS of $1.20, marking a 20% increase, while adjusted diluted EPS rose 23% to $1.25. The company invested $207.2 million in infrastructure in the first half of the year, on track for $473 million in capital expenditures for 2025. H2O America also announced its acquisition of Quadvest's assets in the Houston area, a significant growth opportunity due to the region's rapid expansion. Additionally, a quarterly cash dividend of $0.42 per share was declared, reflecting H2O America's commitment to returning value to shareholders. Overall, the company remains focused on its growth strategy and enhancing service across its operational footprint.

Potential Positives

Reported diluted EPS of $0.71 for Q2 2025 represents an 11% increase compared to the previous year's quarter, indicating strong financial performance.
The company has declared a quarterly cash dividend of $0.42 per share, marking an increase from the prior year and demonstrating a commitment to returning value to shareholders.
Entered into an agreement to acquire Quadvest’s assets in the high-growth Houston region, positioning the company for significant growth and expansion opportunities.
Year-to-date reported diluted EPS is $1.20, reflecting a 20% increase over the prior year, showcasing overall business growth and resilience.

Potential Negatives

Operating expenses increased by 14% compared to the same quarter last year, driven primarily by higher water production costs and increased administrative expenses.
The company incurred expenses of $1.5 million related to merger and acquisition activities, which may indicate challenges in integration or realization of benefits from such activities.
Regulatory changes and legislative adjustments may expose the company to potential risks such as increased costs and operational uncertainties in various states, particularly regarding water quality and treatment initiatives.

FAQ

What was H2O America's diluted EPS for Q2 2025?

H2O America's diluted EPS for Q2 2025 was $0.71, an 11% increase from the previous year.

How much did H2O America invest in infrastructure year-to-date 2025?

H2O America invested $207.2 million in infrastructure through June 30, 2025, on track for full-year expenditures of $473 million.

What significant acquisition did H2O America announce?

H2O America announced an agreement to acquire Quadvest's assets in the high-growth Houston region.

What is H2O America's 2025 adjusted diluted EPS guidance?

H2O America reaffirmed its 2025 adjusted diluted EPS guidance of $2.90 to $3.00.

What cash dividend did H2O America declare for Q3 2025?

H2O America declared a quarterly cash dividend of $0.42 per share, payable on September 2, 2025.

Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.

Full Release

Second quarter 2025 reported diluted EPS of $0.71, an 11% increase in diluted EPS over the prior year, and adjusted diluted EPS (non-GAAP) ¹ of $0.75, a 14% increase in adjusted diluted EPS over the prior year
2025 year-to-date reported diluted EPS of $1.20, a 20% increase in diluted EPS over the prior year, and adjusted diluted EPS (non-GAAP) of $1.25, a 23% increase in adjusted diluted EPS over the prior year
2025 year-to-date infrastructure investment was $207.2 million ² , on track for full-year capital expenditures of $473.0 million ²
Entered into an agreement to acquire all of Quadvest’s assets in the high-growth Houston region, filed a Notice of Intent to Determine Fair Market Value (FMV) with the PUCT
Quadvest's active connections and connections under contract and pending development up 4%, or 5,400 connections, between December 31, 2024 and June 30, 2025
Declares $0.42 cash dividend per share of common stock

SAN JOSE, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- H2O America (NASDAQ: HTO) today reported financial results for the Second quarter of 2025.

"We are pleased with our second-quarter results, which highlight the strength of our local water operations and the disciplined execution of our proven business strategy," stated Andrew F. Walters, H2O America chief executive officer." In Maine, we achieved a constructive outcome in our Camden Rockland general rate case and received authorization to introduce new affordability programs to our customers – key steps that reflect both regulatory process and our commitment to community needs. We also secured new or enhanced regulatory mechanisms in Connecticut and Texas to further reduce lag, while in California we received approval to recover our investment in the advanced metering infrastructure project. Across our national footprint, we invested $207.2 million ² to maintain and improve our water supply and infrastructure, keeping us firmly on track to meet both our 2025 and five-year capital expenditure goals."

Walters continued, "Following the close of the second quarter, we announced a strategic agreement for our Texas Water subsidiary to acquire Quadvest's assets in the greater Houston area – one of the fastest growing regions in the country. This acquisition represents a significant growth opportunity, positioning our Texas operations within the top 2% of fastest growing counties in the U.S. From December 31, 2024 and June 30, 2025 the number of Quadvest's active connections increased by 7% from 47,000 to 50,500, while the number of connections under contract and pending development grew 2% from 89,000 to 90,900."

Second Quarter 2025 Operating Results

Net income prepared in accordance with U.S. Generally Accepted Accounting Principles (GAAP) for the quarter ended June 30, 2025 was $24.7 million, a 19% increase compared to $20.7 million in the same quarter last year. Diluted EPS for the quarter was $0.71 versus $0.64 in the prior year quarter, an increase of 11%. Adjusting for merger and acquisition activities and real estate transactions, H2O America's adjusted net income (non-GAAP) in the second quarter of 2025 was $26.2 million, an increase of 23% compared to $21.3 million in the prior-year period. Adjusted diluted EPS (non-GAAP) for the quarter was $0.75 versus $0.66 in the prior year quarter, an increase of 14%.

The difference between GAAP net income and adjusted net income for the quarter ended June 30, 2025 was due to expenses incurred for merger and acquisition activities of $1.5 million, net of tax. A full reconciliation of GAAP net income to adjusted net income for the quarter ended June 30, 2025 is included in the tables at the end of this news release.

Operating revenue for the second quarter was $198.3 million, compared to $176.2 million for the same quarter last year, a 13% increase. The increase was driven by rate increases of $17.6 million, primarily in California and Connecticut and higher customer usage of $4.9 million driven primarily by weather conditions.

Operating expenses for the quarter ended June 30, 2025 were $154.4 million, up 14% compared to $135.6 million for the same quarter last year. This change in operating expenses primarily reflects:

An increase in water production expenses of $10.4 million compared to the same quarter last year due primarily due to higher purchased water and groundwater extraction charges; and
An increase in administrative and general expenses of $8.3 million primarily due to increases in customer credit losses as a result of the collection of funds in the prior year from the California Extended Water and Wastewater Arrearage Payment Program, as well as increases in acquisition, insurance, and contracted work costs.

The effective consolidated income tax rates for the second quarter of 2025 and 2024 were approximately 16% and 15%, respectively.

Year-to-Date Operating Results

Net income prepared in accordance with GAAP for the six months through June 30, 2025 was $41.2 million, a 27% increase compared to $32.4 million in the same period of 2024. GAAP diluted EPS for the six months was $1.20, an increase of 20% compared to $1.00 diluted EPS in the same period last year. Non-GAAP adjusted net income for the six months through June 30, 2025 was $42.9 million, a 30% increase compared to $33.0 million in the same period last year. Non-GAAP adjusted diluted EPS for the first six months was $1.25, an increase of 23% compared to $1.02 adjusted diluted EPS in the same period last year. A full reconciliation of GAAP net income to adjusted net income for the six months ended June 30, 2025 is included in the tables at the end of this news release.

Operating revenue year-to-date was $365.9 million compared to $325.6 million for the same period last year, a 12% increase. The increase was driven by rate increases of $34.8 million, primarily in California and Connecticut, and higher customer usage of $5.9 million driven primarily by weather conditions. This was partially offset by a decrease of $2.4 million due to regulatory mechanism adjustments.

Operating expenses for the first six months of 2025 were $286.1 million, which was up 11% compared to $257.1 million for the same period last year. This change in operating expenses primarily reflects:

An increase in water production expenses of $17.5 million compared to the same period last year primarily related to increased water pass-through costs and higher customer usage; and
An increase in administrative and general expenses of $10.3 million primarily due to an increase related to customer credit losses as a result of the collection of funds in the prior year from the California Extended Water and Wastewater Arrearage Payment Program, as well as increases in acquisition, insurance, and contracted work costs.

The effective consolidated income tax rates for the first six months of 2025 and 2024 were approximately 16% for both periods.

Capital Expenditures

Through June 30, 2025, H2O America has invested $207.2 million ² in infrastructure, which is approximately 44% of the planned 2025 capital expenditures of $473 million ² . We are on track to meet our full-year capital expenditure target.

Growth through Acquisition

On July 7, 2025, H2O America, entered into an agreement, through its Texas Water subsidiary, to acquire the assets of Quadvest, a water and wastewater utility serving the rapidly growing greater Houston area. Upon completion, this acquisition will position our Texas operations as the second largest investor-owned water and wastewater utility in the state and drive significant customer growth. The combined company will serve seven of the 50 fastest-growing counties in the United States - placing us in the top 2% nationwide based on 2024 U.S. Census Bureau data. The transaction is expected to be accretive in 2028 and meaningfully accretive to our long-term growth rate.

Additional information on the Quadvest acquisition is available in the news release and presentation that were issued on July 8, 2025 that are available at H2O America's website.

Rate Activity and Regulatory Updates

California

On June 24, 2025, the CPUC approved advice letter 616, which increased the authorized revenue requirement by $22.5 million, or 4.0%, to offset the increases to purchased potable water charges, the groundwater extraction fee, and purchased recycled water charges from its water wholesalers effective July 1, 2025.

On June 27, 2025, the California Public Utilities Commission (CPUC) approved Advice Letter 617, which requested a $6.8 million, or 1.2%, increase in revenue on July 1, 2025 for San Jose Water's investment in its advance metering infrastructure (AMI) project.

Connecticut

On July 1, 2025, Connecticut Governor Lamont signed the Water Quality and Treatment Adjustment (WQTA) into law. The WQTA is an infrastructure recovery mechanism established to recover the capital investment needed to treat per- and polyfluoroalkyl substances (PFAS) and other emerging contaminants. We expect the WQTA will be available to Connecticut Water beginning in 2026, and it is expected that the $190 million estimated for PFAS treatment by Connecticut Water to meet water quality standards will be recovered through this mechanism. WQTA provides for an annual filing to recover the total capital invested during the period. The maximum surcharge is 7.5% per year and 15% between general rate cases.

On April 1, 2025, a $1.6 million revenue increase for Connecticut Water's infrastructure investment projects completed through the Water Infrastructure and Conservation Adjustment (WICA) was implemented. The cumulative WICA surcharge is now 4.9%.

Maine

On June 27, 2025, the Maine Public Utilities Commission (MPUC) issued a final decision in the general rate case for Maine Water's Camden-Rockland division. The MPUC authorized a $865,000 revenue increase above current authorized revenues.

On June 24, 2025, the MPUC approved the requested Water Infrastructure Charge increases in the Biddeford Saco and Oakland divisions, the combined authorized increase was $547,000, or 3.0% over current authorized revenues. The application was filed on April 15, 2025.

On May 29, 2025, Governor Mills signed legislation that allows Maine water utilities to offer affordability programs to customers. The company is working with the Office of Public Advocate on the development and implementation of an affordability tariff as part of Maine Water's application before the MPUC to unify the company's ten rate districts into a single tariff that was filed on December 31, 2024.

Texas

On July 9, 2025, Texas Water filed a Notice of Intent to Determine Fair Market Value with the Public Utilities Commission of Texas (PUCT) for the Quadvest transaction. Under Texas's FMV regulation, the PUCT is expected to name three appraisers who will have 120 days to determine the value of Quadvest's regulated water and wastewater assets. The FMV will be the average of the appraisals. Recovery of FMV will take place as part of TWC's next rate case.

On May 15, 2025, the PUCT approved Texas Water's request for a System Improvement Charge (SIC) and authorized an additional $4.1 million in revenues effective on May 15, 2025.

During 2025, two key pieces of water utility legislation were passed by the Texas State Legislature and signed by Governor Abbott that provide an opportunity to reduce regulatory lag. The first authorizes water utilities to adopt a future or hybrid test year in general rate cases; traditionally, Texas has been a historical test year jurisdiction for water utilities. The second reduces the timeline for processing of SIC applications from 120 days to 60 days. Texas Water supported these pieces of legislation, and we believe they are in the best interest of customers and the company.

Reaffirming 2025 Guidance

The company is reaffirming 2025 adjusted diluted EPS guidance of $2.90 to $3.00 ¹ and our non-linear long-term diluted EPS growth of 5% to 7% through 2029, anchored off of 2022's diluted EPS of $2.43. Based on current business conditions, the company believes it will achieve growth over the period in the top half of the range.

Our guidance is subject to risks and uncertainties, including, without limitation, those factors outlined in the Forward-Looking Statements of this release and the Risk Factors section of the company’s annual and quarterly reports filed with the Securities and Exchange Commission.

Dividend

On July 25, 2025, the directors of H2O America declared a quarterly cash dividend on common stock of $0.42 per share, payable on September 2, 2025, to shareholders of record at the close of business on August 11, 2025. The 2025 annualized dividend is expected to be $1.68 per share compared with $1.60 per share in 2024.

Dividends have been paid on H2O America’s and its predecessor’s common stock for more than 80 consecutive years, and the annual dividend amount has increased for 57 consecutive years, placing H2O America in an exclusive group of companies.

Financial Results Call Information

Andrew F. Walters, chief executive officer, Ann P. Kelly, chief financial officer and treasurer, and Bruce A. Hauk, president and chief operating officer, will review results for the second quarter in a live webcast presentation at 11 a.m. Pacific Daylight Time, or 2 p.m. Eastern Daylight Time, on Tuesday, July 29, 2025.

Interested parties may access the webcast and related presentation materials at the website www.sjwgroup.com. An archive of the webcast will be available until October 20, 2025.

Non-GAAP Financial Measures

H2O America's net income and diluted EPS are prepared in accordance with GAAP and represent the earnings as reported to the Securities and Exchange Commission. Adjusted net income and Adjusted diluted EPS are non-GAAP financial measures representing GAAP earnings adjusted to exclude the effects of non-utility real estate transactions and costs associated with mergers and acquisition activities, if any. These non-GAAP financial measures are provided as additional information for investors to evaluate the performance of H2O America's business activities excluding these items. Management also believes these non-GAAP financial measures help investors and analysts better understand our actual results compared to our guidance on a non-GAAP basis. H2O America uses adjusted net income and/or adjusted diluted EPS as the primary performance measurements when communicating with analysts and investors regarding our outlook and results. Adjusted net income and Adjusted diluted EPS are also used internally to measure performance. However, these non-GAAP financial measures may be different from non-GAAP financial measures used by other companies, even when the same or similarly titled terms are used to identify such measures, limiting their usefulness for comparative purposes. Further, these non-GAAP financial measures should be considered as a supplement to the financial information prepared on a GAAP basis rather than an alternative to the respective GAAP financial measures.

About H2O America

H2O America is among the largest investor-owned pure-play water and wastewater utilities in the United States, providing life-sustaining and high-quality water service to 1.6 million people. H2O America’s locally led and operated water utilities - San Jose Water Company in California, The Connecticut Water Company in Connecticut, The Maine Water Company in Maine, and SJWTX, Inc. (dba The Texas Water Company) in Texas - possess the financial strength, operational expertise, and technological innovation to safeguard the environment, deliver outstanding service to customers, and provide opportunities to employees. H2O America remains focused on investing in its operations, remaining actively engaged in its local communities, and delivering continued sustainable value to its stockholders. For more information about H2O America, please visit www.sjwgroup.com.

Forward-Looking Statements

This release contains forward-looking statements within the meaning of the federal securities laws relating to future events and future results of H2O America and its subsidiaries that are based on current expectations, estimates, forecasts, and projections about H2O America and its subsidiaries and the industries in which H2O America and its subsidiaries operate and the beliefs and assumptions of the management of H2O America. Some of these forward-looking statements can be identified by the use of forward-looking words such as “believes,” “expects,” “estimates,” “anticipates,” “intends,” “seeks,” “plans,” “projects,” “may,” “should,” “will,” “approximately,” “strategy,” or the negative of those words or other comparable terminology. These forward-looking statements are only predictions and are subject to risks, uncertainties, and assumptions that are difficult to predict. Therefore, actual results may differ materially and adversely from those expressed in any forward-looking statements.

The accuracy of such statements is subject to a number of risks, uncertainties and assumptions including, but not limited to, the following factors: (1) the risks associated with the proposed transactions with Quadvest, including, the risk of the proposed transactions not closing on the anticipated timeline, or at all, the ability to obtain required regulatory approvals, and the ability to successfully integrate Quadvest’s operations and realize the projected financial and other benefits of the proposed transactions; (2) the effect of water, utility, environmental and other governmental policies and regulations, including regulatory actions concerning rates, authorized return on equity, authorized capital structures, capital expenditures, PFAS and other decisions; (3) changes in demand for water and other services; (4) unanticipated weather conditions and changes in seasonality including those affecting water supply and customer usage; (5) the effect of the impact of climate change; (6) unexpected costs, charges or expenses; (7) our ability to successfully evaluate investments in new business and growth initiatives; (8) contamination of our water supplies and damage or failure of our water equipment and infrastructure; (9) the risk of work stoppages, strikes and other labor-related actions; (10) catastrophic events such as fires, earthquakes, explosions, floods, ice storms, tornadoes, hurricanes, terrorist acts, physical attacks, cyber-attacks, epidemic, or similar occurrences; (11) changes in general economic, political, legislative, business and financial market conditions; and (12) the ability to obtain financing on favorable terms, or at all (including the financing for the proposed transactions with Quadvest in a timely manner), which can be affected by various factors, including credit ratings, changes in interest rates, compliance with regulatory requirements, compliance with the terms and conditions of our outstanding indebtedness, and general market and economic conditions. The risks, uncertainties and other factors may cause the actual results, performance or achievements of H2O America to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements.

Results for a quarter are not indicative of results for a full year due to seasonality and other factors. In addition, actual results, performance or achievements are subject to other risks and uncertainties that relate more broadly to our overall business, including those more fully described in our filings with the SEC, including our most recent reports on Form 10-K, Form 10-Q and Form 8-K. Forward-looking statements are not guarantees of future performance, and speak only as of the date made, and H2O America undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise, except as required by law.

H2O America Contacts:

Ann P. Kelly
Chief Financial Officer and Treasurer
408.385.4752
Ann.Kelly@H2O-America.com

Daniel J. Meaney
Director of Investor Relations
860.664.6016
Daniel.Meaney@H2O-America.com

______________________________

¹ Adjusted net income and adjusted diluted EPS are non-GAAP financial measures as defined below. See the tables below for reconciliations to the most comparable GAAP measures.

² Includes both utility plant additions and capitalizable costs associated with cloud-computing arrangements.

H2O America Condensed Consolidated Statements of Income (Unaudited) (in thousands, except share and per share data)

	Three months ended June 30,					Six months ended June 30,
		2025		2024			2025		2024
Operating revenue	$	198,255		176,174		$	365,854		325,556
Operating expense:
Production Expenses:
Purchased water		37,421		38,129			63,374		64,321
Power		3,851		2,737			7,334		5,164
Groundwater extraction charges		26,354		17,552			44,645		29,678
Other production expenses		13,243		12,052			24,483		23,101
Total production expenses		80,869		70,470			139,836		122,264
Administrative and general		28,795		20,468			56,555		46,256
Maintenance		7,470		7,881			14,969		14,568
Property taxes and other non-income taxes		8,506		8,419			17,701		17,249
Depreciation and amortization		28,750		28,366			57,032		56,736
Total operating expense		154,390		135,604			286,093		257,073
Operating income		43,865		40,570			79,761		68,483
Other (expense) income:
Interest on long-term debt and other interest expense		(18,122	)	(18,294	)		(36,394	)	(35,878	)
Pension non-service credit		1,620		939			3,223		1,889
Other, net		1,982		1,205			2,777		3,856
Income before income taxes		29,345		24,420			49,367		38,350
Provision for income taxes		4,670		3,724			8,141		5,955
Net income		24,675		20,696			41,226		32,395
Other comprehensive loss, net		—		—			—		(442	)
Comprehensive income	$	24,675		20,696		$	41,226		31,953

Earnings per share
—Basic	$	0.71		0.64		$	1.20		1.00
—Diluted	$	0.71		0.64		$	1.20		1.00
Dividends per share	$	0.42		0.40		$	0.84		0.80
Weighted average shares outstanding
—Basic		34,777,152		32,397,501			34,280,727		32,237,115
—Diluted		34,860,349		32,460,894			34,367,212		32,302,741

H2O America Condensed Consolidated Balance Sheets (Unaudited) (in thousands, except share and per share data)

	June 30, 2025		December 31, 2024
Assets
Utility plant:
Land	$	44,681	44,657
Depreciable plant and equipment		4,395,856	4,249,314
Construction work in progress		241,793	179,486
Intangible assets		51,604	51,604
Total utility plant		4,733,934	4,525,061
Less: accumulated depreciation and amortization		1,079,538	1,036,450
Net utility plant		3,654,396	3,488,611

Nonutility properties		1,314	1,314
Less: accumulated depreciation		99	98
Net nonutility properties		1,215	1,216

Current assets:
Cash and cash equivalents.		19,849	11,114
Accounts receivable:
Customers, net of allowances for credit losses of $994 and $1,172 on June 30, 2025 and December 31, 2024, respectively		76,758	68,679
Income tax		—	5,953
Other		7,666	7,059
Accrued unbilled revenue		67,960	60,847
Prepaid expenses		8,427	10,297
Current regulatory assets		12,626	18,172
Other current assets		7,164	8,593
Total current assets		200,450	190,714
Other assets:
Regulatory assets, less current portion		232,650	224,055
Investments		18,878	18,087
Postretirement benefit plans		68,682	66,422
Goodwill		640,311	640,311
Other		30,344	28,893
Total other assets		990,865	977,768
Total assets	$	4,846,926	4,658,309

H2O America Condensed Consolidated Balance Sheets (Unaudited) (in thousands, except share and per share data)
	June 30, 2025		December 31, 2024
Capitalization and liabilities
Capitalization:
Stockholders’ equity:
Common stock, $0.001 par value; authorized 70,000,000 shares; issued and outstanding shares 35,287,080 on June 30, 2025 and 33,629,169 on December 31, 2024	$	35	34
Additional paid-in capital		914,330	827,796
Retained earnings		549,646	537,184
Accumulated other comprehensive income		1,960	1,960
Total stockholders’ equity		1,465,971	1,366,974
Long-term debt, less current portion		1,692,212	1,706,904
Total capitalization		3,158,183	3,073,878

Current liabilities:
Lines of credit		160,840	119,124
Current portion of long-term debt		18,923	3,648
Accrued groundwater extraction charges, purchased water and power		38,310	25,118
Accounts payable		48,231	56,256
Accrued interest		16,126	17,476
Accrued payroll		11,579	15,193
Current regulatory liabilities		2	1,122
Other current liabilities		20,223	23,236
Total current liabilities		314,234	261,173

Deferred income taxes		286,031	276,043
Advances for construction		172,612	155,397
Contributions in aid of construction		339,949	340,738
Postretirement benefit plans		44,033	45,063
Regulatory liabilities, less current portion		508,980	483,719
Other noncurrent liabilities		22,904	22,298
Commitments and contingencies
Total capitalization and liabilities	$	4,846,926	4,658,309

H2O America Reconciliation of Non-GAAP Financial Measures (Unaudited) (in thousands, except per share data)

	Three months ended June 30,					Six months ended June 30,
		2025		2024			2025		2024
Reported GAAP Net Income	$	24,675		20,696		$	41,226		32,395
Adjustments:
Loss on sale of real estate investments ¹		—		909			—		909
Expense for merger and acquisition activities ²		2,093		—			2,347		—
Tax effect of above adjustments ³		(586	)	(291	)		(657	)	(291	)
Adjusted Net Income (non-GAAP)	$	26,182		21,314		$	42,916		33,013

Reported GAAP Diluted Earnings Per Share	$	0.71		0.64		$	1.20		1.00
Adjustments:
Loss on sale of non-utility real estate, net of tax		—		0.02			—		0.02
Expense for merger and acquisition activities, net of tax		0.04		—			0.05		—
Adjusted Diluted Earnings Per Share (non-GAAP)	$	0.75		0.66		$	1.25		1.02

¹ Included in the "Other, net" line on the condensed consolidated statements of comprehensive income.
² Included in the "Administrative and general" line on the condensed consolidated statements of income.
³ The tax effect on all adjustments is calculated at the applicable statutory rate.

Read Full Article

NOV Inc. Reports Second Quarter 2025 Financial Results: Revenues at $2.19 Billion, Net Income Declines 52% Year-Over-Year

2 hours ago | July 28, 2025 9:50 p.m. UTC

NOV Inc. reported Q2 2025 revenues of $2.19 billion, with a net income of $108 million and decreased adjusted EBITDA.

Quiver AI Summary

NOV Inc. reported second quarter 2025 revenues of $2.19 billion, reflecting a 4% sequential increase but a 1% decrease year-over-year. Net income fell to $108 million, or $0.29 per share, a 52% drop compared to the previous year, primarily due to a significant gain from a business sale last year. Adjusted EBITDA decreased by 10% to $252 million. The company noted a mixed sales performance, with improved capital equipment revenues offset by weaker spare parts sales, and cited macroeconomic challenges including OPEC+ production changes and regional conflicts affecting customer confidence and order deferrals. Despite these challenges, offshore activity remains relatively strong. For the third quarter, NOV expects revenues to decline by 1-3% year-over-year and plans to implement further cost control measures. During the quarter, the company returned $176 million to shareholders through dividends and stock repurchases.

Potential Positives

Revenues of $2.19 billion, marking a 4% sequential increase, highlighting positive quarterly performance.
Returned $176 million of capital to shareholders through share repurchases and dividends, demonstrating commitment to shareholder value.
Secured multiple significant contracts, including a multi-year agreement for instrumentation and digital services and contracts for key projects in gas infrastructure and offshore capabilities, indicating strong demand for NOV's advanced technological solutions.

Potential Negatives

Revenues decreased by 1% year-over-year, indicating potential challenges in maintaining sales growth in a competitive market.
Net income dropped by 52% compared to the previous year, raising concerns about profitability and cost management.
New orders fell significantly by $557 million year-over-year, suggesting a decrease in customer demand and market activity, which may impact future revenue and operational stability.

FAQ

What are NOV's second quarter 2025 revenue figures?

NOV reported revenues of $2.19 billion for the second quarter of 2025, a decrease of 1% year-over-year.

How much net income did NOV achieve in Q2 2025?

NOV's net income for Q2 2025 was $108 million, equivalent to $0.29 per share.

What factors affected NOV's operating profit?

Operating profit decreased due to a significant pre-tax gain from a business sale in the previous year, and market headwinds.

What is the outlook for NOV in the second half of 2025?

NOV expects lower industry activity levels and a revenue decline of 1-3% year-over-year through the second half of 2025.

What financial measures does NOV consider non-GAAP?

NOV uses non-GAAP measures like Free Cash Flow and Adjusted EBITDA to evaluate its financial performance and trends.

Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.

$NOV Hedge Fund Activity

We have seen 223 institutional investors add shares of $NOV stock to their portfolio, and 216 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

PACER ADVISORS, INC. removed 7,358,552 shares (-59.8%) from their portfolio in Q1 2025, for an estimated $111,997,161
AMERIPRISE FINANCIAL INC removed 5,087,705 shares (-89.0%) from their portfolio in Q1 2025, for an estimated $77,434,870
BANK OF NEW YORK MELLON CORP removed 4,657,393 shares (-51.8%) from their portfolio in Q1 2025, for an estimated $70,885,521
AQR CAPITAL MANAGEMENT LLC added 3,362,853 shares (+88.9%) to their portfolio in Q1 2025, for an estimated $51,182,622
FIRST TRUST ADVISORS LP added 3,292,990 shares (+220.1%) to their portfolio in Q1 2025, for an estimated $50,119,307
ARIEL INVESTMENTS, LLC removed 2,294,639 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $34,924,405
DEPRINCE RACE & ZOLLO INC removed 1,983,938 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $30,195,536

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$NOV Analyst Ratings

Wall Street analysts have issued reports on $NOV in the last several months. We have seen 6 firms issue buy ratings on the stock, and 3 firms issue sell ratings.

Here are some recent analyst ratings:

Stifel issued a "Buy" rating on 07/16/2025
Susquehanna issued a "Positive" rating on 07/01/2025
Wells Fargo issued a "Underweight" rating on 06/05/2025
Morgan Stanley issued a "Overweight" rating on 05/16/2025
RBC Capital issued a "Outperform" rating on 04/30/2025
JP Morgan issued a "Overweight" rating on 04/30/2025
Barclays issued a "Underweight" rating on 04/30/2025

To track analyst ratings and price targets for $NOV, check out Quiver Quantitative's $NOV forecast page.

$NOV Price Targets

Multiple analysts have issued price targets for $NOV recently. We have seen 10 analysts offer price targets for $NOV in the last 6 months, with a median target of $16.5.

Here are some recent targets:

Stephen Gengaro from Stifel set a target price of $22.0 on 07/16/2025
Charles Minervino from Susquehanna set a target price of $18.0 on 07/01/2025
Roger Read from Wells Fargo set a target price of $10.0 on 06/05/2025
Elizabeth Porter from Morgan Stanley set a target price of $15.0 on 05/16/2025
Luke Lemoine from Piper Sandler set a target price of $16.0 on 05/01/2025
David Anderson from Barclays set a target price of $11.0 on 04/30/2025
Arun Jayaram from JP Morgan set a target price of $17.0 on 04/30/2025

Full Release

FOR IMMEDIATE RELEASE

Revenues of $2.19 billion, up 4% sequentially and down 1% year-over-year
Net Income of $108 million, or $0.29 per share
Adjusted EBITDA* of $252 million
Cash flow from operations of $191 million and free cash flow* of $108 million
Returned $176 million of capital to shareholders through share repurchases and dividends

*Free Cash Flow, Excess Free Cash Flow and Adjusted EBITDA are non-GAAP measures, see “Non-GAAP Financial Measures,” “Reconciliation of Cash Flows from Operating Activities to Free Cash Flow and Excess Free Cash Flow” and “Reconciliation of Net Income to Adjusted EBITDA” below.

HOUSTON, July 28, 2025 (GLOBE NEWSWIRE) -- NOV Inc. (NYSE: NOV) today reported second quarter 2025 revenues of $2.19 billion, a decrease of one percent compared to the second quarter of 2024. Net income decreased 52 percent to $108 million, or $0.29 per share, and operating profit decreased 54 percent to $143 million, or 6.5 percent of sales. The decline in net income and operating profit is primarily attributed to a pre-tax gain of approximately $130 million on the sale of a business during the second quarter of 2024. The Company recorded $19 million within Other Items during the second quarter of 2025 (see Corporate Information for additional details). Adjusted EBITDA decreased 10 percent year-over-year to $252 million, or 11.5 percent of sales.

“Sales improved four percent sequentially, with an increase in capital equipment revenues more than offsetting a decline in spare part and product sales,” said Clay Williams, Chairman and CEO. “Macroeconomic uncertainty, the rapid unwinding of OPEC+ production quotas, and conflict in the Middle East led to greater caution among our customers, deferred orders, and lower year-over-year revenues. These market headwinds and a shift in sales mix pressured margins during the quarter.

“Customers in North America continued to trim oil-directed drilling, which was only partly offset by modestly increasing gas drilling. Offshore activity remains comparatively strong, despite certain project delays, and we remain encouraged by the steady application of unconventional technologies in new international basins. Overall, the softer market has made it more challenging to offset tariffs and other inflationary costs. In response, NOV is implementing additional cost control initiatives and further adjusting our global supply chain to better mitigate increasing costs.

“Looking ahead, we expect current market dynamics to persist resulting in lower industry activity levels through the second half of the year, with offshore activity resuming growth in 2026. Longer-term, we expect rising demand for secure, reliable, and lower-cost sources of energy will drive investment in our core markets. NOV’s technology leadership, customer-focus, and commitment to improving efficiencies has the Company well positioned to navigate through the near-term environment while positioning the company for future growth.”

Energy Products and Services
Energy Products and Services generated revenues of $1.03 billion in the second quarter of 2025, a decrease of two percent from the second quarter of 2024. Operating profit decreased $45 million from the prior year to $83 million, or 8.1 percent of sales, and included $6 million in Other Items. Adjusted EBITDA decreased $38 million from the prior year to $146 million, or 14.2 percent of sales. The decline in revenue was due to lower levels of global drilling activity affecting demand for the segment’s shorter cycle consumable products, partially offset by higher sales from the segment’s capital equipment offerings. Profitability was impacted by a less favorable sales mix, tariffs and other inflationary pressures, and certain charges in Latin America.

Energy Equipment
Energy Equipment generated revenues of $1.21 billion in the second quarter of 2025, flat when compared to the second quarter of 2024. Operating profit was $122 million, or 10.1 percent of sales, and included $9 million in Other Items. Operating profit decreased $110 million from the prior year primarily attributed to a pre-tax gain of approximately $130 million on the sale of a business during the second quarter of 2024. Adjusted EBITDA increased $16 million from the prior year to $158 million, or 13.1 percent of sales. Higher revenue out of backlog offset lower sales of aftermarket parts and services. Improved profitability was driven by strong execution on higher-margin backlog.

New orders totaled $420 million, a decrease of $557 million when compared to the $977 million of new orders booked during the second quarter of 2024. Orders shipped from backlog in the second quarter of 2025 were $632 million, representing a book-to-bill of 66 percent, compared to $553 million orders shipped and a book-to-bill of 177 percent in the second quarter of 2024. As of June 30, 2025, backlog for capital equipment orders for Energy Equipment was $4.30 billion, a decrease of $31 million from the second quarter of 2024.

Q3 2025 Outlook
The Company is providing financial guidance for the third quarter of 2025, which constitutes “forward-looking statements” as described further below under “Cautionary Note Regarding Forward-Looking Statements.”

For the third quarter of 2025 management expects year-over-year consolidated revenues to decline between one to three percent with Adjusted EBITDA expected to be between $230 million and $250 million.

Corporate Information
NOV repurchased approximately 5.5 million shares of common stock for $69 million during the second quarter. Including a supplemental dividend of $0.21 per share and a regular dividend of $0.075 per share, NOV returned a total of $176 million in capital to shareholders during the quarter.

During the second quarter of 2025, NOV recorded $19 million in Other Items, primarily related to severance costs, facility closures and streamlining our business processes (see Reconciliation of Net Income to Adjusted EBITDA).

As of June 30, 2025, the Company had total debt of $1.73 billion, with $1.50 billion available on its primary revolving credit facility, and $1.08 billion in cash and cash equivalents.

Significant Achievements
NOV was awarded a multi-year contract to provide instrumentation and digital services across the US fleet of a major land drilling contractor. By standardizing data aggregation, delivery, and visualization, the contractor is reducing complexity while offering advanced digital capabilities to its customers. NOV’s next-generation Electronic Drilling Recorder (EDR) and Remote Drilling Monitoring (RDM) applications, powered by the Max™ Platform, enable real-time insights and seamless collaboration from wellsite to office.

NOV signed a contract to engineer and supply a monoethylene glycol (MEG) recovery system for a project in the Eastern Mediterranean. This award supports long-term gas infrastructure development and reinforces NOV’s capabilities in complex gas process system solutions.

NOV secured a contract to deliver a Submerged Swivel and Yoke (SSY) system for a floating liquefied natural gas (FLNG) project in Argentina. The SSY system is a critical mooring and fluid transfer solution that connects the FLNG vessel to its subsea infrastructure while allowing the vessel to weathervane with changing sea and wind conditions. The SSY system enables continuous and safe transfer of gas without disconnecting, maximizing uptime and ensuring safe, uninterrupted operations.

NOV secured a multi-year, multi-drilling rig contract to provide surface automation packages for four land rigs and one jack-up rig for a major Middle East operator. The NOVOS™ process automation technology and the Kaizen™ AI-powered drilling optimizer will work in tandem to enhance drilling consistency, efficiency, and performance on these rigs. The contract also includes automation lifecycle management services across all rigs, ensuring continued technology upgrades and operational support. In comparable deployments, this automation suite has delivered a 52% increase in gross rate of penetration (ROP) and a 34% reduction in drilling time relative to offset wells.

NOV secured contracts to provide the vessel design and jacking system for a next-generation wind turbine installation jack-up vessel for a customer in Asia. The project is based on the proven GustoMSC™ NG-16000X vessel design and marks a key step forward in advanced offshore wind capabilities.

NOV completed four high-profile automation package installations on offshore rigs for four different customers, including one with the ATOM RTX™ robotic system. The rigs are now equipped with advanced automation capabilities that enhance operational performance in demanding drilling environments. One operator has already reported nearly 99% utilization of the Multi-Machine Control pipe-handling system, along with robotic pipe doping operations that have enabled a hands-free red zone during tripping activities. The rig is also delivering best-in-class slip-to-slip drilling connection times, outperforming all other assets in the region.

NOV received three new orders totaling 93,800 ft of 16- and 20-in., 750 psi Star Super Seal Key-Lock™ (SSKL) pipe to support produced water infrastructure in the Permian Basin. NOV will manufacture the pipe domestically at its expanded facility in San Antonio, Texas. Previously produced internationally, this product line now benefits from reduced freight costs and shorter lead times, helping NOV better serve operators in one of the most active energy regions in the US.

NOV delivered advanced composite piping systems and underground diesel storage solutions for backup power generation at major data center facilities in New Jersey, Arizona, and North Dakota. These systems support critical operations at hyperscale data centers, including a flagship campus in North Dakota, which is expected to be the largest of its kind in the US. NOV’s composite solutions are well positioned to support the growing need for data center infrastructure to support increasing demand for cloud computing, artificial intelligence, and big data analytics.

An NOV-packed bottomhole assembly (BHA)—featuring the MONZA™ 40 drilling motor with a 7" 5/6 8.2 ERT™ power section, NOV High Flow Agitator™ friction reduction tool, and a ReedHycalog™ 8¾" Tektonic™ TKC63 fixed cutter bit—enabled operators to drill 5,200 ft in just 22.5 hours in the Eagle Ford Shale, setting a new 24-hour footage record. The BHA drilled both the curve and lateral sections while achieving an average rate of penetration (ROP) of 224.42 ft per hour. This performance milestone highlights how the integration of NOV technologies drives drilling efficiency, giving customers a single-source solution for high-performance BHAs that deliver results.

NOV introduced its Agitator™X2 dual Agitator friction reduction technology featuring the NOV’s AgitatorZP tool and AgitatorHE tool into Argentina’s unconventional market during the quarter. In one deployment, the dual Agitator technology drilled a 3,500-m lateral in the Vaca Muerta formation, marking the longest lateral drilled in the field using a steerable motor assembly. The unique design of AgitatorZP tool allows the use of dual Agitator tools while maintaining the pressure drop of a single tool, delivering effective friction reduction without compromising hydraulic efficiency.

NOV is advancing drilling performance in the Bakken with the release of ION+™ Intrepid 14.5 mm polycrystalline diamond compact (PDC) cutters. Operators are breaking rate of penetration (ROP) records across 2-, 3-, and 4-mile production sections by maintaining cutter sharpness and minimizing sliding time. One operator achieved a record-low sliding time of just 2.5% through a 4-mile lateral, significantly reducing rig costs. In addition, NOV secured a multi-year drill bit contract to support the New Gas Consortium (NGC) Project offshore Angola. The agreement includes an initial order for advanced drill bits and positions NOV to support future deepwater campaigns in the region.

NOV delivered an integrated package of coiled tubing units, nitrogen converters, pressure control equipment, injector heads, coiled tubing monitoring systems, and a coiled tubing lift frame to a leading multinational oilfield services company operating in Latin America. NOV continues to experience strong demand for its critical well intervention technologies in international markets.

NOV is driving new standards in high-pressure/high-temperature (HP/HT) drilling performance. In South Texas and the Haynesville Shale, NOV’s Tundra™ Max mud chiller has been deployed across several drilling campaigns, helping operators manage extreme downhole temperatures and reduce nonproductive time. To further enhance temperature control in long laterals, these projects also featured NOV’s TK™-Drakon thermally insulating drill pipe coating, a next-generation solution delivering measurable gains in bottomhole circulating temperature, tool life, and rig time. In addition, Grant Prideco booked six strings of 4.5-in. Delta™ 425 drill pipe with TK-Drakon. With more than one million feet of TK-Drakon-coated pipe now in the field, and growing traction in the market, NOV is enabling operators to access deeper, hotter, more complex targets.

Second Quarter Earnings Conference Call
NOV will hold a conference call to discuss its second quarter 2025 results on July 29, 2025 at 10:00 AM Central Time (11:00 AM Eastern Time). The call will be broadcast simultaneously at www.nov.com/investors . A replay will be available on the website for 30 days.

About NOV
NOV (NYSE: NOV) delivers technology-driven solutions to empower the global energy industry. For more than 150 years, NOV has pioneered innovations that enable its customers to safely produce abundant energy while minimizing environmental impact. The energy industry depends on NOV’s deep expertise and technology to continually improve oilfield operations and assist in efforts to advance the energy transition towards a more sustainable future. NOV powers the industry that powers the world.
Visit www.nov.com for more information.

Non-GAAP Financial Measures
This press release contains certain non-GAAP financial measures that management believes are useful tools for internal use and the investment community in evaluating NOV’s overall financial performance. These non-GAAP financial measures are broadly used to value and compare companies in the oilfield services and equipment industry. Not all companies define these measures in the same way. In addition, these non-GAAP financial measures are not a substitute for financial measures prepared in accordance with GAAP and should therefore be considered only as supplemental to such GAAP financial measures. Additionally, Free Cash Flow and Excess Free Cash Flow do not represent the Company’s residual cash flow available for discretionary expenditures, as the calculation of these measures does not account for certain debt service requirements or other non-discretionary expenditures. Please see the attached schedules for reconciliations of the differences between the non-GAAP financial measures used in this press release and the most directly comparable GAAP financial measures.

This press release contains certain forward-looking non-GAAP financial measures, including Adjusted EBITDA. The Company has not provided a reconciliation of projected Adjusted EBITDA. Management cannot predict with a reasonable degree of accuracy certain of the necessary components of net income, such as other income (expense), which includes fluctuations in foreign currencies. As such, a reconciliation of projected net income to projected Adjusted EBITDA is not available without unreasonable effort. The actual amount of other income (expense), provision (benefit) for income taxes, equity income (loss) in unconsolidated affiliates, depreciation and amortization, and other amounts excluded from Adjusted EBITDA could have a significant impact on net income.

Cautionary Note Regarding Forward-Looking Statements
This document contains, or has incorporated by reference, statements that are not historical facts, including estimates, projections, and statements relating to our business plans, objectives, and expected operating results that are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements often contain words such as “may,” “can,” “likely,” “believe,” “plan,” “predict,” “potential,” “will,” “intend,” “think,” “should,” “expect,” “anticipate,” “estimate,” “forecast,” “expectation,” “goal,” “outlook,” “projected,” “projections,” “target,” and other similar words, although some such statements are expressed differently. Other oral or written statements we release to the public may also contain forward-looking statements. Forward-looking statements involve risk and uncertainties and reflect our best judgment based on current information. You should be aware that our actual results could differ materially from results anticipated in such forward-looking statements due to a number of factors, including but not limited to changes in oil and gas prices, customer demand for our products, potential catastrophic events related to our operations, protection of intellectual property rights, compliance with laws, and worldwide economic activity, including matters related to recent Russian sanctions and changes in U.S. trade policies, including the imposition of tariffs and retaliatory tariffs and their related impacts on the economy. Given these uncertainties, current or prospective investors are cautioned not to place undue reliance on any such forward-looking statements. We undertake no obligation to update any such factors or forward-looking statements to reflect future events or developments. You should also consider carefully the statements under “Risk Factors,” as disclosed in our most recent Annual Report on Form 10-K, as updated in Part II, Item 1A of our most recent Quarterly Report on Form 10-Q, and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” of our most recent Annual Report on Form 10-K, which address additional factors that could cause our actual results to differ from those set forth in such forward-looking statements, as well as additional disclosures we make in our press releases and other securities filings. We also suggest that you listen to our quarterly earnings release conference calls with financial analysts.

Certain prior period amounts have been reclassified in this press release to be consistent with current period presentation.

CONTACT:
Amie D'Ambrosio
Director, Investor Relations
(713) 375-3826
Amie.DAmbrosio@nov.com


NOV INC. CONSOLIDATED STATEMENTS OF INCOME (Unaudited) (In millions, except per share data)

	Three Months Ended									Six Months Ended
	June 30,						March 31,			June 30,
	2025			2024			2025			2025			2024
Revenue:
Energy Products and Services	$	1,025		$	1,050		$	992		$	2,017		$	2,067
Energy Equipment		1,207			1,204			1,146			2,353			2,382
Eliminations		(44	)		(38	)		(35	)		(79	)		(78	)
Total revenue		2,188			2,216			2,103			4,291			4,371
Gross profit		446			590			447			893			1,048
Gross profit %		20.4	%		26.6	%		21.3	%		20.8	%		24.0	%

Selling, general, and administrative		303			277			295			598			573
Operating profit		143			313			152			295			475
Interest expense, net		(12	)		(14	)		(11	)		(23	)		(30	)
Equity income in unconsolidated affiliates		1			8			—			1			37
Other expense, net		(17	)		(14	)		(20	)		(37	)		(24	)
Income before income taxes		115			293			121			236			458
Provision for income taxes		1			70			47			48			114
Net income		114			223			74			188			344
Net income (loss) attributable to noncontrolling interests		6			(3	)		1			7			(1	)
Net income attributable to Company	$	108		$	226		$	73		$	181		$	345
Per share data:
Basic	$	0.29		$	0.57		$	0.19		$	0.48		$	0.88
Diluted	$	0.29		$	0.57		$	0.19		$	0.48		$	0.87
Weighted average shares outstanding:
Basic		375			395			381			378			394
Diluted		376			397			383			380			398

NOV INC. CONSOLIDATED BALANCE SHEETS (In millions)

	June 30,		December 31,
	2025		2024
ASSETS	(Unaudited)
Current assets:
Cash and cash equivalents	$	1,080	$	1,230
Receivables, net		1,902		1,819
Inventories, net		1,929		1,932
Contract assets		655		577
Prepaid and other current assets		215		212
Total current assets		5,781		5,770

Property, plant and equipment, net		1,990		1,922
Lease right-of-use assets		541		549
Goodwill and intangibles, net		2,119		2,138
Other assets		932		982
Total assets	$	11,363	$	11,361

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	823	$	837
Accrued liabilities		742		861
Contract liabilities		513		492
Current portion of lease liabilities		103		102
Current portion of long-term debt		38		37
Accrued income taxes		20		18
Total current liabilities		2,239		2,347

Long-term debt		1,690		1,703
Lease liabilities		540		544
Other liabilities		336		339
Total liabilities		4,805		4,933

Total stockholders’ equity		6,558		6,428
Total liabilities and stockholders’ equity	$	11,363	$	11,361

NOV INC. CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (In millions)

	Three Months Ended			Six Months Ended
	June 30,			June 30,
	2025			2025			2024
Cash flows from operating activities:
Net income	$	114		$	188		$	344
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		87			176			169
Working capital, net		(41	)		(135	)		(222	)
Other operating items, net		31			97			63
Net cash provided by operating activities		191			326			354

Cash flows from investing activities:
Purchases of property, plant and equipment		(83	)		(167	)		(151	)
Business acquisitions, net of cash acquired		—			—			(252	)
Business divestitures, net of cash disposed		—			—			176
Other		2			5			1
Net cash used in investing activities		(81	)		(162	)		(226	)

Cash flows from financing activities:
Borrowings against lines of credit and other debt		—			—			419
Payments against lines of credit and other debt		(9	)		(13	)		(422	)
Cash dividends paid		(107	)		(135	)		(50	)
Share repurchases		(69	)		(150	)		(37	)
Other		(13	)		(35	)		(23	)
Net cash used in financing activities		(198	)		(333	)		(113	)
Effect of exchange rates on cash		11			19			(4	)
Increase (decrease) in cash and cash equivalents		(77	)		(150	)		11
Cash and cash equivalents, beginning of period		1,157			1,230			816
Cash and cash equivalents, end of period	$	1,080		$	1,080		$	827

NOV INC. RECONCILIATION OF CASH FLOWS FROM OPERATING ACTIVITIES TO FREE CASH FLOW AND EXCESS FREE CASH FLOW (Unaudited) (In millions)

Presented below is a reconciliation of cash flow from operating activities to “Free Cash Flow”. The Company defines Free Cash Flow as cash flow from operating activities less purchases of property, plant and equipment, or “capital expenditures” and Excess Free Cash Flow as cash flows from operations less capital expenditures and other investments, including acquisitions and divestitures. Management believes this is important information to provide because it is used by management to evaluate the Company’s operational performance and trends between periods and manage the business. Management also believes this information may be useful to investors and analysts to gain a better understanding of the Company’s results of ongoing operations. Free Cash Flow and Excess Free Cash Flow are not intended to replace GAAP financial measures.

	Three Months Ended			Six Months Ended
	June 30,			June 30,
	2025			2025			2024

Total cash flows provided by operating activities	$	191		$	326		$	354
Capital expenditures		(83	)		(167	)		(151	)
Free Cash Flow	$	108		$	159		$	203
Business acquisitions, net of cash acquired		—			—			(252	)
Business divestitures, net of cash disposed		—			—			176
Excess Free Cash Flow	$	108		$	159		$	127

NOV INC. RECONCILIATION OF NET INCOME TO ADJUSTED EBITDA (Unaudited) (In millions)

Presented below is a reconciliation of Net Income to Adjusted EBITDA. The Company defines Adjusted EBITDA as Operating Profit excluding Depreciation, Amortization, Gains and Losses on Sales of Fixed Assets, and, when applicable, Other Items. Adjusted EBITDA % is a ratio showing Adjusted EBITDA as a percentage of sales. Management believes this is important information to provide because it is used by management to evaluate the Company’s operational performance and trends between periods and manage the business. Management also believes this information may be useful to investors and analysts to gain a better understanding of the Company’s results of ongoing operations. Adjusted EBITDA and Adjusted EBITDA % are not intended to replace GAAP financial measures, such as Net Income and Operating Profit %. Other Items include gain on business divestiture, impairment, restructure, severance, facility closure costs and inventory charges and credits.

	Three Months Ended									Six Months Ended
	June 30,						March 31,			June 30,
	2025			2024			2025			2025			2024
Operating profit:
Energy Products and Services	$	83		$	128		$	83		$	166		$	249
Energy Equipment		122			232			134			256			327
Eliminations and corporate costs		(62	)		(47	)		(65	)		(127	)		(101	)
Total operating profit	$	143		$	313		$	152		$	295		$	475

Operating profit %:
Energy Products and Services		8.1	%		12.2	%		8.4	%		8.2	%		12.0	%
Energy Equipment		10.1	%		19.3	%		11.7	%		10.9	%		13.7	%
Eliminations and corporate costs		—			—			—			—			—
Total operating profit %		6.5	%		14.1	%		7.2	%		6.9	%		10.9	%

Other items, net:
Energy Products and Services	$	6		$	1		$	5		$	11		$	1
Energy Equipment		9			(119	)		3			12			(123	)
Corporate		4			—			5			9			1
Total other items	$	19		$	(118	)	$	13		$	32		$	(121	)

(Gain) loss on sales of fixed assets:
Energy Products and Services	$	—		$	—		$	(2	)	$	(2	)	$	(1	)
Energy Equipment		(1	)		—			—			(1	)		—
Corporate		4			—			—			4			—
Total (gain) loss on sales of fixed assets	$	3		$	—		$	(2	)	$	1		$	(1	)

Depreciation & amortization:
Energy Products and Services	$	57		$	55		$	59		$	116		$	109
Energy Equipment		28			29			28			56			57
Corporate		2			2			2			4			3
Total depreciation & amortization	$	87		$	86		$	89		$	176		$	169

Adjusted EBITDA:
Energy Products and Services	$	146		$	184		$	145		$	291		$	358
Energy Equipment		158			142			165			323			261
Eliminations and corporate costs		(52	)		(45	)		(58	)		(110	)		(97	)
Total Adjusted EBITDA	$	252		$	281		$	252		$	504		$	522

Adjusted EBITDA %:
Energy Products and Services		14.2	%		17.5	%		14.6	%		14.4	%		17.3	%
Energy Equipment		13.1	%		11.8	%		14.4	%		13.7	%		11.0	%
Eliminations and corporate costs		—			—			—			—			—
Total Adjusted EBITDA %		11.5	%		12.7	%		12.0	%		11.7	%		11.9	%

Reconciliation of Adjusted EBITDA:
GAAP net income attributable to Company	$	108		$	226		$	73		$	181		$	345
Noncontrolling interests		6			(3	)		1			7			(1	)
Provision for income taxes		1			70			47			48			114
Interest and financial costs		22			22			22			44			46
Interest income		(10	)		(8	)		(11	)		(21	)		(16	)
Equity income in unconsolidated affiliates		(1	)		(8	)		—			(1	)		(37	)
Other expense, net		17			14			20			37			24
(Gain) loss on sales of fixed assets		3			—			(2	)		1			(1	)
Depreciation and amortization		87			86			89			176			169
Other items, net		19			(118	)		13			32			(121	)
Total Adjusted EBITDA	$	252		$	281		$	252		$	504		$	522

Read Full Article

Twin Hospitality Group Inc. to Host Conference Call for Q2 2025 Financial Results

2 hours ago | July 28, 2025 9:50 p.m. UTC

Twin Hospitality Group will host a conference call on July 30, 2025, to discuss Q2 financial results.

Quiver AI Summary

Twin Hospitality Group Inc. announced that it will hold a conference call on July 30, 2025, at 5:15 PM ET to discuss its second quarter 2025 financial results, which will be released beforehand. The call, led by CEO Kim Boerema and CFO Ken Kuick, can be accessed by phone or streamed live on the company's website. A replay will be available for a limited time after the call. Twin Hospitality operates the Twin Peaks and Smokey Bones restaurant brands, focusing on redefining casual dining with unique concepts and menu offerings, including made-from-scratch food and a variety of beverages at Twin Peaks and meat-centric dishes at Smokey Bones.

Potential Positives

Twin Hospitality will be hosting a conference call to review second quarter 2025 financial results, indicating transparency and engagement with stakeholders.
The company plans to release its financial results prior to the call, suggesting timely communication of important financial information.
The participation of the CEO and CFO in the conference call reinforces leadership's commitment to addressing investors and stakeholders directly.
Twin Peaks and Smokey Bones are highlighted as strong brands in the casual dining sector, showcasing the company's strategic focus on experiential dining and growth potential.

Potential Negatives

The press release does not provide any specific financial results or performance indicators for the second quarter of 2025, potentially leading to uncertainty about the company's current financial health.
The lack of prior financial disclosures or context may raise concerns among investors regarding the company's transparency and communication practices.
There is a potential risk of negative investor sentiment if the financial results, set to be released at a later date, do not meet market expectations.

FAQ

When is the Twin Hospitality second quarter 2025 financial results call?

The conference call is scheduled for Wednesday, July 30, 2025, at 5:15 PM ET.

How can I access the Twin Hospitality conference call?

You can access the call by dialing 1-877-407-0792 in the U.S. or 1-201-689-8263 internationally.

Is there a way to listen to the conference call after it has ended?

Yes, a replay will be available until August 13, 2025, using 1-844-512-2921 in the U.S. or 1-412-317-6671 internationally.

Who will host the financial results conference call?

The call will be hosted by Kim Boerema, CEO, and Ken Kuick, CFO of Twin Hospitality.

Where can I find more information about Twin Hospitality Group?

More information can be found on their corporate website at https://ir.twinpeaksrestaurant.com/.

Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.

$TWNP Insider Trading Activity

$TWNP insiders have traded $TWNP stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $TWNP stock by insiders over the last 6 months:

BRANDS, INC FAT purchased 7,139,667 shares for an estimated $31,200,344

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

Full Release

DALLAS, July 28, 2025 (GLOBE NEWSWIRE) -- Twin Hospitality Group Inc. (“ Twin Hospitality ”) (NASDAQ: TWNP), the operating unit for the Twin Peaks and Smokey Bones restaurant brands, today announced that the Company will host a conference call to review its second quarter 2025 financial results on Wednesday, July 30, 2025 at 5:15 PM ET. A press release with second quarter 2025 financial results will be issued prior to the conference call that day.

The conference call can be accessed live over the phone by dialing 1-877-407-0792 from the U.S. or 1-201-689-8263 internationally. A replay will be available after the call until Wednesday, August 13, 2025, and can be accessed by dialing 1-844-512-2921 from the U.S. or 1-412-317-6671 internationally. The passcode is 13754155. Hosting the call will be Kim Boerema, Chief Executive Officer, and Ken Kuick, Chief Financial Officer.

The conference call will also be webcast live from the corporate website at https://twinpeaksrestaurant.com under the “Investors” section. A replay of the webcast will be available through the corporate website shortly after the call has concluded.

About Twin Hospitality Group Inc.

Twin Hospitality Group Inc. (NASDAQ: TWNP) is a restaurant company that strategically develops and operates and franchises specialty casual dining restaurant concepts with a goal to redefine the casual dining category with its experiential driven brands, Twin Peaks and Smokey Bones. Twin Peaks, known as the ultimate sports lodge, is an award-winning restaurant and sports bar brand with 114 locations across 27 states and Mexico and is known for its made-from-scratch food, 29 degree draft beer, innovative cocktail program and sports on wall-to-wall televisions. Smokey Bones is a full-service, meat-centric restaurant brand and concept with 51 locations, across 16 states specializing in ribs and a variety of other slow-smoked, fire-grilled and seared meats, along with a full bar. For more information, please visit https://ir.twinpeaksrestaurant.com/ .

Investor Relations:
ICR
ir@twinpeaksrestaurant.com

Media Relations:
Destinee Rollins
destinee.rollins@tprest.com

Read Full Article

Insider Sale: President of $MEDP Sells 41,801 Shares

2 hours ago | July 28, 2025 9:45 p.m. UTC

JESSE J GEIGER, the President of $MEDP, sold 41,801 shares of the company on 07-24-2025 for an estimated $18,940,451. We received data on the trade from a recent SEC filing. This was a sale of approximately 53.4% of their shares of this class of stock. Following this trade, they now own 36,503 shares of this class of $MEDP stock.

$MEDP Insider Trading Activity

$MEDP insiders have traded $MEDP stock on the open market 5 times in the past 6 months. Of those trades, 1 have been purchases and 4 have been sales.

Here’s a breakdown of recent trading of $MEDP stock by insiders over the last 6 months:

JESSE J GEIGER (President) sold 41,801 shares for an estimated $18,940,451
KEVIN M. BRADY (CFO & Treasurer) sold 12,000 shares for an estimated $5,450,760
BRIAN T CARLEY sold 4,003 shares for an estimated $1,383,396
FRED B JR DAVENPORT sold 1,712 shares for an estimated $516,715
STEPHEN P EWALD (General Counsel & Corp. Secy.) purchased 2 shares for an estimated $652

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$MEDP Hedge Fund Activity

We have seen 277 institutional investors add shares of $MEDP stock to their portfolio, and 283 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

MAWER INVESTMENT MANAGEMENT LTD. added 696,219 shares (+inf%) to their portfolio in Q1 2025, for an estimated $212,130,967
CAPITAL WORLD INVESTORS removed 434,736 shares (-99.2%) from their portfolio in Q1 2025, for an estimated $132,459,711
PROFICIO CAPITAL PARTNERS LLC removed 241,751 shares (-99.7%) from their portfolio in Q1 2025, for an estimated $73,659,112
VULCAN VALUE PARTNERS, LLC added 224,578 shares (+221.6%) to their portfolio in Q1 2025, for an estimated $68,426,670
GOLDMAN SACHS GROUP INC removed 159,008 shares (-36.0%) from their portfolio in Q1 2025, for an estimated $48,448,147
CAMBER CAPITAL MANAGEMENT LP removed 125,000 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $38,086,250
KENSICO CAPITAL MANAGEMENT CORP removed 121,100 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $36,897,959

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$MEDP Analyst Ratings

Wall Street analysts have issued reports on $MEDP in the last several months. We have seen 1 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

Mizuho issued a "Outperform" rating on 07/25/2025
TD Cowen issued a "Sell" rating on 07/23/2025

To track analyst ratings and price targets for $MEDP, check out Quiver Quantitative's $MEDP forecast page.

$MEDP Price Targets

Multiple analysts have issued price targets for $MEDP recently. We have seen 7 analysts offer price targets for $MEDP in the last 6 months, with a median target of $436.0.

Here are some recent targets:

Ann Hynes from Mizuho set a target price of $510.0 on 07/25/2025
Luke Sergott from Barclays set a target price of $450.0 on 07/23/2025
Charles Rhyee from TD Cowen set a target price of $366.0 on 07/23/2025
Eric Coldwell from Baird set a target price of $490.0 on 07/23/2025
Jailendra Singh from Truist Securities set a target price of $436.0 on 07/23/2025
Justin Bowers from Deutsche Bank set a target price of $430.0 on 07/23/2025
Michael Cherny from Leerink Partners set a target price of $330.0 on 03/24/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read Full Article

Live Oak Bancshares Announces Pricing of Underwritten Offering for Series A Preferred Stock

2 hours ago | July 28, 2025 9:40 p.m. UTC

Live Oak Bancshares priced an offering of depositary shares for its 8.375% Series A Preferred Stock, enhancing capital.

Quiver AI Summary

Live Oak Bancshares, Inc. announced the pricing of an offering of 4,000,000 depositary shares, representing a 1/40th interest in its 8.375% Fixed Rate Series A Non-Cumulative Perpetual Preferred Stock. Each depositary share has a liquidation preference of $25, and dividends will be paid quarterly beginning September 15, 2025. Live Oak has the option to redeem the shares after September 15, 2030. The net proceeds will support its capital position and balance sheet growth. The company plans to list the depositary shares on the NYSE under the symbol "LOB PR A," with closing expected around August 4, 2025. The offering's registration statement was previously filed with the SEC.

Potential Positives

Live Oak Bancshares successfully priced an offering of 4,000,000 depositary shares, enhancing its capital structure with an attractive fixed dividend rate of 8.375%.
The net proceeds from the offering are expected to support balance sheet growth and enhance the company's capital position, indicating a strategy for future expansion.
The company plans to list the depositary shares on the New York Stock Exchange under the symbol “LOB PR A,” potentially increasing visibility and investment interest.

Potential Negatives

The issuance of preferred stock at an 8.375% rate suggests potential difficulties in obtaining funding through traditional means, which may indicate a weakened financial position.
The necessity to enhance the Company’s capital position through this offering could raise concerns among investors about existing capital adequacy.
Forward-looking statements included in the release contain potential risks and uncertainties that could negatively impact investor confidence in the Company's future performance.

FAQ

What is the Series A Preferred Stock being offered by Live Oak Bancshares?

The Series A Preferred Stock is a non-cumulative perpetual preferred stock with an 8.375% fixed annual dividend.

When will dividends on the Series A Preferred Stock be paid?

Dividends will be paid quarterly on March 15, June 15, September 15, and December 15, beginning September 15, 2025.

How many depositary shares are included in this offering?

The offering includes 4,000,000 depositary shares, each representing a 1/40th interest in the Series A Preferred Stock.

What will Live Oak Bancshares use the proceeds from this offering for?

The proceeds are expected to support balance sheet growth and enhance the Company's capital position.

When is the expected closing date for the offering?

The offering is expected to close on or about August 4, 2025, subject to customary conditions.

Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.

$LOB Insider Trading Activity

$LOB insiders have traded $LOB stock on the open market 3 times in the past 6 months. Of those trades, 2 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $LOB stock by insiders over the last 6 months:

WILLIAM HENDERSON CAMERON has made 2 purchases buying 10,000 shares for an estimated $260,110 and 0 sales.
TONYA WILLIAMS BRADFORD sold 2,500 shares for an estimated $66,275

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$LOB Hedge Fund Activity

We have seen 119 institutional investors add shares of $LOB stock to their portfolio, and 90 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

CAPITAL INTERNATIONAL INVESTORS removed 2,041,706 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $54,431,881
AMERIPRISE FINANCIAL INC removed 755,257 shares (-91.4%) from their portfolio in Q1 2025, for an estimated $20,135,151
MILLENNIUM MANAGEMENT LLC added 596,841 shares (+655.6%) to their portfolio in Q1 2025, for an estimated $15,911,781
BALYASNY ASSET MANAGEMENT L.P. added 353,105 shares (+2211.7%) to their portfolio in Q1 2025, for an estimated $9,413,779
CITIGROUP INC added 239,356 shares (+428.2%) to their portfolio in Q1 2025, for an estimated $6,381,230
D. E. SHAW & CO., INC. added 225,459 shares (+141.8%) to their portfolio in Q1 2025, for an estimated $6,010,736
LOOMIS SAYLES & CO L P removed 219,632 shares (-93.5%) from their portfolio in Q1 2025, for an estimated $5,855,389

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Full Release

WILMINGTON, N.C., July 28, 2025 (GLOBE NEWSWIRE) -- Live Oak Bancshares, Inc. (NYSE: LOB) (“Live Oak” or the “Company”) announced the pricing of an underwritten offering of 4,000,000 depositary shares, each representing a 1/40th ownership interest in a share of 8.375% Fixed Rate Series A Non-Cumulative Perpetual Preferred Stock (the “Series A Preferred Stock”), with a liquidation preference of $25 per depositary share.

When, as and if declared by the board of directors of Live Oak, dividends will be payable on the Series A Preferred Stock from the date of issuance at a rate of 8.375% per annum, payable quarterly in arrears on March 15, June 15, September 15, and December 15 of each year, beginning on September 15, 2025. Live Oak may, at its option, redeem the Series A Preferred Stock on any dividend payment date on or after September 15, 2030, or following a regulatory capital treatment event as described in the prospectus supplement and accompanying prospectus relating to the offering, in each case at a redemption price equal to $1,000 per share of Series A Preferred Stock (equivalent to $25 per depositary share), plus any declared and unpaid dividends, without accumulation of any undeclared dividends to, but excluding, the redemption date. Live Oak intends to apply to list the depositary shares on the New York Stock Exchange under the symbol “LOB PR A.”

Net proceeds from the offering are expected to be used for general corporate purposes, including to support balance sheet growth at Live Oak Banking Company and to enhance the Company’s capital position.

Morgan Stanley & Co. LLC; RBC Capital Markets, LLC; UBS Investment Bank; and Keefe, Bruyette & Woods, A Stifel Company are serving as joint bookrunning managers for the offering.

The Company expects to close the offering, subject to customary conditions, on or about August 4, 2025.

The Company filed a “shelf” registration statement (File No. 333-269263) (including a base prospectus (the “Base Prospectus”)) on January 17, 2023 and the related preliminary prospectus supplement on July 28, 2025 (the “Preliminary Prospectus Supplement”) with the Securities and Exchange Commission (“SEC”) for the offering to which this communication relates. You may obtain these documents for free by visiting EDGAR on the SEC’s website at www.sec.gov . Alternatively, the Company, any underwriter, or any dealer participating in the offering will arrange to send you the Base Prospectus and the Preliminary Prospectus Supplement if you request it by calling Morgan Stanley & Co. LLC toll-free at 1-866-718-1649, RBC Capital Markets, LLC at 1-866-375-6829, UBS Investment Bank at 1-833-481-0269 or Keefe, Bruyette & Woods, A Stifel Company at 1-800-966-1559.

This press release shall not constitute an offer to sell, or the solicitation of an offer to buy any securities, nor shall there be any offer or sale of these securities in any jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.

Important Note Regarding Forward-Looking Statements
This press release contains forward-looking statements which reflect management’s current views with respect to, among other things, future events and financial performance. These statements are often, but not always, made through the use of words or phrases such as "may," "might," "should," "could," "predict," "potential," "believe," "expect," "continue," "will," "anticipate," "seek," "estimate," "intend," "plan," "projection," "goal," "target," "outlook," "aim," "would," "annualized" and "outlook," or the negative version of those words or other comparable words or phrases of a future or forward-looking nature. Forward-looking statements in this press release include, but are not limited to, statements regarding the offering, including the expected closing of the offering. These forward-looking statements are not historical facts, and are based on current expectations, estimates and projections about the industry, management's beliefs and certain assumptions made by management, many of which, by their nature, are inherently uncertain and beyond our control. Accordingly, management cautions that any such forward-looking statements are not guarantees of future performance and are subject to risks, assumptions, estimates and uncertainties that are difficult to predict. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable as of the date made, actual results may prove to be materially different from the results expressed or implied by the forward-looking statements. A number of important factors could cause actual results to differ materially from those indicated in these forward-looking statements, including the impacts of factors identified in "Risk Factors" or "Management's Discussion and Analysis of Financial Condition and Results of Operations" in the Company’s Annual Report on Form 10-K and other periodic filings with the Securities and Exchange Commission. Any forward-looking statements presented herein are made only as of the date of this press release, and the Company does not undertake any obligation to update or revise any forward-looking statements to reflect changes in assumptions, the occurrence of unanticipated events, or otherwise.

About Live Oak Bancshares
Live Oak Bancshares, Inc. (NYSE: LOB) is a financial holding company and parent company of Live Oak Bank. Live Oak Bancshares and its subsidiaries partner with businesses that share a groundbreaking focus on service and technology to redefine banking. To learn more, visit www.liveoakbank.com .

Read Full Article

Nano Dimension's Subsidiary Desktop Metal Files for Chapter 11 Bankruptcy Protection

2 hours ago | July 28, 2025 9:40 p.m. UTC

Nano Dimension's subsidiary, Desktop Metal, has filed for Chapter 11 bankruptcy to address significant liabilities and liquidity issues.

Quiver AI Summary

Nano Dimension Ltd. announced that its subsidiary, Desktop Metal, has filed for Chapter 11 bankruptcy protection due to significant liabilities and liquidity challenges arising from previous management decisions. The independent Board of Directors of Desktop Metal made the filing after exploring various strategic options. Nano Dimension's CEO, Ofir Baharav, emphasized that the company is focused on maintaining its financial strength to pursue strategic opportunities effectively, ensuring maximum benefit for shareholders. Nano Dimension specializes in advanced Digital Manufacturing technologies and aims to support critical industries like defense, aerospace, and medical devices.

Potential Positives

Nano Dimension aims to safeguard its financial strength, positioning itself as a well-capitalized leader in its ecosystem despite the challenges faced by its subsidiary.
The company highlights its focus on pursuing strategic opportunities from a position of maximum strength, which could benefit shareholders in the long term.
Nano Dimension operates in growth sectors such as defense, aerospace, automotive, and medical devices, suggesting potential for future expansion and profitability.

Potential Negatives

Desktop Metal, a subsidiary of Nano Dimension, filing for bankruptcy protection raises serious concerns about the financial stability and viability of the parent company.
This bankruptcy could signal deeper issues within Nano Dimension, particularly regarding their management of liabilities and strategic direction.
The press release shifts focus onto Desktop Metal's prior management decisions, which may lead to reputational damage for Nano Dimension as they are seen as responsible for the subsidiary's failures.

FAQ

What recent decision did Desktop Metal make?

Desktop Metal has filed for bankruptcy protection under Chapter 11 of the Bankruptcy Code.

Who made the decision for Desktop Metal's bankruptcy filing?

The decision was made by Desktop Metal’s independent Board of Directors after exploring strategic alternatives.

What is Nano Dimension's stance on financial strength?

Nano Dimension aims to safeguard its financial strength and maintain its position as a well-capitalized company.

How does Nano Dimension plan to address its shareholders?

Nano Dimension intends to pursue strategic opportunities for growth and value for its shareholders.

What industries does Nano Dimension serve?

Nano Dimension delivers advanced manufacturing technologies to defense, aerospace, automotive, electronics, and medical devices industries.

Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.

$NNDM Hedge Fund Activity

We have seen 69 institutional investors add shares of $NNDM stock to their portfolio, and 72 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

BLACKROCK, INC. removed 4,875,042 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $7,751,316
GROUP ONE TRADING LLC added 1,908,207 shares (+319.9%) to their portfolio in Q1 2025, for an estimated $3,034,049
STATE STREET CORP removed 1,744,562 shares (-81.7%) from their portfolio in Q1 2025, for an estimated $2,773,853
IMMERSION CORP added 1,358,052 shares (+inf%) to their portfolio in Q1 2025, for an estimated $2,159,302
MARSHALL WACE, LLP added 996,726 shares (+inf%) to their portfolio in Q1 2025, for an estimated $1,584,794
ARETE WEALTH ADVISORS, LLC removed 914,559 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $1,454,148
SUSQUEHANNA INTERNATIONAL GROUP, LLP added 776,021 shares (+59.5%) to their portfolio in Q1 2025, for an estimated $1,233,873

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Full Release

Waltham, Massachusetts, July 28, 2025 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (Nasdaq: NNDM) (“Nano Dimension” or the “Company”), a leader in Digital Manufacturing solutions, today announced that its subsidiary, Desktop Metal, Inc. (“Desktop Metal”), has filed for bankruptcy protection under Chapter 11 of the Bankruptcy Code.

The decision to file for bankruptcy protection was made by Desktop Metal’s independent Board of Directors, who conducted a process to explore available strategic alternatives and address Desktop Metal’s significant liabilities and liquidity needs stemming from decisions made by its prior management.

Ofir Baharav, Nano Dimension’s CEO said: “We are safeguarding our financial strength and preserving our position as the best capitalized company in our ecosystem. This is what enables the Company’s to pursue strategic opportunities from a position of maximum strength—and that is exactly what the Company’s shareholders should expect from us.”

About Nano Dimension

Driven by strong trends in onshoring, national security, and increasing product customization, Nano Dimension (Nasdaq: NNDM) delivers advanced Digital Manufacturing technologies to the defense, aerospace, automotive, electronics, and medical devices industries, enabling rapid deployment of high-mix, low-volume production with IP security and sustainable manufacturing practices.

For more information, please visit https://www.nano-di.com/ .

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include statements regarding Nano’s future growth, strategic plan and value to shareholders, and all other statements other than statements of historical fact that address activities, events or developments that Nano intends, expects, projects, believes or anticipates will or may occur in the future. Such statements are based on management’s beliefs and assumptions made based on information currently available to management. These forward-looking statements involve known and unknown risks and uncertainties, which may cause the Company’s actual results and performance to be materially different from those expressed or implied in the forward-looking statements. Accordingly, we caution you that any such forward-looking statements are not guarantees of future performance and are subject to risks, assumptions, estimates and uncertainties that are difficult to predict. Because such statements deal with future events and are based on the current expectations of Nano, they are subject to various risks and uncertainties. The forward-looking statements contained or implied in this communication are subject to other risks and uncertainties, including those discussed under the heading “Risk Factors” in Nano’s annual report on Form 20-F filed with the Securities and Exchange Commission (the “SEC”) on May 12, 2025, and in any subsequent filings with the SEC. Except as otherwise required by law, Nano undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this communication.

Investors: ICR - nano-di@icrinc.com
Media: NanoDimension@feintuchpr.com

Read Full Article

Insider Purchase: Director at $none Buys 1,611 Shares

2 hours ago | July 28, 2025 9:31 p.m. UTC

WIll Jordan, a director at $none, bought 1,611 shares of the company on 07-28-2025 for an estimated $125,013. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings of this class of stock by approximately 3.6%. Following this trade, they now own 46,096 shares of this class of $none stock.

$none Insider Trading Activity

$none insiders have traded $none stock on the open market 11 times in the past 6 months. Of those trades, 7 have been purchases and 4 have been sales.

Here’s a breakdown of recent trading of $none stock by insiders over the last 6 months:

JACK W BELL has made 0 purchases and 2 sales selling 2,942 shares for an estimated $224,971.
WILL JORDAN has made 2 purchases buying 2,942 shares for an estimated $224,971 and 0 sales.
JAMES RANDALL CLEMONS sold 1,332 shares for an estimated $100,033
JOHN FOSTER` (EVP) has made 2 purchases buying 105 shares for an estimated $8,135 and 0 sales.
LISA POMINSKI sold 59 shares for an estimated $4,501
JOHN MCDEARMAN (President & CEO) purchased 33 shares for an estimated $2,478
HERBERT ELMER RICHERSON purchased 18 shares for an estimated $1,396
CLARK OAKLEY (EVP) purchased 8 shares for an estimated $610

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read Full Article

GBank Financial Holdings Inc. Reports Second Quarter 2025 Earnings with Increased Net Income and Record Loan Originations

2 hours ago | July 28, 2025 9:30 p.m. UTC

GBank Financial Holdings Inc. reported a second-quarter net income of $4.8 million, reflecting growth from previous quarters.

Quiver AI Summary

GBank Financial Holdings Inc. reported a net income of $4.8 million, or $0.33 per diluted share, for the second quarter of 2025, reflecting a slight increase from $4.5 million in the previous quarter and a marginal increase from $4.7 million in Q2 2024. Total net revenue was $17.8 million, up 2.4% from the first quarter of 2025, with a notable record of $160.5 million in SBA lending and commercial banking loan originations. Despite a decline in non-interest income attributed to the temporary halt in credit card issuance, the Company saw a strong recovery in credit card transaction volume beginning in June 2025. The provision for credit losses increased to $1.1 million, reflecting the growth in non-guaranteed loans. Total assets rose to $1.23 billion, up 3.6% from the prior quarter, driven primarily by an increase in loans and deposit growth. Overall, GBank maintains a positive outlook for future performance, focusing on resuming credit card issuance and continuing strong SBA loan originations.

Potential Positives

Net income increased to $4.8 million for the second quarter of 2025, up from $4.5 million in the previous quarter, showcasing continuous profitability growth.
SBA lending and commercial banking loan originations reached an all-time record of $160.5 million, reflecting strong demand and operational performance.
Total assets rose to $1.23 billion, marking a 22.1% increase compared to the previous year, indicating substantial growth and financial stability.
Stockholders’ equity increased by 3.5% in the quarter to $151.7 million, driven by retained earnings from net income, which enhances overall financial strength.

Potential Negatives

Decline in non-interest income by 1.5% compared to the previous quarter, attributed to a pause in credit card issuance and lower-than-expected gain on loan sale margins.
Decrease in credit card transaction volume of 22% from the first quarter of 2025 to the second quarter of 2025, indicating potential issues in revenue generation from this segment.
Increase in provision for credit losses on loans by $369 thousand compared to the first quarter of 2025, signaling higher expected credit losses and a deterioration in the quality of loan assets.

FAQ

What was GBank's net income for Q2 2025?

GBank reported a net income of $4.8 million for the second quarter of 2025.

How did GBank perform in terms of loan originations?

Loan originations reached a record $160.5 million in the second quarter of 2025.

What was the credit card transaction volume in Q2 2025?

Credit card transaction volume decreased to $82.2 million in the second quarter of 2025.

How did GBank's non-interest income change in Q2 2025?

Non-interest income decreased slightly to $5.4 million in Q2 2025 compared to Q1 2025.

What is GBank's earnings per share for Q2 2025?

The earnings per share for GBank in Q2 2025 was $0.33, up from $0.31 in Q1 2025.

Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.

$GBFH Insider Trading Activity

$GBFH insiders have traded $GBFH stock on the open market 21 times in the past 6 months. Of those trades, 0 have been purchases and 21 have been sales.

Here’s a breakdown of recent trading of $GBFH stock by insiders over the last 6 months:

CHARLES WILLIAM JR. GRIEGE has made 0 purchases and 2 sales selling 100,000 shares for an estimated $4,200,875.
ALFRED LEE FINLEY has made 0 purchases and 6 sales selling 32,417 shares for an estimated $1,365,431.
EDWARD MICHAEL NIGRO (Executive Chairman) has made 0 purchases and 6 sales selling 34,239 shares for an estimated $1,347,524.
ALAN CURTIS SKLAR has made 0 purchases and 7 sales selling 1,808 shares for an estimated $65,167.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$GBFH Hedge Fund Activity

We have seen 4 institutional investors add shares of $GBFH stock to their portfolio, and 0 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

CHAPIN DAVIS, INC. added 203,600 shares (+inf%) to their portfolio in Q2 2025, for an estimated $7,209,475
RVW WEALTH, LLC added 11,275 shares (+inf%) to their portfolio in Q2 2025, for an estimated $399,247
DESTINY WEALTH PARTNERS, LLC added 10,285 shares (+inf%) to their portfolio in Q2 2025, for an estimated $364,191
FNY INVESTMENT ADVISERS, LLC added 10,000 shares (+166.7%) to their portfolio in Q1 2025, for an estimated $374,000
KENNEDY CAPITAL MANAGEMENT LLC added 0 shares (+0.0%) to their portfolio in Q1 2025, for an estimated $0
EMERALD MUTUAL FUND ADVISERS TRUST added 0 shares (+0.0%) to their portfolio in Q1 2025, for an estimated $0

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Full Release

LAS VEGAS, July 28, 2025 (GLOBE NEWSWIRE) -- GBank Financial Holdings Inc. (the “Company”) (NASDAQ: GBFH ), the parent company of GBank (the “Bank”), today reported net income for the quarter ended June 30, 2025 of $4.8 million, or $0.33 per diluted share, compared to $4.5 million, or $0.31 per diluted share during the first quarter of 2025, and $4.7 million, or $0.36 per diluted share, for the second quarter of 2024. For the six months ended June 30, 2025, net income was $9.2 million, or $0.63 per diluted share, compared to $8.4 million, or $0.65 per diluted share, for the comparable six-month period of 2024.

Second Quarter 2025 Financial Highlights (Unaudited)

Net revenue ⁽¹⁾ of $17.8 million, a 2.4% increase compared to the first quarter of 2025
Gain on loan sales of $2.6 million on loans sold of $82.1 million, compared to gain on loan sales of $2.5 million on loans sold of $68.7 million for the first quarter of 2025
Gain on loan sales margin ⁽¹⁾ of 3.16% compared to 3.63% for the first quarter of 2025
Credit card transaction volume of $82.2 million and net interchange fees of $1.5 million, compared to $105.6 million and $2.0 million, respectively, for the first quarter of 2025
U.S. Small Business Administration (“SBA”) lending and commercial banking loan originations of $160.5 million, an all-time record for the Company, compared to $133.0 million for the first quarter of 2025
Non-performing assets, excluding guaranteed portions ⁽¹⁾ , of $4.6 million as of June 30, 2025, representing 0.37% of total assets

Edward M. Nigro, the Executive Chairman of the Company, stated, “Our second quarter non-interest income declined by 1.5% compared to the first quarter of 2025 as a result of our pause in credit card issuance and further by the lower-than-expected gain on loan sale margin for SBA loan sales of 3.16%. Mitigating each occurrence are two key factors: (i) we have restarted credit card applications and third quarter 2025 transaction volume is already trending 35% above second quarter 2025; and, (ii) our SBA loan originations remain strong at $132 million for second quarter and the pipeline remains robust. We fully expect our credit card transaction growth to continue, and we are optimistic that gain on loan sale margins will return to more normal levels.”

Financial Results

Income Statement

Net interest income totaled $12.4 million for the second quarter of 2025, reflecting an increase of $494 thousand, or 4.2%, compared to $11.9 million for the first quarter of 2025, and an increase of $1.0 million, or 9.2%, compared to the second quarter of 2024.

The increase in net interest income when compared to the first quarter of 2025 was primarily driven by higher average balances of interest earning assets partially offset by higher deposit interest expense, as the growth in earning assets was primarily funded by money market, savings, and certificates of deposit growth. The cost of interest-bearing liabilities continued to favorably trend downward, from 4.48% during the second quarter of 2024 to 4.07% for the quarter ended June 30, 2025. Interest income for the second quarter of 2025 also reflected the net effect of the reversal of $92 thousand of interest accruals and discounts attributable to $2.0 million of commercial loans placed on nonaccrual status during the quarter. Comparatively, the first quarter of 2025 reflected the net effect of the reversal of $100 thousand of interest accruals, deferred fees, and deferred costs attributable to $2.8 million of commercial loans placed on nonaccrual status.

The increase in net interest income during the second quarter of 2025 when compared to the second quarter of 2024 was primarily volume driven, as higher interest income from growth in average loan and interest-bearing cash balances more than offset increases in interest expense resulting from higher average balances of interest-bearing deposits.

⁽¹⁾ See Reconciliation of Non-GAAP Financial Measures

The yield on investment securities was 4.73% for the second quarter of 2025, compared to 4.94% for the first quarter of 2025 and 4.74% for the second quarter of 2024. The decrease in the yield when compared to the previous quarter was the result of a changing investment mix during the second quarter of 2025 designed to address asset-liability management objectives.

The Company’s net interest margin for the second quarter of 2025 decreased to 4.31%, compared to 4.47% for the first quarter of 2025 and 4.82% for the second quarter of 2024. The decrease in net interest margin during the second quarter of 2025 when compared to the previous quarter was attributable to both (i) a slight decrease in loan yield quarter-over-quarter, and (ii) a decrease in yield on investment securities as discussed above. The decrease in net interest margin when compared to the second quarter of 2024 is reflective of the 100 basis point decrease in the target federal funds rate during the second half of 2024 by the Federal Reserve.

The Company recorded a provision for credit losses on loans of $1.1 million for the second quarter of 2025, an increase of $369 thousand compared to $710 thousand during the first quarter of 2025, and an increase of $796 thousand when compared to the second quarter of 2024. No provision for credit losses on loans was recorded during the first quarter of 2024. The provision for credit losses on loans recorded in the second quarter of 2025 reflects quarterly organic growth in non-guaranteed loans of $36.3 million and the replenishment of reserves to offset charge-offs taken during the period.

Non-interest income was $5.4 million for the second quarter of 2025, compared to $5.5 million for the first quarter of 2025, and $4.2 million for the second quarter of 2024. The $79 thousand decrease in non-interest income during the second quarter of 2025 when compared to the first quarter of 2025 was primarily due to a decrease in net interchange fees of $468 thousand resulting from the planned operational improvements undertaken by the Bank during the quarter, which contributed to a temporary lag in credit card activity. The $1.2 million increase in non-interest income during the second quarter of 2025 when compared to the second quarter of 2024 was driven by (i) an increase in credit card net interchange fees of $1.4 million, and (ii) a $216 thousand increase in loan servicing income. These increases were partially offset by a $570 thousand decrease in gain on sale of loans due to less favorable secondary market pricing during the second quarter of 2025.

Net revenue totaled $17.8 million for the second quarter of 2025, representing an increase of $415 thousand, or 2.4%, compared to $17.4 million for the first quarter of 2025. Net revenue for the second quarter of 2025 increased $2.3 million, or 14.6%, when compared to $15.5 million for the second quarter of 2024.

Non-interest expense was $10.4 million during the second quarter of 2025, compared to $10.9 million for the first quarter of 2025 and $9.1 million for the second quarter of 2024. The Company’s efficiency ratio was 58.5% for the second quarter of 2025, compared to 62.8% for the first quarter of 2024 and 58.9% for the second quarter of 2024. The quarter-over-quarter decrease in non-interest expense is primarily due to the non-recurring legal, professional, and audit fees associated with the preparation of filings made with the U.S. Securities and Exchange Commission for the registration of its shares of common stock and listing on the Nasdaq Capital Market, which totaled $759 thousand during the first quarter of 2025, compared to $290 thousand during the second quarter of 2025. The increase in non-interest expense from the second quarter of 2024 was driven by a $483 thousand increase in employee compensation costs due to increased stock-based compensation expense and staffing levels, as well as a $798 thousand increase in other expenses due to the previously mentioned legal, professional, and audit fees associated with the registration and listing of our shares of common stock, as well as increases in data processing, supplies, and other non-interest expenses to support the growth of the organization.

Income tax expense was $1.5 million for the quarter ended June 30, 2025, compared to $1.2 million for the first quarter of 2025, and $1.4 million for the second quarter of 2024. The Company’s effective tax rate was 23.6% for the quarter ended June 30, 2025, compared to 19.1% for the quarter ended March 31, 2025, and 23.1% for the quarter ended June 30, 2024. The fluctuations in the effective tax rate are largely driven by the timing and volume of certain stock-based compensation transactions resulting in tax benefits to the Company, as well as the timing and volume of state tax adjustments.

Net income was $4.8 million for the second quarter of 2025, an increase of $285 thousand from $4.5 million for the first quarter of 2025, and an increase of $79 thousand from $4.7 million for the second quarter of 2024. Diluted earnings per share totaled $0.33 for the second quarter of 2025, compared to $0.31 for the first quarter of 2025 and $0.36 for the second quarter of 2024. Earnings per share and other share-based metrics have been impacted by the shares issued in the previously disclosed private placement of shares of common stock completed in October 2024.

The Company had 188 full-time equivalent employees as of June 30, 2025, compared to 175 full-time equivalent employees as of March 31, 2025, and 155 full-time equivalent employees as of June 30, 2024.

Balance Sheet

Total loans, net of deferred fees and costs, were $871.6 million as of June 30, 2025, compared to $843.4 million as of March 31, 2025, and $772.9 million as of June 30, 2024. Loans, net of deferred fees and costs increased $28.3 million during the second quarter of 2025 primarily due to increases in commercial real estate, commercial and industrial, construction, and consumer loans, and partially offset by decreases in multifamily and residential loans. The increase in loans, net of deferred fees and costs, of $98.8 million from June 30, 2024, was primarily driven by increases of $88.5 million in commercial real estate loans. Total guaranteed loans as a percentage of loans ⁽¹⁾ were 22.1% as of June 30, 2025, compared to 24.2% as of March 31, 2025, and 27.9% as of June 30, 2024.

The Company’s allowance for credit losses totaled $9.2 million as of June 30, 2025, compared to $9.0 million as of March 31, 2025, and $7.3 million as of June 30, 2024. The allowance for credit losses as a percentage of total loans was 1.06% as of June 30, 2025, compared to 1.07% as of March 31, 2025, and 0.95% as of June 30, 2024. The allowance for credit losses as a percentage of total loans, excluding guaranteed portions ⁽¹⁾ , was 1.36% as of June 30, 2025, compared to 1.41% as of March 31, 2025, and 1.32% as of June 30, 2024.

Deposits totaled $1.032 billion as of June 30, 2025, an increase of $36.5 million from $995.9 million as of March 31, 2025, and an increase of $192.1 million from $840.4 million as of June 30, 2024. By deposit type, the increase from the prior quarter was driven by an increase of $25.5 million in certificates of deposit and a $29.5 million increase in savings and money market accounts. Noninterest-bearing deposits totaled $228.9 million as of June 30, 2025, a decrease of $13.7 million from $242.7 million as of March 31, 2025, and an increase of $8.5 million from $220.4 million as of June 30, 2024.

The Company’s ratio of loans to deposits was 84.4% as of June 30, 2025, compared to 84.7% as of March 31, 2025, and 92.0% as of June 30, 2024.

The Company held no short-term borrowings as of June 30, 2025 or March 31, 2025, compared to short term borrowings of $12.0 million as of June 30, 2024. As of June 30, 2025, the Company had approximately $520.2 million in available borrowing capacity from the Federal Reserve Bank of San Francisco, the Federal Home Loan Bank of San Francisco, and through its various fed funds lines of credit with its correspondent banks.

Subordinated notes outstanding totaled $26.1 million as of June 30, 2025, March 31, 2025 and June 30, 2024.

Stockholders’ equity was $151.7 million as of June 30, 2025, compared to $146.6 million as of March 31, 2025, and $110.9 million as of June 30, 2024. The increase in stockholders’ equity from March 31, 2025 is attributable to increases in retained earnings resulting from net income earned during the quarter. The increase in stockholders’ equity since June 30, 2024 was the result of the previously disclosed private placement of shares of common stock completed in October 2024 and net income earned over the previous twelve months.

The Company’s ratio of common equity to total assets was 12.3% as of June 30, 2025 and March 31, 2025, compared to 11.0% as of June 30, 2024. The Bank’s Tier 1 leverage ratio was 13.8% as of June 30, 2025, compared to 14.2% as of March 31, 2025, and 12.9% as of June 30, 2024. The increase in the Bank’s Tier 1 leverage ratio was the result of the downstream of $15.0 million in additional capital from the Company to the Bank during the first quarter of 2025. The Company’s book value per share was $10.63 as of June 30, 2025, an increase of 3.5% from $10.27 as of March 31, 2025, and an increase of 25.2% from $8.49 as of June 30, 2024. The increase in book value per share from March 31, 2025 is attributable to net income earned during the second quarter of 2025.

Total assets increased 3.6% to $1.23 billion as of June 30, 2025, from $1.19 billion as of March 31, 2025, and increased 22.1% from $1.01 billion as of June 30, 2024. The increase in total assets from March 31, 2025 was primarily driven by increases in loans and investment securities. The increase in total assets from June 30, 2024 was primarily driven by increases in loans, interest bearing deposits with banks, and investment securities.

Asset Quality

The provision for credit losses on loans totaled $1.1 million for the second quarter of 2025, compared to $710 thousand for the first quarter of 2025 and $283 thousand for the second quarter of 2024. Net loan charge-offs in the second quarter of 2025 totaled $870 thousand, or 0.38% of average net loans (annualized), compared to net loan charge-offs of $828 thousand, or 0.39% of average net loans (annualized) in the first quarter of 2025 and $29 thousand of net loan charge-offs, or 0.01% of average net loans (annualized) during the second quarter of 2024.

⁽¹⁾ See Reconciliation of Non-GAAP Financial Measures

Nonaccrual loans decreased $993 thousand during the quarter to $18.2 million as of June 30, 2025, and increased $11.8 million from $6.5 million as of June 30, 2024. The guaranteed portion of nonaccrual loans totaled $13.8 million as of June 30, 2025. Loans past due 90 days and accruing interest totaled $146 thousand as of June 30, 2025, compared to $1.2 million as of March 31, 2025, and $1.1 million as of June 30, 2024. The balance of loans past due 90 days and accruing of $146 thousand at June 30, 2025 was comprised entirely of credit card balances which are non-guaranteed.

The Company held no other real estate owned as of June 30, 2025, March 31, 2025, or June 30, 2024.

Total non-performing assets totaled $18.4 million as of June 30, 2025, a decrease of $2.0 million from $20.4 million as of March 31, 2025, and an increase of $10.8 million from $7.6 million as of June 30, 2024. Non-performing assets, excluding guaranteed portions, totaled $4.6 million as of June 30, 2025, a decrease of $1.1 million from $5.7 million as of March 31, 2025 and an increase of $2.4 million from $2.2 million as of June 30, 2024.

Loans past due between 30 and 89 days and accruing interest totaled $8.2 million as of June 30, 2025, a decrease of $6.7 million from $14.9 million as of March 31, 2025, and an increase of $7.1 million from $1.1 million as of June 30, 2024. The guaranteed portion of loans past due between 30 and 89 days and accruing interest totaled $5.7 million as of June 30, 2025.

The ratio of total non-performing assets to total assets was 1.49% as of June 30, 2025, compared to 1.71% as of March 31, 2025, and 0.75% as of June 30, 2024. The ratio of non-performing assets, excluding guaranteed portions, to total assets ⁽¹⁾ was 0.37% as of June 30, 2025, compared to 0.48% as of March 31, 2025, and 0.22% as of June 30, 2024.

The Company continues to closely monitor credit quality in light of the ongoing economic uncertainty caused by, among other factors, the prolonged elevated interest rate environment, stronger than expected employment data in recent periods, continued uncertainty regarding U.S. trade and tariff policy and the lingering inflationary pressures, and the risk of the resurgence of elevated levels of inflation, in the United States and our market areas. Accordingly, additional provisions for credit losses may be necessary in future periods.

Other Financial Highlights

SBA Lending and Commercial Banking

SBA lending and commercial banking loan originations totaled $160.5 million for the second quarter of 2025, compared to $133.0 million for the first quarter of 2025 and $126.9 million for the second quarter of 2024. Loan sale volume increased to $82.1 million during the second quarter of 2025, compared to $68.7 million for the first quarter of 2025, and $77.9 million for the second quarter of 2024. Gain on sale of loans increased 2.2% to $2.6 million, compared to $2.5 million for the first quarter of 2025, and decreased 18.0% from $3.2 million for the second quarter of 2024. The average pretax gain on sale of loans margin was 3.16% for the second quarter of 2025, compared to 3.69% for the first quarter of 2025 and 4.36% for the second quarter of 2024.

Gaming FinTech

During the second quarter of 2025, the Company completed its efforts to enhance critical systems to internally control all aspects of our credit card operations including applications processing, Know Your Customer, credit processing, customer service and compliance/risk management. Due to the growth in credit card transaction volumes the Bank has also begun developing entirely new platforms for the program targeted for completion in the fourth quarter of 2025.

As expected, the above enhancements disrupted our credit card marketing/growth in the second quarter of 2025 and this, combined with the anticipated seasonal decline in gaming volume in the second quarter, resulted in a 22% decline in transaction volume from $105 million during the first quarter of 2025 to $82 million during the second quarter of 2025. However, we began processing new card applications mid-June and, as of the date of this press release, the Company is seeing significantly higher transaction volume over the second quarter.

Credit card balances were $3.7 million as of June 30, 2025, compared to $2.3 million as of March 31, 2025, and $891 thousand as of June 30, 2024. Through June 30, 2025, and since the launch of credit card operations, the Bank has processed over $246 million in gaming transactions.

The Prepaid Access/Slot program involving BoltBetz is continuing to make significant progress. The technology development process is complete and functional, and the program remains subject to the receipt of final regulatory approvals.

The PPA pipeline continues to develop new payments agreements with both the Prepaid Access accounts and virtual ATM providers which are expected to launch in the coming quarters following the receipt of final regulatory approvals.

⁽¹⁾ See Reconciliation of Non-GAAP Financial Measures

BankCard Services LLC (“BCS”) and GBank now have sixteen active payment and Pooled Player (PPA™) and Pooled Consumer (PCA™) Program clients. Currently, BCS and GBank are conducting due diligence for five new clients, with anticipated onboarding in future quarters. Gaming FinTech deposits averaged $39.5 million for the second quarter of 2025, compared to $37.1 million for the first quarter of 2025.

Earnings Call

The Company will host its second quarter 2025 earnings call on Tuesday July 29, 2025, at 10:00 a.m., PST. Interested parties can participate remotely via Internet connectivity. There will be no physical location for attendance.

Interested parties may join online, via the ZOOM app on their smartphones, or by telephone:

ZOOM Conference ID 826 3030 7240
Passcode: 549549

Joining by ZOOM Conference (audio only):

Log in on your computer at
https://us02web.zoom.us/j/82630307240?pwd=TU4yZXJqMEc2VGZoUm5rRTl0OVFxdz09
or use the ZOOM app on your smartphone.

Joining by Telephone

Dial (408) 638-0968. The conference ID is 826 3030 7240. Passcode: 549549.

About GBank Financial Holdings Inc.

GBank Financial Holdings Inc. is a bank holding company headquartered in Las Vegas, Nevada and is listed on the Nasdaq Capital Market under the symbol “GBFH.” Through our wholly owned bank subsidiary, GBank, we operate two full-service commercial branches in Las Vegas, Nevada to provide a broad range of business, commercial and retail banking products and services to small businesses, middle-market enterprises, public entities and affluent individuals in Nevada, California, Utah, and Arizona. Please visit www.gbankfinancialholdings.com for more information.

Non-GAAP Financial Measures

Some of the financial measures included in this press release are not measures of financial performance recognized in accordance with generally accepted accounting principles in the United States (“GAAP”). The Company believes these non-GAAP financial measures provide both management and investors a more complete understanding of the Company’s financial position and performance. These non-GAAP financial measures are supplemental and are not a substitute for any analysis based on GAAP financial measures.

We classify a financial measure as being a non-GAAP financial measure if that financial measure excludes or includes amounts, or is subject to adjustments that have the effect of excluding or including amounts, that are included or excluded, as the case may be, in the most directly comparable measure calculated and presented in accordance with GAAP as in effect from time to time in the United States in our statements of income, balance sheets or statements of cash flows. Not all companies use the same calculation of these measures; therefore, this presentation may not be comparable to other similarly titled measures as presented by other companies.

A reconciliation of non-GAAP financial measures to GAAP financial measures is provided at the end of this press release.

Available Information

The Company routinely posts important information for investors on its web site (under www.gbankfinancialholdings.com and, more specifically, under the News & Media tab at www.gbankfinancialholdings.com/press-releases ). The Company intends to use its web site as a means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD (Fair Disclosure) promulgated by the U.S. Securities and Exchange Commission (the “SEC”). Accordingly, investors should monitor the Company’s web site, in addition to following the Company’s press releases, SEC filings, public conference calls, presentations and webcasts.

The information contained on, or that may be accessed through, the Company’s web site is not incorporated by reference into, and is not a part of, this document.

Notice Regarding Disclosures and Forward-Looking Statements

This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities. Any offers, solicitations or offers to buy, or any sales of securities will be made in accordance with the registration requirements of the Securities Act of 1933, as amended (“Securities Act”). This announcement is being issued in accordance with Rule 135 under the Securities Act.

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements reflect the Company’s current views with respect to future events and the Company’s financial performance. Any statements about the Company’s expectations, beliefs, plans, predictions, forecasts, objectives, assumptions or future events or performance are not historical facts and may be forward-looking. These statements are often, but not always, made through the use of words or phrases such as “anticipate,” “believes,” “can,” “could,” “may,” “predicts,” “potential,” “should,” “will,” “estimate,” “plans,” “projects,” “continuing,” “ongoing,” “expects,” “intends” and similar words or phrases. The Company cautions that the forward-looking statements in this press release are based largely on the Company’s expectations and are subject to a number of known and unknown risks and uncertainties that are subject to change based on factors which are, in many instances, beyond the Company’s control. Factors that could cause such changes include, but are not limited to, (i) the impact on us and our customers of a decline in general economic conditions and any regulatory responses thereto; (ii) potential recession in the United States and our market areas; (iii) the impacts related to or resulting from uncertainty in the banking industry as a whole; (iv) increased competition for deposits in our market areas and related changes in deposit customer behavior; (v) the impact of changes in market interest rates, whether due to a continuation of the elevated interest rate environment or further reductions in interest rates and a resulting decline in net interest income; (vi) the lingering inflationary pressures, and the risk of the resurgence of elevated levels of inflation, in the United States and our market areas; (vii) the uncertain impacts of ongoing quantitative tightening and current and future monetary policies of the Board of Governors of the Federal Reserve System; (viii) changes in unemployment rates in the United States and our market areas; (ix) adverse changes in customer spending and savings habits; (x) declines in commercial real estate values and prices; (xi) a deterioration of the credit rating for U.S. long-term sovereign debt or uncertainty regarding United States fiscal debt, deficit and budget matters; (xii) cyber incidents or other failures, disruptions or breaches of our operational or security systems or infrastructure, or those of our third-party vendors or other service providers, including as a result of cyber-attacks; (xiii) severe weather, natural disasters, acts of war or terrorism, geopolitical instability or other external events, including as a result of the policies of the current U.S. presidential administration or Congress; (xiv) the impacts of tariffs, sanctions and other trade policies of the United States and its global trading counterparts and the resulting impact on the Company and its customers; (xv) competition and market expansion opportunities; (xvi) changes in non-interest expenditures or in the anticipated benefits of such expenditures; (xvii) the risks related to the development, implementation, use and management of emerging technologies, including artificial intelligence and machine learnings; (xviii) potential costs related to the impacts of climate change; (xix) current or future litigation, regulatory examinations or other legal and/or regulatory actions; and (xx) changes in applicable laws and regulations. Additional information regarding these risks and uncertainties to which the Company’s business and future financial performance are subject is contained in the Company’s most recent filings with SEC, including the sections entitled “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” of such documents, and other documents the Company files or furnishes with the SEC from time to time, which are available on the SEC’s website, www.sec.gov. Actual results, performance or achievements could differ materially from those contemplated, expressed, or implied by the forward-looking statements due to additional risks and uncertainties of which the Company is not currently aware or which it does not currently view as, but in the future may become, material to its business or operating results. Due to these and other possible uncertainties and risks, the Company can give no assurance that the results contemplated in the forward-looking statements will be realized and readers are cautioned not to place undue reliance on the forward-looking statements contained in this press release. Any forward-looking statements presented herein are made only as of the date of this press release, and the Company does not undertake any obligation to update or revise any forward-looking statements to reflect changes in assumptions, new information, the occurrence of unanticipated events, or otherwise, except as required by applicable law. All forward-looking statements, express or implied, included in the press release are qualified in their entirety by this cautionary statement.

For Further Information, Contact:

GBank Financial Holdings Inc.
T. Ryan Sullivan
President and CEO
702-851-4200
rsullivan@g.bank


GBank Financial Holdings Inc. Condensed Consolidated Balance Sheets (Unaudited)

																Linked Quarter						Quarter Year-Over-Year
																6/30/25 vs. 3/31/25						6/30/25 vs. 6/30/24
($’s in 000, except per share data)	Jun 30, 2025			Mar 31, 2025			Dec 31, 2024			Sep 30, 2024			Jun 30, 2024			$ Var			% Var			$ Var			% Var
Assets
Cash and Due From Banks	$	11,877		$	6,701		$	9,262		$	5,798		$	5,409		$	5,176			77.2	%	$	6,468			119.6	%
Interest-Bearing Deposits With Other Financial Institutions		131,352			140,270			114,860			65,160			82,749			(8,918	)		-6.4	%		48,603			58.7	%
Total Cash and Cash Equivalents		143,229			146,971			124,122			70,958			88,158			(3,742	)		-2.5	%		55,071			62.5	%

Investment Securities:
Available For Sale, at Fair Value		82,886			71,468			65,609			39,381			2,330			11,418			16.0	%		80,556			3457.3	%
Held to Maturity, at Amortized Cost		39,515			39,903			40,569			46,043			56,520			(388	)		-1.0	%		(17,005	)		-30.1	%

Loans Held For Sale		45,242			41,313			32,649			68,317			40,489			3,929			9.5	%		4,753			11.7	%
Loans, Net of Deferred Fees and Costs:
Commercial and Industrial		59,021			56,885			64,000			53,490			50,498			2,136			3.8	%		8,523			16.9	%
Commercial Real Estate - Non-owner Occupied		682,021			672,379			630,551			607,864			583,463			9,642			1.4	%		98,558			16.9	%
Commercial Real Estate - Owner Occupied		96,526			81,768			88,802			86,785			106,595			14,758			18.0	%		(10,069	)		-9.4	%
Construction and Land Development		4,371			3,201			2,934			2,161			529			1,170			36.6	%		3,842			726.3	%
Multifamily		18,987			19,011			17,374			17,398			17,420			(24	)		-0.1	%		1,567			9.0	%
Residential		6,810			7,619			10,584			12,025			13,443			(809	)		-10.6	%		(6,633	)		-49.3	%
Consumer		3,894			2,502			1,713			1,276			909			1,392			55.6	%		2,985			328.4	%
Total Loans, Net of Deferred Fees and Costs		871,630			843,365			815,958			780,999			772,857			28,265			3.4	%		98,773			12.8	%
Less: Allowance for Credit Losses		(9,205	)		(8,997	)		(9,114	)		(7,934	)		(7,342	)		(208	)		2.3	%		(1,863	)		25.4	%
Total Net Loans		862,425			834,368			806,844			773,065			765,515			28,057			3.4	%		96,910			12.7	%

Loan Servicing Asset		9,736			9,231			8,976			8,046			7,698			505			5.5	%		2,038			26.5	%
Restricted Investment in Bank Stock		5,513			4,652			4,652			4,652			4,652			861			18.5	%		861			18.5	%
All Other Assets		43,878			42,106			38,943			37,540			43,992			1,772			4.2	%		(114	)		-0.3	%
Total Assets	$	1,232,424		$	1,190,012		$	1,122,364		$	1,048,002		$	1,009,354		$	42,412			3.6	%	$	223,070			22.1	%
Liabilities
Non-Interest Bearing Demand	$	228,913		$	242,650		$	239,672		$	229,875		$	220,438		$	(13,737	)		-5.7	%	$	8,475			3.8	%
Interest Bearing Demand		57,254			62,035			68,132			65,623			65,120			(4,781	)		-7.7	%		(7,866	)		-12.1	%
Savings and Money Market		309,559			280,056			256,724			244,091			222,115			29,503			10.5	%		87,444			39.4	%
Certificates of Deposit		436,738			411,201			370,552			343,931			332,695			25,537			6.2	%		104,043			31.3	%
Total Deposits		1,032,464			995,942			935,080			883,520			840,368			36,522			3.7	%		192,096			22.9	%

Short-Term Borrowings		-			-			-			-			12,000			-			0.0	%		(12,000	)		-100.0	%
Subordinated Debt		26,126			26,107			26,088			26,070			26,051			19			0.1	%		75			0.3	%
Operating Lease Liability		6,121			6,299			4,839			5,032			5,221			(178	)		-2.8	%		900			17.2	%
Other Liabilities		15,964			15,048			15,657			16,997			14,769			916			6.1	%		1,195			8.1	%
Total Liabilities		1,080,675			1,043,396			981,664			931,619			898,409			37,279			3.6	%		182,266			20.3	%

Equity
Common Stock		1			1			1			1			1			-			0.0	%		-			0.0	%
Additional Paid-in Capital		79,291			78,718			77,571			57,287			56,966			573			0.7	%		22,325			39.2	%
Retained Earnings		73,662			68,906			64,437			59,192			54,177			4,756			6.9	%		19,485			36.0	%
Accumulated Other Comprehensive Loss		(1,205	)		(1,009	)		(1,309	)		(97	)		(199	)		(196	)		19.4	%		(1,006	)		505.5	%
Total Stockholders’ Equity		151,749			146,616			140,700			116,383			110,945			5,133			3.5	%		40,804			36.8	%
Total Liabilities & Stockholders’ Equity	$	1,232,424		$	1,190,012		$	1,122,364		$	1,048,002		$	1,009,354		$	42,412			3.6	%	$	223,070			22.1	%

Book Value Per Common Share	$	10.63		$	10.27		$	9.87		$	8.91		$	8.49		$	0.36			3.5	%	$	2.14			25.2	%

GBank Financial Holdings Inc. Condensed Consolidated Income Statements (Unaudited)

	Three Months Ended															Six Months Ended
($’s in 000, except per share data)	Jun 30, 2025			Mar 31, 2025			Dec 31, 2024			Sep 30, 2024			Jun 30, 2024			Jun 30, 2025			Jun 30, 2024
Interest Income
Loans	$	17,659		$	16,836		$	17,231		$	17,347		$	16,360		$	34,495		$	31,690
Deposits With Other Financial Institutions		1,365			1,192			1,099			1,367			1,165			2,557			2,137
Investment Securities		1,414			1,281			1,177			924			868			2,695			1,882
Other Interest Bearing Balances		117			100			103			102			96			217			170
Total Interest Income		20,555			19,409			19,610			19,740			18,489			39,964			35,879

Interest Expense
Deposits		7,905			7,230			7,535			7,194			6,848			15,135			13,046
Short-term Borrowings and Subordinated Debt		262			285			286			287			293			547			682
Total Interest Expense		8,167			7,515			7,821			7,481			7,141			15,682			13,728

Net Interest Income		12,388			11,894			11,789			12,259			11,348			24,282			22,151
Provision for Credit Losses - Loans		(1,079	)		(710	)		(1,337	)		(570	)		(283	)		(1,789	)		(283	)
Provision for Credit Losses - Unfunded Commitments		(13	)		(11	)		(13	)		(8	)		(12	)		(24	)		(32	)
Net Interest Income after Provision for Credit Losses		11,296			11,173			10,439			11,681			11,053			22,469			21,836

Non-Interest Income
Gain on Sales of Loans		2,593			2,537			3,998			2,838			3,163			5,130			5,246
Loan Servicing Income		750			703			597			566			534			1,453			594
Service Charges and Fees		54			56			54			48			41			110			82
Net Interchange Fees		1,535			2,003			947			284			146			3,538			166
Other Income		452			164			168			166			282			616			483
Total Non-Interest Income		5,384			5,463			5,764			3,902			4,166			10,847			6,571

Non-Interest Expenses
Salaries and Employee Benefits		6,235			6,400			5,813			5,495			5,752			12,635			11,042
Occupancy Expenses		400			392			398			404			417			792			865
Other Expenses		3,761			4,115			3,509			3,156			2,963			7,876			5,601
Total Non-Interest Expenses		10,396			10,907			9,720			9,055			9,132			21,303			17,508

Income Before Provision For Income Taxes		6,284			5,729			6,483			6,528			6,087			12,013			10,899
Provision For Income Taxes		(1,486	)		(1,224	)		(1,239	)		(1,513	)		(1,411	)		(2,710	)		(2,523	)
Net Income Before Equity Investment Loss		4,798			4,505			5,244			5,015			4,676			9,303			8,376
Net Loss Attributable to Equity Investment		(43	)		(35	)		-			-			-			(78	)		-
Net Income	$	4,755		$	4,470		$	5,244		$	5,015		$	4,676		$	9,225		$	8,376

Earnings Per Share	$	0.33		$	0.31		$	0.37		$	0.38		$	0.36		$	0.65		$	0.65
Earnings Per Share (Diluted)	$	0.33		$	0.31		$	0.37		$	0.38		$	0.36		$	0.63		$	0.65
Average Common Shares Outstanding		14,274			14,256			14,095			13,067			12,845			14,265			12,812
Diluted Average Common Shares Outstanding		14,551			14,549			14,327			13,236			12,964			14,536			12,964

GBank Financial Holdings Inc. Quarter-to-Date Average Balances, Rates, and Interest Income and Expense (Unaudited)

	For the Three Months Ended
	June 30, 2025							March 31, 2025							June 30, 2024
(Dollars in thousands)	Average				Yield/			Average				Yield/			Average				Yield/
	Balance		Interest		Rate ⁽¹⁾			Balance		Interest		Rate ⁽¹⁾			Balance		Interest		Rate ⁽¹⁾
ASSETS:
Interest Bearing Deposits	$	115,974	$	1,365		4.72	%	$	102,628	$	1,192		4.71	%	$	80,062	$	1,165		5.85	%
Investment Securities:
Taxable		119,880		1,414		4.73	%		105,222		1,281		4.94	%		73,696		868		4.74	%
Loans and Loans Held For Sale		911,028		17,659		7.77	%		866,690		16,836		7.88	%		789,516		16,360		8.33	%
Restricted Investment in Bank Stock		5,362		117		8.75	%		4,652		100		8.72	%		4,400		96		8.78	%
Total Earning Assets		1,152,244		20,555		7.16	%		1,079,192		19,409		7.29	%		947,674		18,489		7.85	%

Cash and Due From Banks		6,782							6,216							6,302
Other Assets		41,894							39,177							33,607
Total Assets	$	1,200,920						$	1,124,585						$	987,583

LIABILITIES & STOCKHOLDERS’ EQUITY
Deposits:
Interest-bearing Demand	$	60,320		316		2.10	%	$	65,693		355		2.19	%	$	67,038		395		2.37	%
Money Market and Savings		303,814		2,929		3.87	%		264,085		2,411		3.70	%		217,081		2,137		3.96	%
Certificates of Deposit		413,940		4,660		4.52	%		385,704		4,464		4.69	%		330,271		4,316		5.26	%
Total Interest-Bearing Deposits		778,074		7,905		4.08	%		715,482		7,230		4.10	%		614,390		6,848		4.48	%

Short-Term Borrowings		-		-		0.00	%		-		-		0.00	%		517		7		5.45	%
Subordinated Debt		26,113		262		4.02	%		26,095		285		4.43	%		26,040		286		4.42	%
Total Interest-Bearing Liabilities		804,187		8,167		4.07	%		741,577		7,515		4.11	%		640,947		7,141		4.48	%

Noninterest-bearing Deposits		223,201							218,874							220,842
Other Liabilities		22,404							20,139							18,849
Stockholders’ Equity		151,128							143,995							106,945
Total Liabilities & Stockholders’ Equity	$	1,200,920						$	1,124,585						$	987,583

Net Interest Income			$	12,388						$	11,894						$	11,348

Total Yield on Earning Assets						7.16	%						7.29	%						7.85	%
Cost on Interest-Bearing Liabilities						4.07	%						4.11	%						4.48	%
Average Interest Spread						3.08	%						3.18	%						3.37	%
Net Interest Margin						4.31	%						4.47	%						4.82	%
Net Interest Margin (Bank Only)						4.40	%						4.58	%						4.94	%

^{(1) Ratios are annualized on an actual/actual basis}

GBank Financial Holdings Inc. Year-to-Date Average Balances, Rates, and Interest Income and Expense (Unaudited)

	For the Six Months Ended
	June 30, 2025							June 30, 2024
(Dollars in thousands)	Average				Yield/			Average				Yield/
	Balance		Interest		Rate ⁽¹⁾			Balance		Interest		Rate ⁽¹⁾
ASSETS:
Interest Bearing Deposits	$	109,338	$	2,557		4.72	%	$	73,081	$	2,137		5.88	%
Investment Securities:
Taxable		112,591		2,695		4.83	%		85,890		1,882		4.41	%
Loans and Loans Held For Sale		888,982		34,495		7.82	%		758,651		31,690		8.40	%
Restricted Investment in Bank Stock		5,009		217		8.74	%		3,811		170		8.97	%
Total Earning Assets		1,115,920		39,964		7.22	%		921,433		35,879		7.83	%

Cash and Due From Banks		6,501							6,119
Other Assets		40,543							33,604
Total Assets	$	1,162,964						$	961,156

LIABILITIES & STOCKHOLDERS’ EQUITY
Deposits:
Interest-bearing Demand	$	62,992		672		2.15	%	$	66,170		788		2.39	%
Money Market and Savings		284,060		5,340		3.79	%		201,727		3,897		3.88	%
Certificates of Deposit		399,899		9,123		4.60	%		319,746		8,361		5.26	%
Total Interest-Bearing Deposits		746,951		15,135		4.09	%		587,643		13,046		4.46	%

Short-Term Borrowings		-		-		0.00	%		4,049		111		5.51	%
Subordinated Debt		26,104		547		4.23	%		26,031		571		4.41	%
Total Interest-Bearing Liabilities		773,055		15,682		4.09	%		617,723		13,728		4.47	%

Noninterest-bearing Deposits		221,050							220,804
Other Liabilities		21,278							18,427
Stockholders’ Equity		147,581							104,202
Total Liabilities & Stockholders’ Equity	$	1,162,964						$	961,156

Net Interest Income			$	24,282						$	22,151

Total Yield on Earning Assets						7.22	%						7.83	%
Cost on Interest-Bearing Liabilities						4.09	%						4.47	%
Average Interest Spread						3.13	%						3.36	%
Net Interest Margin						4.39	%						4.83	%
Net Interest Margin (Bank Only)						4.49	%						4.96	%

^{(1) Ratios are annualized on an actual/actual basis}

GBank Financial Holdings Inc. Additional Financial Information (Unaudited)

	Three Months Ended															Six Months Ended
($’s in 000, except per share data)	Jun 30, 2025			Mar 31, 2025			Dec 31, 2024			Sep 30, 2024			Jun 30, 2024			Jun 30, 2025			Jun 30, 2024
Key Performance Metrics
Return on Average Assets-Net Income ⁽¹⁾		1.59	%		1.61	%		1.93	%		1.96	%		1.90	%		1.60	%		1.75	%
Return on Average Stockholders’ Equity ⁽¹⁾		12.62	%		12.59	%		15.13	%		17.29	%		17.59	%		12.61	%		16.17	%
Efficiency Ratio		58.50	%		62.84	%		55.38	%		56.03	%		58.86	%		60.64	%		60.96	%
Net Interest Margin ⁽¹⁾		4.31	%		4.47	%		4.53	%		5.00	%		4.82	%		4.39	%		4.83	%
Net Revenue ⁽²⁾	$	17,772		$	17,357		$	17,553		$	16,161		$	15,514		$	35,129		$	28,722
Common Equity / Assets		12.3	%		12.3	%		12.5	%		11.1	%		11.0	%		12.3	%		11.0	%
Tier 1 Leverage Ratio - Bank		13.82	%		14.23	%		12.90	%		13.08	%		12.88	%		13.82	%		12.88	%

Selected Loan Metrics
Guaranteed Portion of Loans Held for Sale	$	45,242		$	41,313		$	32,649		$	68,317		$	40,489		$	45,242		$	40,489
Guaranteed Portion of Loans Held for Investment		192,324			204,239			201,267			203,027			215,382			192,324			215,382
Total Guaranteed Loans		237,566			245,552			233,916			271,344			255,871			237,566			255,871
Guaranteed Loans as a Percent of Total Loans ⁽²⁾		22.1	%		24.2	%		24.7	%		26.0	%		27.9	%		22.1	%		27.9	%
SBA Loan Originations	$	132,256		$	129,351		$	103,886		$	146,918		$	121,807		$	261,607		$	251,074
SBA Loans Sold	$	82,140		$	68,720		$	98,545		$	71,386		$	77,905		$	150,860		$	146,477
Gain on Loan Sales Margin ⁽²⁾		3.16	%		3.69	%		4.06	%		3.98	%		4.36	%		3.40	%		3.58	%

Asset Quality
Total nonaccrual loans	$	18,227		$	19,220		$	14,128		$	5,381		$	6,470		$	18,227		$	6,470
Loans past due 90 days and still accruing		146			1,153			40			27			1,142			146			1,142
Other real estate owned		-			-			-			-			-			-			-
Total non-performing assets	$	18,373		$	20,373		$	14,168		$	5,408		$	7,612		$	18,373		$	7,612
Non-performing assets: guaranteed portion	$	13,792		$	14,687		$	9,321		$	3,838		$	5,396		$	13,792		$	5,396
Non-performing assets: non-guaranteed portion	$	4,581		$	5,686		$	4,847		$	1,570		$	2,216		$	4,581		$	2,216

Non-performing assets to total assets		1.49	%		1.71	%		1.26	%		0.52	%		0.75	%		1.49	%		0.75	%
Non-performing assets, excluding guaranteed, to total assets ⁽²⁾		0.37	%		0.48	%		0.43	%		0.15	%		0.22	%		0.37	%		0.22	%
Net charge-offs (recoveries)	$	870		$	828		$	157		$	(22	)	$	29		$	1,698		$	29

Loans past due 30-89 days and accruing	$	8,182		$	14,853		$	11,822		$	12,390		$	1,054		$	8,182		$	1,054
Loans past due 30-89 days and accruing: guaranteed portion	$	5,650		$	11,915		$	8,713		$	8,535		$	-		$	5,650		$	-
Loans past due 30-89 days and accruing: non-guaranteed portion	$	2,532		$	2,938		$	3,109		$	3,855		$	1,054		$	2,532		$	1,054

Allowance for Credit Losses (ACL)	$	9,205		$	8,997		$	9,114		$	7,934		$	7,342		$	9,205		$	7,342
Nonaccrual loans	$	18,227		$	19,220		$	14,128		$	5,381		$	6,470		$	18,227		$	6,470
ACL to nonaccrual loans		51	%		47	%		65	%		147	%		113	%		51	%		113	%
ACL to nonaccrual loans, excluding guaranteed ⁽²⁾		208	%		168	%		190	%		514	%		130	%		208	%		130	%
ACL to loans		1.06	%		1.07	%		1.12	%		1.02	%		0.95	%		1.06	%		0.95	%
ACL to loans, excluding guaranteed ⁽²⁾		1.36	%		1.41	%		1.48	%		1.37	%		1.32	%		1.36	%		1.32	%

Book Value
Stockholders’ Equity	$	151,749		$	146,616		$	140,700		$	116,383		$	110,945		$	151,749		$	110,945
Common shares outstanding		14,274			14,271			14,252			13,067			13,061			14,274			13,061
Book value per common share	$	10.63		$	10.27		$	9.87		$	8.91		$	8.49		$	10.63		$	8.49
Full-Time Equivalent Employees		188			175			169			159			155			188			155

⁽¹⁾ Ratios are annualized on an actual/actual basis
⁽²⁾ See Reconciliation of Non-GAAP Financial Measures

GBank Financial Holdings Inc. Reconciliation of Non-GAAP Financial Measures (Unaudited)

	Three Months Ended															Six Months Ended
($'s in 000, except per share data)	Jun 30, 2025			Mar 31, 2025			Dec 31, 2024			Sep 30, 2024			Jun 30, 2024			Jun 30, 2025			Jun 30, 2024

Net Revenue ⁽¹⁾
Net Interest Income	$	12,388		$	11,894		$	11,789		$	12,259		$	11,348		$	24,282		$	22,151
Non-Interest Income		5,384			5,463			5,764			3,902			4,166			10,847			6,571
Net Revenue	$	17,772		$	17,357		$	17,553		$	16,161		$	15,514		$	35,129		$	28,722

Gain on Loan Sales Margin ⁽¹⁾
Gain on Sale of Loans	$	2,593		$	2,537		$	3,998		$	2,838		$	3,163		$	5,130		$	5,246
Loans Sold		82,140			68,720			98,545			71,386			77,905			150,860			146,477
Gain on Loan Sales Margin		3.16	%		3.69	%		4.06	%		3.98	%		4.06	%		3.40	%		3.58	%

Guaranteed Loans as a Percent of Loans ⁽²⁾
SBA and USDA Guaranteed Loans	$	192,324		$	204,239		$	201,267		$	203,027		$	215,382		$	192,324		$	215,382
Loans, Net of Deferred Fees and Costs		871,630			843,365			815,958			780,999			772,857			871,630			772,857
Guaranteed Loans as a % of Loans		22.1	%		24.2	%		24.7	%		26.0	%		27.9	%		22.1	%		27.9	%

Non-performing assets, excluding guaranteed, to total assets ⁽²⁾
Non-performing assets	$	18,373		$	20,373		$	14,168		$	5,408		$	7,612		$	18,373		$	7,612
Less: SBA and USDA guaranteed portions of non-performing assets		13,792			14,687			9,321			3,838			5,396			13,792			5,396
Non-performing assets, excluding guaranteed portions		4,581			5,686			4,847			1,570			2,216			4,581			2,216
Total assets		1,232,424			1,190,012			1,122,364			1,048,002			1,009,354			1,232,424			1,009,354
Non-performing assets, excluding guaranteed, to total assets		0.37	%		0.48	%		0.43	%		0.15	%		0.22	%		0.37	%		0.22	%

Allowance for credit losses (ACL) to nonaccrual loans, excluding guaranteed ⁽²⁾
Nonaccrual loans	$	18,227		$	19,220		$	14,128		$	5,381		$	6,470		$	18,227		$	6,470
Less: SBA and USDA guaranteed portions of nonaccrual loans		13,792			13,859			9,321			3,838			833			13,792			833
Nonaccrual loans, excluding guaranteed portions		4,435			5,361			4,807			1,543			5,637			4,435			5,637
ACL to nonaccrual loans, excluding guaranteed		208	%		168	%		190	%		514	%		130	%		208	%		130	%

ACL to loans, excluding guaranteed ⁽²⁾
Loans, net of deferred fees and costs	$	871,630		$	843,365		$	815,958		$	780,999		$	772,857		$	871,630		$	772,857
Less: SBA and USDA guaranteed portions of loans		192,324			204,239			201,267			203,027			215,382			192,324			215,382
Loans, excluding guaranteed		679,306			639,126			614,691			577,972			557,475			679,306			557,475
ACL to loans, excluding guaranteed		1.36	%		1.41	%		1.48	%		1.37	%		1.32	%		1.36	%		1.32	%

Non-GAAP Financial Measures Footnotes
(1) We believe this non-GAAP measurement presents trends in income generation of the Company.
(2) We believe these non-GAAP measurements provide useful metrics regarding the at-risk assets of the Company.

Read Full Article

FAT Brands to Host Conference Call for Second Quarter 2025 Financial Results

2 hours ago | July 28, 2025 9:30 p.m. UTC

FAT Brands will hold a conference call on July 30, 2025, to discuss its Q2 financial results.

Quiver AI Summary

FAT Brands Inc. (NASDAQ: FAT), a prominent global franchising company that manages various restaurant brands, has announced it will hold a conference call to discuss its financial results for the second quarter of 2025 on July 30, 2025, at 4:30 PM ET. A press release detailing these financial results will be issued earlier that day. Interested parties can access the call by phone or via a live webcast on the company's website, and a replay will be available until August 20, 2025. The call will be led by Chairman Andy Wiederhorn and Co-CEO Ken Kuick. FAT Brands owns and operates 18 restaurant brands, including Fatburger and Johnny Rockets, with over 2,300 locations globally.

Potential Positives

The announcement of a conference call to review second quarter 2025 financial results demonstrates transparency and commitment to keeping stakeholders informed.
Hosting financial discussions with both the Chairman and Co-CEO emphasizes strong leadership and accountability within the company.
The availability of a replay for the conference call and webcast ensures that all interested parties can access the information, enhancing investor relations.
The mention of owning and franchising over 2,300 units worldwide highlights the company's significant market presence and growth potential in the restaurant industry.

Potential Negatives

The upcoming conference call to discuss second quarter 2025 financial results may indicate that the company is facing ongoing financial scrutiny or challenges that warrant a dedicated discussion.
The need for a replay of the conference call may suggest that there could be significant information that stakeholders will want to revisit, potentially indicating complexity or serious implications in the company's performance.

FAQ

When is the FAT Brands second quarter 2025 financial results conference call?

The conference call is scheduled for Wednesday, July 30, 2025, at 4:30 PM ET.

How can I access the FAT Brands conference call?

You can access the call by dialing 1-877-704-4453 in the U.S. or 1-201-389-0920 internationally.

Will the conference call be available for replay?

Yes, a replay will be available until August 20, 2025. Call 1-844-512-2921 in the U.S. or 1-412-317-6671 internationally.

Who is hosting the FAT Brands conference call?

The conference call will be hosted by Andy Wiederhorn and Ken Kuick.

Where can I find additional information about FAT Brands?

For more information, visit the FAT Brands corporate website at www.fatbrands.com.

Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.

$FAT Insider Trading Activity

$FAT insiders have traded $FAT stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $FAT stock by insiders over the last 6 months:

MARK ELENOWITZ purchased 1,000 shares for an estimated $2,200

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$FAT Hedge Fund Activity

We have seen 6 institutional investors add shares of $FAT stock to their portfolio, and 12 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

DIVISADERO STREET CAPITAL MANAGEMENT, LP removed 175,428 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $505,232
CITADEL ADVISORS LLC added 23,966 shares (+inf%) to their portfolio in Q1 2025, for an estimated $69,022
FNY INVESTMENT ADVISERS, LLC removed 11,948 shares (-74.4%) from their portfolio in Q1 2025, for an estimated $34,410
NORTHERN TRUST CORP removed 8,795 shares (-27.7%) from their portfolio in Q1 2025, for an estimated $25,329
GEODE CAPITAL MANAGEMENT, LLC removed 2,768 shares (-6.0%) from their portfolio in Q1 2025, for an estimated $7,971
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. removed 1,464 shares (-9.9%) from their portfolio in Q1 2025, for an estimated $4,216
RENAISSANCE TECHNOLOGIES LLC removed 1,000 shares (-4.3%) from their portfolio in Q1 2025, for an estimated $2,880

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$FAT Analyst Ratings

Wall Street analysts have issued reports on $FAT in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Loop Capital issued a "Buy" rating on 05/12/2025

To track analyst ratings and price targets for $FAT, check out Quiver Quantitative's $FAT forecast page.

Full Release

LOS ANGELES, July 28, 2025 (GLOBE NEWSWIRE) -- FAT (Fresh. Authentic. Tasty.) Brands Inc. (NASDAQ: FAT) (“FAT Brands” or the “Company”), a leading global franchising company and parent company of iconic brands including Round Table Pizza, Fatburger, Johnny Rockets, Twin Peaks, Fazoli’s and 13 other restaurant concepts, today announced that the Company will host a conference call to review its second quarter 2025 financial results on Wednesday, July 30, 2025 at 4:30 PM ET. A press release with second quarter 2025 financial results will be issued prior to the conference call that day.

The conference call can be accessed live over the phone by dialing 1-877-704-4453 from the U.S. or 1-201-389-0920 internationally. A replay will be available after the call until Wednesday, August 20, 2025, and can be accessed by dialing 1-844-512-2921 from the U.S. or 1-412-317-6671 internationally. The passcode is 13754156. Hosting the call will be Andy Wiederhorn, Chairman, and Ken Kuick, Co-Chief Executive Officer and Chief Financial Officer.

The conference call will also be webcast live from the corporate website at www.fatbrands.com, under the “Investors” section. A replay of the webcast will be available through the corporate website shortly after the call has concluded.

About FAT (Fresh. Authentic. Tasty.) Brands

FAT Brands (NASDAQ: FAT) is a leading global franchising company that strategically acquires, markets, and develops fast casual, quick-service, casual dining, and polished casual dining concepts around the world. The Company currently owns 18 restaurant brands: Round Table Pizza, Fatburger, Marble Slab Creamery, Johnny Rockets, Fazoli’s, Twin Peaks, Great American Cookies, Smokey Bones, Hot Dog on a Stick, Buffalo’s Cafe & Express, Hurricane Grill & Wings, Pretzelmaker, Elevation Burger, Native Grill & Wings, Yalla Mediterranean and Ponderosa and Bonanza Steakhouses, and franchises and owns over 2,300 units worldwide. For more information on FAT Brands, please visit www.fatbrands.com .

Investor Relations:
ICR
Michelle Michalski
IR-FATBrands@icrinc.com

Media Relations:

Erin Mandzik
emandzik@fatbrands.com

###

Read Full Article